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Abstract 
Background: Cutaneous Leishmaniasis caused by the Leishmania mexicana complex is 
associated with unpleasant or disfiguring lesions, for which there only limited treatment 
options. The life cycle of L. mexicana consists of two stages which involve different immune 
evasion mechanisms: promastigote and amastigote. Understanding parasitic interactions with 
host cells and developing a protective vaccine could improve the management and treatment 
of the disease. 
 
Aims:  
 To construct and compare the immunogenicity of 3 Leishmania genes in 3 different 
plasmids  
 Study the effect of long term in vitro culture on the virulency of L. mexicana and its 
interaction with host cells  
 To analyse the influence of Leishmania infection on MHC class I expression by 
susceptible human cell lines (U937 macrophages, U937 and MonoMac-6 monocytes), and 
Toll-like receptor, cytokines and chemokines gene expression profiles  
 
Methodology: Three Leishmania genes (L. mexicana GP63, L. donovani centrin1 and            L. 
donovani centrin3) were cloned into three plasmids (pcRT7/CT-TOPO; VR1012; and 
pcDNA3.1/Hygro(-)). The immunogenicity of the prepared DNA constructs and their empty 
counterparts was assessed in Balb/c mice using gene gun immunisation method. An in vivo 
model of attenuated L. mexicana was produced by growing the parasite in vitro for up to 
passage 20, and testing the infectivity of these parasites in vivo and in vitro. The influence of 
infecting target cells with virulent and avirulent L. mexicana at different growth stages on 
MHC class I expression was determined by flow cytometry. Gene expression profiles were 
determined by qPCR analysis of extracted mRNA. 
 
Results: All tested Leishmania DNA constructs were highly immunogenic compared to the 
controls, as assessed using ELISPOT and cell proliferation assays. A novel survival assay 
developed in this study illustrated that macrophages derived from immunised mice were 
resistant to Leishmania infection.  The parasite at passage 1 was highly infectious (virulent), 
but this progressively decreased to be completely avirulent at passage 20. This was associated 
with a significant down regulation of virulence-associated genes (GP63, LPG2, CPC, CPB2, 
CPB2.8, CHT1, LACK and LDCEN3) at passage 20, and was also accompanied by 
morphological changes.  The avirulent parasite was unable to transform to the pathogenic 
amastigote stage in infected target cells. The gene expression profile of toll-like receptors 
(TLR-1, TLR-2, TLR-4, and TLR-9), cytokines (IL-1, IL-6, IL-10, IL-12β, TNF-α, and TGF-
β), and chemokines (CCL-1, CCL-2, CCL-3, CCL-4, CCL-5, and        CCL-22) in target cells 
was were induced and inhibited according to the virulence status of the parasite. Similar and 
significant down regulation of MHC class 1 was induced by infection of target cells for 24 
hours with both virulent and avirulent L. mexicana parasite, however after 48 hours of 
infection only cells infected with avirulent but not virulent parasite have significantly restored 
their MHC class I expression. 
 
Conclusions: Since no differences in the immunogenicity of the three plasmids encoding the 
same Leishmania gene were observed, immunogenicity is not dependent on the plasmid type. 
The failure of the avirulent L. mexicana parasite to infect Balb/c mice, and its inability to 
produce the pathogenic amastigote stage in vitro suggests that it might have potential as a 
vaccine candidate. This was also supported by the up regulation of Th2 mediators following 
the infection with virulent compared avirulent parasites. The level of MHC class I down 
regulation was dependent on parasite growth stage, virulency and infection dose.  
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1. General Introduction 
1.1  Leishmania and Leishmaniasis 
Leishmaniasis is a medical term used to describe complex symptoms that are caused by 
several types of an obligatory intracellular protozoan parasite belonging to the family 
Trypanosomatidae, genus Leishmania (Charmoy, 2010). Leishmaniasis is considered 
to be one of the two most important neglected endemic diseases (after Malaria) in 
tropical areas, (Bhowmick, et. al., 2008). According to the World Health Organization 
(WHO), Leishmaniasis is currently epidemic in about 88 countries, over 12 million 
people are infected, 350 million are at the risk of infection worldwide and most of them 
are children (Olivier, et al, 2005). Thus, Leishmania spp infection is becoming a big 
concern for public health in the developing, as well as developed countries. The main 
challenge of Leishmania parasite infection is that, in spite of all attempts, an effective 
vaccine to prevent the spread of Leishmaniasis does not exist to date. Furthermore, 
Visceral Leishmaniasis has been reported as an opportunistic infection in HIV-1 
patients across the globe (Mathur, et. al., 2006), as illustrated in (Figure 1.1.1).  
 
Figure 2.2-1 Visceral Leishmaniasis and HIV Distribution 
The map illustrates the number of  HIV individuals infected at different parts of the world 
 (Adapted from Visceral Leishmaniasis-HIV co-infection: emerging in South-America) 
(http://www.ectmihbarcelona2011.org/docs/Lindoso.pdf)  
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The disease is initiated by the bite of an infected female sand fly, which belong to Order 
of Diptera, Family of Psychodidae, subfamily Phlebotominae, and there are two genus 
belonging to this subfamily: 
I) The genus Phlebotomus (Old World sand flies spp), which is found in the 
Mediterranean, Southern Europe, Africa, the Middle East, Central Asia, and South 
Asia. 
II) The genus Lutzomyia (New World sand flies spp), which is found in the Americas. 
Interestingly, different species of sand fly females deliver different Leishmania species, 
as a consequence of which, different symptoms are developed (Ready, 2011). 
1.2  Leishmaniasis history and Leishmania parasite life 
cycle 
The history of Leishmaniasis is documented within two times, Old World Cutaneous 
Leishmaniasis and New World Cutaneous Leishmaniasis. The discovery of Old 
Cutaneous Leishmaniasis was reported in the first century anno domini (AD), whereas 
New Cutaneous Leishmaniasis was reported in the 16th century (Cox, 2002). 
Leishmaniasis was known as Kal-Zara in India, but the cause of this disease was 
unknown until the British scientist William Leishman developed the first Leishman's 
stain in 1901. Charles Donovan used this stain in 1903 to examine material from an 
infected patient.  He found that the macrophages were heavily loaded with small 
organisms, which was the first indicator of the parasite infection. Later Donovan named 
these organisms (amastigotes) L. donovani. Nicolle and Comple following the in vitro 
incubation of samples from infected patients produced the second stage of the parasite 
life cycle (promastigotes). Col. Shortt and others confirmed the role of sand flies in 
Leishmania transmission in 1942 (Ul Bari, 2006). It has been well documented that the 
Leishmania parasite life cycle consists of two different morphological forms: a non-
pathogenic form and pathogenic form, and these are found in different hosts:  an 
invertebrate vector and mammalian host, respectively (Killick, 1990; Inverso, et. al., 
1993). The non-pathogenic form is an extracellular stage, and found in the mid-gut of 
Phlebotomus sand flies. This stage is a cylinder shape 10–20 µm in length known as a 
promastigote and is characterized by high motility due to the presence of a flagellum 
(Figure 1.2.1.A). In contrast, the pathogenic form is a rounded cell, and of 3-7 µm in 
diameter, called the amastigote stage (Figure 1.2.1.B). This is found in macrophages of 
mammalian hosts such as humans, rodents and dogs (Ashford, 2000; Cox, 2002). 
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Infection of the mammalian host is initiated by the bite of an infected female sand fly, 
which delivers active metacyclic promastigotes into the host during blood feeding. 
Inside the mammalian host, the metacyclic promastigotes are taken up by various 
immune cells, usually antigen presenting cells such as macrophages and dendritic cells 
(DCs). Later, promastigotes are converted into the amastigote stage inside highly acidic 
compartments in host cells called parasitophorsis vacuoles (PV). Amastigotes grow and 
multiply by binary fission, which eventually leads to cells rupturing and releasing free 
amastigotes to infect new macrophages. Therefore, whenever the non-infected female 
of a sand fly feeds on the infected mammalian host, infected macrophages are taken up 
with the blood meal and amastigotes are released inside the digestive tract due to the 
action of digestive enzymes. Free amastigotes travel back to attach themselves to the 
epithelium of the host midgut. The parasites at this stage rapidly multiply by binary 
fission and grow to procyclic promastigotes (Rogers et al., 2002; Gossage, et. al., 2003). 
After approximately seven days of blood meal feeding, the late stage (procyclic 
promastigotes) becomes less attached to the mid gut epithelium due to chemical 
changes in their surface molecules. This allows them to travel towards the front of 
digestive system. At this point, the parasites are transformed to metacyclic 
promastigotes, which are regurgitated into the bite site.  This stage is categorised by a 
small cell body, long flagellum, free and rapid movement (Saraiva, et. al., 1995), 
(Figure 1.2.2). 
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Figure 2.2-1 Diagram illustrating the Leishmania promastigote (A) and amastigote (B)  
(Morphology and intracellular organelles, adapted from Besteiro, et. al., 2007) 
(Permission is not required for this type of reuse) 
 
 
Figure 2.2-2 Diagram illustrating the Leishmania spp life cycle in two hosts 
 (1) Sand fly can be infected, following a blood meal from an infected mammalian host. 
Amastigotes in the midgut of the newly infected sand fly transformed into procyclic (A) and 
metacyclic (B) promastigotes to be cycled into a new host. In the mammalian host, 
promastigotes attack APCs and transform inside them into the pathogenic amastigote stage. This 
grows and multiplies by binary fission leading to host cell rupture and infection of more APCs. 
(Note: Parasite pictures in this diagram obtained from the current work).  
1) General introduction 
 
5 
 
1.2.1 Leishmaniasis epidemiology 
Leishmaniasis is a disease, which mostly associates with tropical and subtropical areas, 
where the environmental conditions are supporting the presence of the disease 
transmission vector. Leishmaniasis as previously mentioned is endemic in many areas, 
however, the global epidemiology of Leishmaniasis has not been sufficiently reported 
and the data is based on estimates in particular in the poor countries where most of the 
new cases exist. 
For example, the recently published report by the WHO in 2013 has only shown the 
epidemiological map of Post-kala-azar dermal Leishmaniasis (PKDL), which is 
epidemic in East Africa, Sudan, South Sudan, Ethiopia, Bangladesh, India and Nepal 
(Figure 1.2.3). However, the report did not include statistics on other forms of 
Leishmaniasis. Other reports by WHO have stated that there were 638,702 cases of 
Cutaneous Leishmaniasis (CL) among Americans reported between 2001 and 2011, 
with an annual average of 58,063 new cases. In the same period, 38,808 cases of 
Visceral Leishmaniasis (VL), were also reported, with 96.6% of them in Brazil alone. 
 
Figure 2.2-3 Global distribution of post-kala-azar dermal Leishmaniasis 
(http://www.who.int/leishmaniasis/resources/en/) 
 
1.2.2 Leishmaniasis transmission 
One of the most important key players in the wide distribution of Leishmaniasis, is the 
spread of females Phlebotomus and Lutzomyia sand flies, in both Old and New worlds. 
These flies have been reported as vectors for the survival and development of the non-
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pathogenic form of Leishmania spp (promastigotes) and many viruses (Hendrick and 
Lancelot, 2010). In addition, they can transmit these organisms to the mammalian host 
during their blood meal. Recently, the problem of Leishmaniasis has increased, due to 
climate changes, which have affected the distribution of sand flies across the globe 
(González, et. al., 2010). Of the 500 known sand fly species spread throughout the 
warmer climes around the world, just 31 species have been identified as vectors for 
Leishmania species (Killick, 1990). Interestingly, some species of sand flies can only 
transmit one species of Leishmania parasite. For instance, P. Papatasi (Figure 1.2-4 A) 
can only transmit L. major, whereas P. Sergenti (Figure 1.2-4 B) is known as a 
permissive vector, since it can transmit more than one species simultaneously. Adults 
of female sand flies are highly similar to each other, with small size 2-3mm, hairy body 
and conspicuous black eyes. Females of sand flies take a blood meal at a certain stage 
during their life cycle to lay their eggs in dark and humid places, so becoming a vector. 
 
Figure 2.2-4 Different species of sand flies 
(www.raywilsonbirdphotography.co.uk/Galleries) 
 
  
1) General introduction 
 
7 
 
1.2.3 Leishmania parasite species 
Leishmania is an obligatory intracellular pathogen, the final host of these parasites is 
usually APCs such as macrophages and DCs in various mammalian hosts such as 
humans, rodents and dogs. Leishmania parasites belong to the Order Kinetoplastieda and 
Family Trypanosomatidae. This family was further sub-divided into sub families: 
Leishmania genus including species that complete their development in the anterior and 
midgut of the sand fly, and Viannia genus, which include the species that complete their 
development in the posterior gut of the vector (Lainson, et. al., 1987). Due to the direct 
relationship between the clinical outcome of human diseases and the species causing the 
infection, the typical classification of Leishmania spp was originally based on the clinical 
forms of the disease (section 1.2.4). However, advanced techniques such as Leishmania 
genome sequencing and polymerase chain reaction (PCR) application are now widely 
used in Leishmania spp classification (Saravia, et, al., 1985). 
1.2.4 Clinical forms of Leishmaniasis 
Depending on the state of the host immune system and its genetic background, the 
species of the Leishmania parasite and the place of final localization of the amastigote 
stage, the clinical symptoms of Leishmaniasis have been traditionally sub-divided into 
four main forms: Cutaneous Leishmaniasis (CL), Diffuse Cutaneous Leishmaniasis 
(DCL), Mucocutaneous Leishmaniasis (MCL) and Visceral Leishmaniasis (VL) (Etges, 
et. al., 1986). 
1.2.4.1 Cutaneous Leishmaniasis (CL) 
Cutaneous Leishmaniasis (CL) is the most common and represents 50–75% of all new 
cases of Leishmaniasis (Mathur et. al., 2006). The amastigotes of Leishmania parasite 
species are localized in the skin macrophages, consequently the CL was characterized 
by lesions in the skin at the site of the bite of an infected sand fly. People with CL 
develop lesions a few weeks after bitten by an infected sand fly. CL lesions usually heal 
spontaneously, leaving a depressed scar and long-lasting immunity (Minodier and 
Parola, 2007), although specific anti-Leishmania treatment is required form some 
lesion. CL is caused by several species of Leishmania such as L. amazonensis,                  
L. braziliensis, L. guyanensis, L. mexicana, L. panamensis, L. naiffi, L. venezuelensis, 
L. lainsoni, and L. shawi in the New World. CL in the Old World is caused by L. major, 
L. aethiopica, L. tropica L. arabica, and L. gerbilli (Dowlati, 1996; Murray, et. al., 
2005) (Figure 1.2-5.A). 
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1.2.4.2 Diffuse Cutaneous Leishmaniasis (DCL) 
Diffuse Cutaneous Leishmaniasis (DCL) is caused the infection with L. amazonensis 
in the New World and L. aethiopica in the Old World (Etges, et. al., 1986). DCL 
symptoms are characterised by many lesions at the site of a bite by an infected sand fly. 
It has been reported that DLC lesions cannot heal spontaneously (Weina, et. al., 2004) 
(Figure 1.2-5.B). 
1.2.4.3 Mucocutaneous Leishmaniasis (MCL) 
The intracellular amastigotes in Mucocutaneous Leishmaniasis (MCL), are localized 
in the muco cutaneous membrane macrophages of the nose, mouth, ears and neck 
causing serious tissue disfigurement. MCL symptoms are developed mainly due to 
infection by L. braziliensis and L. guyanensis (Neva and Brown, 1994; Cox, 2002) 
(Finger 1.2-5.C).   
1.2.4.4 Visceral Leishmaniasis (VL) 
This type is the most severe form of Leishmaniasis and almost 100% fatal if untreated, 
since the amastigotes are localized in the spleen, liver and bone marrow. Patients with 
Visceral Leishmaniasis (VL) gradually develop symptoms of a systematic disease, such 
as irregular bouts of fever, substantial weight loss, splenomegaly and hepatomegaly and 
anemia, which eventually leading to the abdomen swelling. VL is caused by 
Leishmania donovani complex such as L. donovani, L. infantum and L. chagasi 
(Chappuis, 2007) (Figure 1.2-5.D).  
 
Figure 2.2-5 A, B, C and D. Leishmaniasis clinical symptoms  
Based on the amastigote localization, clinical manifestations of Leishmaniasis can be divided 
into: A and B, Cutaneous Leishmaniasis and Diffused cutaneous Leishmaniasis (the 
amastigote survive in the skin macrophages). C, Mucocutaneous Leishmaniasis (the 
amastigotes survive in the muco cutaneous membrane macrophages.  D, Visceral 
Leishmaniasis (the amastigotes survive in the spleen and the liver macrophages). 
 (http://dna.kdna.ucla.edu/168-2011/leish_files/leish%202012.pdf) 
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1.3  Leishmania promastigote surface molecules 
Due to the challenges that the Leishmania parasite faces by being in two different hosts 
(invertebrate and mammalian, as promastigotes and amastigotes respectively), they 
develop a unique strategy to enable them both to survive in the sand-fly gut and subvert 
the mammalian host immunity. Many studies have reported that some proteins and 
surface molecules are over expressed during the infectious stage of the parasite 
(metacyclic promastigotes) compared to the non-infectious stage (procyclic 
promastigotes), and therefore they were considered virulent factors. In addition to their 
important role during the parasite life cycle, these proteins and molecules play an 
important role in parasite pathogenesis such as attachment, evasion and surviving inside 
APCs (Olivier, et. al., 2012). 
It is widely known that effective control of Leishmaniasis requires a good understanding 
of the parasite surface structure, which subsequently leads to identification of 
mechanisms used by the parasite to evade the immune system. Therefore, considerable 
attention has been paid to the structure and function of promastigote stage molecules, 
which can modulate and alter host cells mechanisms. Some of the well-known 
Leishmania spp surface molecules that are considered as virulence factors, and which 
have important roles in parasite pathogenicity, are discussed below. 
1.3.1  Leishmania parasite Lipophosphoglycan 
Lipophosphoglycan (LPG) is a main promastigote surface molecule that consists of a 
lipid backbone covered with disaccharide-phosphate components, linked to a glycan 
core (Turco and Descoteaux, 1992; Lodge and Descoteaux, 2005). The LPG molecules 
have multiple biological roles during the course of Leishmania parasite infection. For 
example, LPGs play a protective role in the promastigote against the induction of 
apoptosis by the complement system.  Spath, et. al., (2003) illustrated that LPG1-/-          
L. major were susceptible to lysis by human complement lysis and vulnerable to the 
effects of oxidant reactions. This was in contrast to the findings by Ilg, (2000) who 
reported that the growth and survival of LPG-/- L. mexicana promastigotes inside mouse 
macrophages was not affected. Another study reported the importance of LPG2 in           
L. major surviving in the sand-fly vector and mammalian hosts, as revealed by using 
LPG2-/- L. major promastigotes (Svarovska, et, al., 2010).   An early study by 
Descoteaux and Matlashewski (1989) reported that L. donovani LPG has the ability to 
modulate the intracellular pathways such as protein kinase C (PKC) activity in infected 
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macrophages. The role of LPG in PKC activity was further confirmed by Descoteaux 
and Turco (1999), how demonstrated that purified L. donovani LPG acts as protein 
inhibitors for PKC and blocks macrophage activation in response to LPS stimulation. 
Interestingly, the effect of LPG PKC activity in infected macrophage was cell type 
dependent. For example, L. mexicana LPG inhibited the PKC-α in macrophages 
derived from Balb/c mice, however, LPG purified from L. mexicana stimulated PKC 
activity in C57BL/6 macrophages (Delgado, et. al., 2010).  In addition, Leishmania 
promastigote LPG also contributes to immune evasion and differentiation into resistant 
amastigotes stage via inhibition of phagosome maturation. A study by Desjardins and 
Descoteaux, (1997) using LPG-/- and wild type L. donovani promastigote to infect host 
cells, reported extensive phagosome-lysosome fusing in macrophages infected with 
mutant compared to wild type promastigotes. This phenomenon was further confirmed 
by using L. major in parallel with L. donovani knockdown LPG (where the target gene 
was deleted). Both strains were rapidly killed and removed by the infected 
macrophages. However, treatment with purified LPG prolonged their resistance 
(Descoteaux, Turco, 1999).  Also, it has been shown that LPG interferes with nuclear 
translocation of NK-kβ (nuclear factor kappa-light-chain-enhancer of activated B cells) 
in monocytes which is facilitated by down regulation of IL-12 (interleukin-12) 
production (Argueta, et. al., 2008), and activates the Th2 (T helper type 2) immune 
responses by up regulating of IL-4 (interleukin-4) production by DCs (Liu, et. al., 
2009). 
Apart from its role as a virulence factor, LPG has an important role for the survival of 
the parasite inside the digestive system of the sand fly vector. The LPG structure of 
procyclic promastigotes (non-infective stage in mid-gut) is coated with more units of 
sucrose, which strengthens attachment of the parasite to the mid-gut. After being fully 
developed to metacyclic promastigotes (infective stage in the mid-gut), the structure of 
LPG is reformed with less units of sucrose in order to facilitate de-attachment of 
metacyclic promastigotes which travel to the front of the sand fly digestive system 
(Sacks, et. al., 1995). In addition, LPG shows a capability to protect some   Leishmania 
spp from sand fly digestive enzymes. For example, L. donovani strains deficient in LPG 
fail to finish their development in the vector (Sacks, et. al., 2000).  
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1.3.2 Leishmania cysteine proteases 
Cysteine proteases (CPs) belong to the Leishmania proteinases, which are considered 
as virulence factors due to their ability to hydrolyze peptide bonds in various protein 
structures, thereby causing considerable disruption of cell biology function (Silva, et. 
al., 2012). In addition to the promastigote stage, CPs are also found in the amastigote 
stage (Coombs, 1982), and contribute to parasite transmission (hydrolyze the 
haemoglobin proteins), immune evasion and inflammation response at the site of 
infection (Sajid and Mckerrow, 2000; Mckerrow, et. al., 2006).   
This group of enzymes was thoroughly investigated in L. mexicana in the early 1980s, 
and it was sub-divided into three main groups according to biochemical characteristics 
(Robertson and Coombs, 1994): 
 First group: type I cysteine protease such as CPB genes, which are also found 
in Trypanosoma spp (Mundodi, et. al., 2002). 
 Second group: type II cysteine proteases, the biological function of the second 
group is not fully understood (Rafati, et. al. 2001). 
 Third group: type III cysteine proteases such as CPC gene (Robertson and 
Coombs, 1994).  
Unlike other Leishmania spp, the biological function of CPs was well investigated in 
the L. mexicana complex (Mottram, et. al., 1997; Mottram, et. al., 2004), L. pifano 
(Bryson, et. al., 2009) and L. amazonensis (Lasakosvitsch, et. al., 2003). The biological 
function of CPs was illustrated by knocking (the target gene was removed) parasite CPs 
genes. For example, a study using L. mexicana CPA, CPB and CPC knockout showed 
that lesions in Balb/c mice infected with parasite knockout CPB were significantly 
smaller and less in number compared to the mice injected with parasites CPA or CPC 
genes knockout (Jardim, et. al., 1995; Alexander, et. al., 1998). Interestingly, the 
restoration of the CPB gene did not completely recover the parasite virulence, while 
restoration of multiple copies of CPs genes did so. These findings revealed that multiple 
copies of CPs genes are required for the function of these enzymes. The failure of L. 
mexicana promastigotes CPB knockout to produce full infection in inoculated Balb/c 
mice correlated with the failure of the parasite to mount a Th2 immune response, which 
is associated with IL-4 production (Denise, et. al., 2003).  
Immune responses to parasite infection generally depend on the mice strain. For 
example, infection in C57BL/6 resistant mice was associated with the down regulation 
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of T helper type 1 (Th1) related cytokines, while disease progression in Balb/c mice 
was associated with the generation of Th2 cytokines such as IL-4  (Buxbaum, et. al., 
2003).  
CPB can also inhibit target cell signalling pathways such as NF-κB, AP-1 and STAT1, 
leading to the inhibition of IL-12 production by infected macrophages (Cameron, et. 
al., 2004). This was confirmed when L. mexicana CPB knockout failed to inhibit        
NF-κB. In addition, CPBs of L. amazonensis were reported to prevent antigen 
presentation via MHC II on the surface of PVs (Courret, et. al., 2001), where the ability 
of L. amazonensis amastigotes to degrade MHC II on the PV surface of their host was 
demonstrated. Although the role of CPB in the virulence of the L. mexicana complex 
has been well characterised compared to the L. donovani complex, CPs activity in           
L. braziliensis (the main cause of CL in the New World) has not yet been well defined.  
Non-CPB cysteine proteinases such as CPC and CPA have also been found to 
contribute to the virulence of L. mexicana complex. For example, in vitro experiments 
illustrated that L. mexicana amastigote CPC knockout was able to infect macrophages 
similarly to wild type amastigotes, but that amastigotes were more susceptible to killing 
by infected macrophages (Mottram, et. al., 1997). Somanna, et. al., (2002), reported the 
ability CPC of L. chagasi (belonging to the L. donovani complex) to suppress the 
immune response by up regulating TGF-β expression in infected human cell lines. 
Although it has been reported above, the infectivity of L. mexicana promastigotes CPA 
knockout was as effective in Balb/c mice as wild type promastigotes (Alexander, et. al., 
1998). Nevertheless, the growth and infectivity of L. mexicana promastigote  in which 
both CPA and CPB genes had been knocked out was inhibited more compared to the 
growth and infectivity of parasites when only one gene was knocked out 
(Lasakosvitsch, et. al., 2003).  
1.3.3 Leishmania parasite metalloprotease GP63 
A considerable amount of attention has been paid to the zinc-dependent 
metalloprotease or glycoprotein gp63 (GP63) molecule as an important virulence factor 
in the past few decades (Olivier, et. al., 2012), due to its importance in the immune 
escape mechanisms used by Leishmania parasite. In addition to its expression in 
promastigotes, GP63 protein is also expressed in the amastigote stage across known 
Leishmania spp (Yao, et. al., 2003). This protein (GP63) has a range of activities that 
significantly increases the severity of parasite infection. The importance of GP63 as a 
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virulence factor can be seen in the first few hours of interaction between the 
promastigotes and host cells, through the inhibition of the complement mediated lysis 
through changing the active form of C3b into the iC3b inactive stage (Brittingham, et. 
al., 1995). Cleavage of C3b to iC3b by GP63 does not only fix and reduce the 
complement lytic activity, but also enhances promastigote entrance via C1 and C3 
complement receptors (Mosser and Edelson, 1985). McGwire, et. al., (2003) reported 
another biological role for promastigote GP63 by showing that an extracellular matrix 
of subcutaneous tissue could be degraded by L. mexicana promastigotes GP63. This 
favoured the rapid migration of the host cells to the site of infection, thus increasing 
the possibility of promastigote host cell-entrance.  
GP63 also has an important role in the differentiation and maintenance of the 
intercellular amastigote stage by targeting and modulating the host cell signalling 
mechanisms (Halle, et. al., 2009). For example, Leishmania GP63 can interfere with 
other biological signalling pathways, such as the myristoylated alanine-rich C kinase 
(MARCKS) pathway, which is an important PKC substrate in macrophage responses 
(Corradin, et. al., 1999). Furthermore, GP63 can modulate the protein tyrosine 
phosphatase SHP-1 activation that is required for the IAK2/STAT1-α pathway and 
IFN-γ-NO (interferon gamma-nitric oxide) production (Shio, et. al., 2012). It is worth 
mentioning here that GP63 protein is not only attached to the surface of promastigotes, 
but can be also found as a secreted form (Silverman, et. al., 2010), as many studies have 
reported the modulation and interference of secreted proteins with the infected host 
cells. The GP63 exosomes in L. mexicana can be released into the cytoplasm of infected 
cells under the effect of host temperature. These exosomes are able to block NO 
secretion (Hassaani, et. al., 2011). A similar finding has been reported for L. donovani 
exosomes, which induce IL-10 (Interleukin-10) and TFN-α (tumor necrosis factor) 
production, and inhibited IFN-γ secretion (Silverman, et. al., 2010).  
Although the biological role of GP63 in the promastigote stage has been extensively 
investigated, there are still debates about its biological role in the survival of the 
amastigote stage across Leishmania spp. Nevertheless, Chen, et. al., (2000) 
demonstrated that down regulation of GP63 in L. amazonensis promastigotes reduces 
their survival inside infected macrophages, which may indirectly illustrate the role of 
GP63 in maintaining of amastigote stage. An early study by Chaudhuri, et. al. (1989), 
reported that proteins coated with L. mexicana GP63 were protected from 
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phagolysosome degradation, thereby illustrating the protective role of GP63 to coated 
organisms. This was further supported by the work of Seay, et. al., (1996) who 
demonstrated that attenuated L. mexicana amazonensis has a low survival rate 
compared to virulent L. mexicana amazonensis correlated with a 20-30 fold down 
regulation of GP63.  
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1.4  Immunity to Leishmania parasite infection 
The innate and adaptive immune responses to infection vary according to the pathogen 
type, consequently some of these pathogens would be killed by just the innate immune 
response whereas others require activation of adaptive immune responses. However, 
some pathogens can avoid and/or escape immune defence lines and cause major health 
problems. 
Several studies have established that the immune response to Leishmania infection 
relies on different factors. Some of these factors are related to the mammalian host and 
its genetic background, other factors are related to the parasite species that cause the 
infection (Okwor and Uzonna, 2009; Birnbaum and Craft, 2011). In addition, species 
of the female sand fly genera Phlebotomine and Lutzomyia, which transmit the infection 
to the mammalian host, may contribute to the exacerbation of the Leishmania infection 
(Palatnik, 2008).  
Over evolutionary time, Leishmania parasite species, have developed unique 
mechanisms that favour their survival inside the host immune system. These parasites 
can successful evade and exploit immune defences by being intracellular antigens. 
Studies have illustrated that intracellular amastigotes were more resistant to immunity 
compared to the extracellular promastigote stage. After delivery to the host skin by 
either natural or experimental transmission, Leishmania parasites follow highly specific 
strategies  in order to establish their survival in the new host, as reflected by the extent 
of Leishmaniasis symptoms (Mendez, et. al., 2001; Chang and Mcgwire, 2002; Olivier, 
et. al., 2005). 
1.4.1 Innate immune response to Leishmania infection 
Though the innate immune is the first defence following antigen entrance, the 
mechanisms by which this system works are poorly understood in comparison to the 
adaptive immune response (Parham, 2009). In Leishmania infection, almost all of the 
known components of the innate immune response such as complement system, 
leukocytes (monocytes, macrophage, neutrophils, and DCs), and natural killer (NK) 
cells, contribute to the defence against this parasite. Interestingly, the Leishmania 
parasite can be selective of the target cells that may support their immune evasion. For 
instance, L. major promastigotes were found in skin fibroblasts, whereas other 
Leishmania spp are found in stromal cells (Bogdan, et. al., 2000).  This preference was 
first explained as stromal cells providing a safe environment for the parasite’s survival. 
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It was later reported that infection of particular cells by the Leishmania parasite is an 
immune evasion mechanism. Svensson, et. al., (2004), demonstrated that CCL-1 and 
CXCL-12 chemokines were up regulated in spleen stromal cells infected with L. 
donovani and that they recruited dermal DCs to the site of parasite infection, which 
inhibits the Th1 response. However, a comprehensive understanding of the interaction 
between the Leishmania parasite and various host cells is an extremely important for 
following the development of approaches for controlling Leishmaniasis. 
1.4.1.1 Toll-Like Receptor and Leishmania parasite infection 
Although the immune system sometimes fails to control the infection, nevertheless, 
innate immune components are still able to recognise and interact with the microbes, 
using different strategies. One of the well-established molecules used by the innate 
immune system to recognize foreign antigens, including Leishmania infection, is a 
group of proteins called Toll-Like Receptors (TLRs) (Tuno, et, al., 2008). The TLRs 
can recognize a wide range of biochemical markers on the pathogen’s surface called 
pathogen-associated molecular patterns (PAMPs). It is known that in humans there are 
10 toll-like receptor genes, each of which specific for a different set of pathogenic 
products (Parham, 2009). The interaction of TLRs with PAMPs leads to activation of 
related cells such as monocytes, macrophages, neutrophils, DC, and NK cells (Tuno, et, 
al., 2008). Receptor ligation also trigger the secretion of cytokines from these cells 
(Akira, et. al, 2001; Medzhitov, 2001; Dabbagh and Lewis, 2003).  
The role of TLRs in infection control of many pathogens has been extensively 
investigated (Medzhitov, 2001). Although TLRs are classified as molecules of the non-
specific immune response, different TLRs are usually activated by different antigens 
which related to different pathogens such as bacterial DNA, bacterial endotoxin (LPS), 
virus double stranded RNA (dsRNA) and species of single stranded RNA (ssRNA) 
(Dempsey, et. al., 2003). TLRs are located inside the cells (on lysosome membranes 
such as TLR-3, TLR-7, TLR-8 and TLR-9), and/or outside the cells (on the cytoplasm 
membrane such as TLR-1, TLR-2, TLR-4, TLR-5 and TLR-6) (Tuno, et, al., 2008). 
Both stages of Leishmania spp have the chance to interact with TLRs and modulate the 
initial immune response, which favours their survival inside the host cells. Although 
recognition of the antigens is initiated by the TLRs, the immune response is achieved 
via intracellular activation of NF-κB pathway through myeloid differentiation factor 88 
(MyD88). Briefly, recognition of extracellular antigens like LPS by TLR-4 leads to 
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intracellular binding of the TIR domain of TLR-4 with the TIR domain of MyD88 
protein, this complex is acting as a substrate to start a series of other intracellular 
reactions, which mostly rely on the phosphorylation of protein kinease C (PKC). This 
process is ended by the degradation of the IκB inhibitor which releases the NF-κB to 
travel to the nucleus and bind to the DNA to start gene transcription of inflammatory 
cytokine (Peter, 2009).  
The importance of TLRs and the MyD88 pathway towards Leishmania parasite control 
was first demonstrated in vitro by Hawn, et. al., (2002) using MyD88-/- macrophages. 
Their results showed a down regulation of IL-1 expression in macrophages infected 
with L. major compared to IL-1 expression in MyD88+/+ macrophages. Another study 
has illustrated that MyD88-/- C57B/6 mice were susceptible to L. major infection, 
compared to wild type C57BL/6 mice (Muraille, et. al., 2003).  
It has been found that the role of TLRs contribution to Leishmania parasite infection is 
different according to which TLR ligand is involved in recognition of the parasite 
antigen. For example, the role of TLR-4 in L. major control through NO production 
was investigated using knockout TLR-4 (TLR-4-/-) knockout C57BL/6 mice. The result 
showed that the infection control in wild type C57BL/c mice was achieved via 
enhancement of NO production in infected cells. In contrast, susceptibility of TLR-4-/- 
C57BL/6 mice to L. major infection was associated with decrease in NO production, 
and the infection was controlled after treatment of infected mice with IL-12 (Kropf, et. 
al., 2004; De veer, et. al., 2003). Furthermore, C57BL/6 macrophages that had been 
knocked out for the expression of the signalling lymphocyte activation molecule 
(SLAM), which has an important role in TLR-4 activation, were more susceptible to   
L. major infection compared to their wild type counterparts (Wang, et. al., 2004).  
Although TLR-4 contributes to infection control, TLR-2 was found to exacerbate the 
Leishmania parasite infection. Vargas, et. al., (2009) reported that TLR-2 was required 
for L. braziliensis infection and also that the lack of TLR-2 enhanced the maturation of 
DCs and resulted in a high production of IL-12. This was further confirmed using    
TLR-2 deficient C57BL/6 mice which were more resistant to L. amazonensis infection 
compared to the wild type C57BL/6 mice (Guerra, et. al., 2010).  
1.4.1.2 Chemokine and Leishmania parasite infection 
Infection control and pathogen clearance require a strong immune signal to enable the 
recruitment of immune cells to the site of infection. This process is mediated by a group 
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of small proteins (8-10 kilo Dalton) (Oghumu, et. al., 2010) called chemokines which 
behave as chemo-attractants to direct cell movement (Teixeira, et. al., 2006). Gordon 
(2002) has reported that there is a direct relationship between cytokines and chemokine 
secretion, in that cytokine production leads to the up regulation of chemokine gene 
expression or production. For example, the secretion of IFN-γ controls the production 
of CXCL-9 and CXCL-10 chemokines (Farber, 1997). The secretion of related Th2 
cytokines (IL-4 and IL-13) induces the production of CCL-22 and CCL-6 from infected 
macrophages, and this production can be inhibited by IFN-γ (Bonecchi, et. al., 1998; 
Orlofsky, et. al., 2000). 
Many studies have reported on the importance of the chemokines in Leishmania 
infection control via up regulation of the gene expression profile of chemokines related 
to Th1 immune responses (Ritter and Korner, 2002; Antoniazi et. al., 2004). Th1 related 
chemokines (CCL-2, CXCL-9 and CXCL-10) are highly produced in self-healed CL 
lesions induced by infection with L. mexicana. In contrast, a high production of Th2 
related chemokines such as CCL-3 has been found to be associated with DCL (Ritter 
and Korner, 2002). Arnoldi and Moll (1998) demonstrated the role of CCL-3 
chemokine (also known as macrophage inflammatory protein, (MIP) in murine CL for 
the  transport of  the Leishmania parasite from the infected skin to lymph nodes (LNs) 
by activated Langerhans cells. The role of CCL-2 as a Th1 chemokine was 
demonstrated via its capability to induce anti-Leishmania activity by increasing the 
respiratory burst in infected monocytes (Ritter and Moll, 2000). 
Due to the high immunogenicity of infected sand fly saliva (Sacks and Kamhawi, 2001) 
PMNs are the first cells to arrive at the site of infection. These cells secrete the CXCL-
8 chemokine (also known as IL-8) (Muller, et. al., 2001; Laufs, et. al., 2002), which 
attracts more cells to the infection site. Although the CXCL-9 and CXCL-10 
chemokines are involved in the control of Leishmania infection in CL, their detection 
at a high concentration in the serum of patients with VL (Hailu, et. al., 2004), may 
suggest a role for them in disease progression.  
1.4.1.3 Soluble immune responses to the Leishmania spp infection 
Nitric oxide (NO) activity is one of the well-known microbicidal mechanisms 
contributing to parasite clearance, and levels of this are controlled by the expression of 
inducible nitric oxide synthase (iNOS) in macrophages (Huang, et. al., 2011). The NO, 
which kills the parasite, is produced by the enzymatic oxidation of the guanidine group 
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of L-arginine, which is induced by Th1 immune responses via IFN-γ production 
(Tötemeyer, et. al., 2006). Th2 immune response-related cytokines (IL-4, IL-13 and IL-
10) inhibit the production of NO by producing the arginase enzyme, which competes 
with iNOS for the same substrate (Brittingham, et. al., 1990). The role of NO in parasite 
clearance was clearly demonstrated by infection of mice knocked out for iNOS         
(Wei, et. al., 1995). These mice showed an inability to control infection by NO 
production. Non-specific enzymes are secreted during an antigen phagocytosis process 
by active macrophages. Therefore, these enzymes are also having a major impact on 
killing foreign organisms including Leishmania parasites (Mink, et. al., 2009). 
Experimental modelling shows the need for physical interaction between the parasite 
and macrophages for NO production, since macrophages incubated with Leishmania 
parasite molecules (LPG and GIPL) show no effect on the production of NO, even after 
stimulation of target cells with IFN-γ or LPS, when compared to macrophages infected 
with whole parasites (Proudfoot, et. al., 1995; Proudfoot, et. al., 1996). It has been well 
established that NO has a unique function for parasite clearance. This role was 
illustrated by Diaz, et. al., (2003) who reported that NO levels in the sera of either 
susceptible Balb/c mice or resistant C57BL/6 mice infected with L. mexicana was 
different in both strains.  Their results clearly showed the decrease of NO in the serum 
of infected Balb/c mice was due to the lack of iNOS in susceptible Balb/c macrophages. 
1.4.1.4 Dendritic cells and Leishmania parasite infection 
Dendritic cells (DCs) are group of cells that circulate in the blood in their immature 
state or presented in the tissue such as lymph nodes, where they provide the opportunity 
for antigen recognition to occur via T-cell receptors (Bousso, 2008). These cells after 
being in contact with the antigens become mature and are considered as professional 
APCs. Typically, DCs are classified into three subsets according to their source and 
surface markers in humans:  
 Myeloid DCs (mDC1): this group is CD11c+, and they circulate in the blood. 
 Plasmocytoid DCs (pDC2): this group is CD11c- and is mostly found in the 
lymph organs. 
  Langherans’ cells (LCs): this group is CD205, CD11blow, MHC IIhigh and are 
found in the skin (Brandonisio, et. al., 2004; Soong, 2008). 
DCs are characterised by their movement due to blood circulation compared to other 
APCs such as macrophages. Thus, DCs have unique biological roles in the immune 
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response, where they take up foreign antigens from the site of infection and migrate to 
the lymph organs to present the degraded antigen to naïve T cells via the 
histocompatibility complex (MHC) peptide complex. Studies have reported that the 
responsiveness of DCs to Leishmania spp varies according to DC subtype. For example, 
in vitro infection with different Leishmania spp has shown that mDCs were more 
effective and able to engulf the promastigotes compared to LCs (Von, et. al., 2000). 
Interestingly, parasite infection has been shown to modify the expression of surface 
antigens by DCs, and also their secretion of cytokines and chemokines. Matured DCs 
are recognized by some criteria such as CD40, CD80, CD86, and CD54, as well as the 
high expression of toll-like and chemokine receptors (Brandonisio, et. al., 2004). 
Leishmania spp modulate the expression of matured DCs markers, which enable them 
to be safely transported around the body. For example, infection of Balb/c mice DCs 
with L. mexicana has down regulated the express of CD40, CD80, and CD205 DCs 
markers (Astial, 2011). One of the most important proinflammatory cytokines in 
parasite clearance is interleuken-12 (IL-12), and the main source for this cytokine 
following the initial interaction with the promastigotes is DCs (Konecny, et. al., 1999). 
It has been reported that infection with different Leishmania spp have various effects 
on the secretion of IL-12 from DCs. For example, in vitro infection of murine mDCs 
with L. mexicana promastigotes has blocked IL-12 production and DCs maturation 
(Bennett, et. al., 2001). However, infection of murine pDCs with L. major 
promastigotes caused IL-12 production (Henri, et. al., 2002). IL-12 secretion from 
human mDCs was inhibited following infection with L. donovani and L. tropica, but 
not by L. major promastigotes (McDowell, et. al., 2002).  
Infection with some Leishmania spp can arrest the migration of the DCs. For example, 
Jebbari, et. al., (2002), illustrated that LPG from L. major promastigotes has a negative 
effect on the migration of pDCs and LCs from the site of infection to the lymph organs. 
Other species such as L. amazonensis can delay the maturation of mDCs (Prina, et. al., 
2004), thus they will have enough time to produce the amastigote stage inside infected 
cells.  
1.4.1.5 Natural killer and Leishmania parasite infection 
Natural killer (NK) cells are generated in the bone marrow from the lymphoid progenitor 
cell lineage that gives rise to B and T cells. NK cells are released into the blood, and 
placed finally in different tissues including the circulatory system, where they comprise 
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5-15% of total lymphocytes. NK cells are characterized by their larger size and granular 
cytoplasm when compared with other lymphocytes. These cells have unique cell surface 
molecules, which enable them effectively to carry out their biological role.  NK cells are 
recognized by their expression of  CD16, CD56, killer activation receptors (KARs), 
killer inhibition receptors (KIRs), FcγRIII which mediate the antibody-dependent 
cellular cytotoxicity (ADCC) and TLRs which take part in cytokines and cytotoxicity 
production (Tosi, 2005). In addition, they do not have the natural killer T cells (NKT) 
markers, which are CD3 and TLR. 
The biological role of NK cells is to destroy pathogenic infected cells including some 
tumour cells. Infected or abnormal cells would be recognized by NK cells through their 
surface KAR molecules, which induce NK-cell killing. However, normal cells are 
protected from NK killing mechanisms by their surface KIRs molecules, which inhibit 
and induce a negative signal to NK cell killing mechanisms, these receptors can 
recognize self MHC I-peptide. Therefore, some pathogens such as viruses and parasites 
down regulate the expression of MHC molecules in infected cells so infected cells would 
be less recognized by cytotoxic T cells, but will make them more susceptible to NK 
killing. The mechanism of NK killing is performed by the release of perforins and 
granzymes onto the surface of infected cells. Perforins increase the permeability infected 
cells, and allows the internalisation of proteolytic enzyme (granzymes) thereby leading 
eventually to cell apoptosis. Unlike virus infections, NK cells do not have a direct role 
in parasite infection control, however, they can induce Leishmania cells death by 
infected macrophages through their secreted cytokines such as IFN-γ, and IL-12, which 
promote a Th1 immune response (Prajeeth, et. al., 2011). 
1.4.1.6 The interaction between Leishmania spp and macrophages 
Metacyclic promastigotes are directly injected into the host by infected females of sand 
flies, and the establishment of intracellular amastigotes is the main challenge facing the 
first entrance of promastigotes to the host. As soon as the metacyclic promastigotes 
enter the host, they would be taken up by APCs. Although in vitro studies have shown 
that macrophages are usually the most important APCs during Leishmania infection, 
other studies have reported that neutrophils quickly engulf the metacyclic 
promastigotes, and that these survive inside their phagosomes (Kaye and Scott, 2011).  
Infected neutrophils would be triggered into self-death by apoptosis, and targeted by 
macrophage engulfment, where they become target antigens for the macrophages. 
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These antigens in turn enter the macrophages in a silent phase, leading to the successful 
amastigote transformation (Ravichandran and Lorenz, 2007). Use of two-photo 
intravital imaging has given a clear picture of the role of neutrophils following needle 
inoculation or sand fly transmission of L. major to mice model (Peters, et. al., 2008). 
Neutrophils have a similar role following infection with L. infantum. However, the 
depletion of neutrophils at the site of L. braziliensis infection increased mice 
susceptibility (Novais, et. al., 2009; Thalhofer, et. al., 2011). 
 Macrophages are effectively capable of engulfing metacyclic promastigotes injected 
by infected sand fly or needle inoculation into their phagosomes. Different Leishmania 
spp have developed different mechanisms to either activate opsonisation-independent 
phagocytosis (which results a safe host cell entrance), or inhibit the opsonisation-
dependent phagocytosis (caused by the complement system or the immunoglobulin 
proteins) (Horta, et. al., 2012).  
An engulfed parasite is finally arrested inside macrophage organelles called 
parasitophorous vacuole (PVs), in which the metacyclic promastigotes can complete 
their differentiation into the amastigote stage. PVs are well known to be a safe 
environment for parasite growth and multiplication away from host immune responses, 
as the biology and function of macrophages is highly affected after Leishmania 
infection. Moreover, studies have reported that PVs usually have a highly acidic 
condition and also have various lysosome enzymes including proteases (Candolfi, et. 
al., 1994). In addition, PV organelles have been found to contain major 
histocompatibility complex (MHC) class II molecules but not MHC class I molecules, 
after their maturation with IFN-γ (Candolfi, et. al., 1994; Charmoy, 2010). 
One of the major effects of the phagocytosis of Leishmania by macrophages is the 
modulation of several mechanisms and signalling pathways of infected macrophages. 
For example, Leishmania parasites can partly subvert the immune response and thus 
support survival inside the host by modulation of macrophage cytokines production 
(Kane and Mosser, 2000; Cunningham, 2002). Although IL-12 is one of the most 
important cytokines following the infection of macrophages, IL-12 production is 
subsequently followed by activation of the Th1 response and production of IFN-γ 
(Piedrafita, et. al, 1999; Teixeira, et. al, 2006). Many studies have reported the down 
regulation of IL-12 following Leishmania infection (Cunningham, 2002; Kane and 
Mosser, 2000). Moreover, infection with Leishmania parasites up regulates the 
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secretion of anti-inflammatory (IL-10 as well as IL-4) and inhibits the production of 
pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α and IL-1 (Belkaid, 
et. al., 2001; Cunningham, 2002). 
In addition to their essential role in the innate immune response, macrophages are 
important in the adaptive immune response via activation of cell-mediated immune 
responses. Thus, macrophages are not only the host for the promastigotes, but are also 
effective cells that may kill engulfed promastigotes. Therefore, the occurrence of 
Leishmania infection depends on the balance between the ability of macrophages to kill 
and the parasite capable to suppress and evade the immune response. 
Early studies on gene expression profiling of non-infected and L. donovani infected 
Balb/c mice macrophages illustrated that only 40% of several hundred tested genes by 
microarrays were down regulated after infection of macrophages for 4 days            
(Chang, et. al., 2003). Since Leishmaniasis is caused by infection with different 
Leishmania spp, the mechanisms used by these parasites to escape immune host defence 
may also vary. When Gregory, et. al., 2008 applied the microarray technique to assess 
the gene expression profiles of bone marrow-derived macrophages using L. donovani 
and L. major infection, they found no significant difference between these two species 
on the macrophage gene expression profile, even though they caused different clinical 
diseases symptoms.   
Since the macrophages normally express MHC class I and MHC class II molecules, 
they are capable of presenting motifs from degraded foreign antigens on their surface 
to be seen and recognized by other immune cells, in particular naive T cells (Parham, 
2009). However, the biggest challenge in immunity to Leishmaniasis is that the 
Leishmania parasite can be latent for years inside host macrophage. 
1.4.1.7 Inhibition of phagosome maturation in Leishmania parasite 
infection 
As mentioned above, the PVs are a permissive compartment for amastigote 
transformation and proliferation inside host cells including neutrophils, macrophages, 
DCs and fibroblasts (Bogdan, et. al., 2000). It has been demonstrated that PVs have the 
properties of endosomes-phagosome, including the expression of specific membrane 
markers (Morehead, et. al., 2002). In addition, as PVs have different sizes and they vary 
in their morphology, they can hold different amastigote numbers according to the 
Leishmania species and host cell type. For example, species like L. amazonensis and L. 
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mexicana survive in big PVs, which contain many amastigotes compared to L. major 
and L. donovani, which produce small PVs with a single amastigote (Wilson, et. al., 
2008). In extracellular infections, macrophages engulf the antigens inside their 
phagosome which later fuses with host cell lysosomes leading to complete degradation 
of the foreign engulfed antigen or microbes and their expression on MHC molecules. 
The process of phagosome-lysosome fusion is referred to as phagosome maturation 
(Scharton and Scott, 1993). Leishmania species have a unique ability to delay and 
modulate the phagosome-lysosome, thus they would be prevented from being presented 
to adaptive immunity. Phagosome maturation delay after Leishmania spp infection was 
first reported by Desjardins and Descoteaux (1997) following infection of macrophages 
with L. donovani due to the presence of LPG molecules. Infection of transgenic mice 
Rab5 positive bone marrow derived macrophages with L. mexicana promastigotes has 
led to a similar observation (Lippuner, et. al., 2009). In this study, real time imaging 
was used to follow up Rab5 (key factor in phagosome maturation belonging to several 
groups of Rab GTPase), and the results showed that Rab5 was detectable for short time 
(two minutes) in the parasite phagosomes, compared to its expression in phagosomes 
of macrophages treated with latex beads.  
The acidic condition inside the phagosomes is essential for the pathogen’s degradation, 
and the Leishmania parasite could inhibit acidic condition formation. Vinet, et. al., 
(2009) have demonstrated that L. donovani LPG could interfere with the lipid 
microdomains of the phagosome membrane which contain gangliosid GMI, which 
consequently leads to the inhibition of phagosome acidification. Moreover, the 
Leishmania parasite could arrest phagosome maturation at different stages according to 
the type of infected cells. For example, in bone marrow DCs, the phagosome parasite 
compartments have been shown to be arrested at the late endosome stage, which might 
allow the parasite to travel to systemic tissue. In contrast, the phagosome parasite 
compartment in matured bone marrow DCs requires some lysosome fusion (Kaye and 
Scott, 2011). 
Another interesting reported observation related to Leishmania parasite infection is that 
some species could enlarge the size of the phagosome parasite compartment, and this 
might support intracellular survival by diluting the acidification effect (Sacks and Sher, 
2002). A lysosomal trafficking regulator (LYST) gene regulates lysosome size in cells 
(Kaye and Scott, 2011). It has been demonstrated that the LYST gene was induced 
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following infection of mice macrophages and fibroblasts with L. amazonensis 
amastigotes, and this resulted in big PVs, which increase their survival and proliferation 
(Wilson, et. al., 2008).  
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1.4.1.8 Modulation of host cell signalling in Leishmania parasite 
infection 
As the Leishmania parasite has two different stages during its life cycle which take 
place in different (invertebrate and vertebrate) hosts, this may give the parasite 
additional immune evasion mechanisms. An early and rapid modification of host cell 
signalling pathways by the parasite is required firstly for safe internalization, and 
secondly for surviving and proliferating inside the host cell. 
 Modulation of PKC protein via Leishmania parasite infection 
Cell biology and signalling pathways are organized by protein phosphorylation, which 
is controlled by protein phosphatases and protein kinases (Hunter, et. al., 1995; Seger, 
et al., 1995). The protein kinases C (PKC) family have an important role in macrophage 
function by regulating the secretions of cytokines such as IFN-γ and TNF-α, both of 
which are mediators for NO production and the oxidative burst (Shio, et. al., 2012). 
Leishmania parasites could therefore subvert various cell signalling pathways via 
activation of the molecules that play a negative role in cell signalling pathways, or 
inhibit the molecules, which have a positive function in cell signalling pathways, 
thereby favouring their survival and disease progression (Shio, et. al., 2012). It has been 
reported that the ability of Leishmania parasites to modulate the PKC activity was 
related to the presence LPG molecules, which could occupy the binding site of PKC 
active domain (McNeely and Turco 1987; McNeely, et. al., 1989, Descoteaux, et. al., 
1992; Descoteaux and Turco, 1999).  
Myristoylated alanine-rich C-kinase substrate (MARCKS), one of the important PKC 
substrates binds to plasma membrane and has many functional roles in different cell 
types, including macrophages (Olivier, et. al., 2012). It has been reported that 
MARCKS is up regulated following macrophage treatment with LPS, and this is 
facilitated by cytokine secretion (Corradin, et. al., 1999). The same group showed that 
MARCKS activation was inhibited in macrophages infected with L. major. Moreover, 
the role of GP63 in this process has also been  illustrated using GP63 inhibitors. 
Another mechanism which contributes to intracellular parasite clearance and the 
controlled by PKC activity is the generation of Reactive Oxygen Intermediates (ROI) 
(Murray, 1982). The unique role of ROI in parasite control was demonstrated by using 
ROI-deficient mice, which showed susceptibility to L. donovani infection.  However, 
these mice eventually controlled the infection (Murray and Nathan, 1999).               
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Olivier, et. al., (2005), have reported that the production of ROI from human monocytes 
is altered after infection with L. donovani promastigotes as result of PKC activation. 
 It is noteworthy that the subversion of PKC may be Leishmania spp dependent, since 
Corradin, et. al., (1999) have reported the responsibility of GP63 protein in L. major 
infection with respect to this process, whilst Shadab and Ali, (2011) have described the 
importance of LPG protein in L. donovani infection. In addition, Olivier, et. al., (2005) 
reported that LPG from L. donovani amastigotes was also able to modulate PKC 
activity. These findings suggest other mechanisms via which promastigotes and 
amastigote-derived molecules can modulate signalling pathways in infected cell. The 
consequences of PKC modulation following the parasite infection are summarized in 
the following diagram (Figure 1.4.1).   
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Figure 2.2-1 Diagram illustrating the modulation of host cell signalling  
Following the infection, membrane or secreted form Leishmania parasite GP63 can block and 
inhibit an important PKC substrate MARCKS (A), this subsequently induces high destruction 
of host cell functions, and also the de-activation of mTOR protein kinase, an important 
translation to initiate IFN-γ response, and arrests the NF-κB in the cytoplasm. In contrast, 
MARCKS is strongly up regulated after stimulation of macrophages with LPS (B), and this 
leads to a type 1 immune response (Modified from Olivier, et. al., 2012) 
 
 JAK2/STAT1- and IFN-γ-mediated signalling 
One of the most important discoveries in cell biology with regard to activation of IFN-
transcription is the JAK2/STAT1 pathway. A group of factors belonging to Janus 
kinase, also known as Just Another Kinase (JAK), can activate this family. In addition 
to their reported role in cell proliferation, migration, differentiation and apoptosis, JAK 
signalling pathways have a significant role in the immune response. Moreover, JAK 
protein pathways are triggered as a response to cytokines or growth factors binding to 
the host cells (Woldman, et. al., 2001). The STAT family, including STAT1, is located 
in the cell cytoplasm as the inactive form. The extracellular binding of cytokines 
generates the activation of membrane-bound JAK which subsequently phosphorylates 
STAT1. This leads to migration of STAT to the nucleus, its binding to specific DNA 
sequences, and leads to the transcription of specific genes (Olivier, et. al., 2005). 
The presence of the virulence molecules that coat the surface of Leishmania 
promastigote surface such as GP63, LPG2, CPB (Shio, et. al., 2012), can 
dephosphorylate the JAK2/STAT1 signalling pathway, and this directly alters the 
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modulation of such IFN-γ, IL-12, iNOS (inducible nitric oxide) and NO (Nitric oxide) 
in APCs infected with the parasites (Shadab and Ali, 2011).  
The importance of STAT1 with regard to parasite clearance was demonstrated by 
Harnett, et. al., (1999) who showed that STAT1-/- mice developed severe lesions 
following infection with L. major promastigotes. However, infected STAT1-/- mice 
infected with L. donovani exhibited fewer pathological effects compared to control 
mice (Anstead, et. al., 2001).  
Many studies have reported that the Leishmania parasite can modulate the mitogen 
activated protein kinase (MAPKs), a key signalling pathway which mediates responses 
to extracellular stimuli and regulates APCs function such as the generation  of NO and 
the secretion of proinflammatory cytokines (Seger and Krebs, 1995; Liu and Uzonna, 
2012). The effect of Leishmania parasites on MAKPs was evaluated on the basis of 
PTP (Protein tyrosine phosphatases) which was found to be activated as a consequence 
of Leishmania infection (Forget, et. al., 2006). 
Attachment of the Leishmania parasite to macrophages can cause super activation of a 
specific family of proteins called PTP (protein tyrosine phosphatases) such as SHP-1, 
PTPIB and TCPTP, which in turn inhibit and interfere with the JAK kinase family 
(Shapira and Pinelli, 2006; Silverman, et. al., 2008). Gomez, et. al., (2009), have shown 
the role of GP63 in activation of PTPs family using wild type L. major and GP63 
knockout  L. major. This was further investigated by Hassani, et. al., (2011) who 
reported that activation of PTPs family was due to the secretion of GP63 and CPB by 
macrophages infected with L. mexicana. 
A study by Abu-Dayyeh, et. al., (2010), has revealed the effects in life cycle phases of 
L. mexicana on the activation of PTPs. This group showed that both stages of                     
L. mexicana (promastigotes, amastigotes) were able to activate the STH-1 subunit, 
whereas the PTP1B subunit was activated in macrophages infected with promastigotes, 
but not with amastigotes. In addition, L. mexicana knockout CPB (Lmcpb-/-) failed to 
activate PTP1B compared to wild type promastigotes, and this may indicate the role of 
CPB in the activation of PTPs in L. mexicana infection. Activation of PTPs during 
Leishmania infection also has an indirect effect on down regulating the production of 
IFN-γ. Abu-Dayyeh, et. al., (2008), have reported that SHP-1 can bind and block the 
IRAK-1, an important kinase substrate for TLRs signalling. This binding subverts the 
macrophage innate immune response, which is triggered by production of TNF-α, IL-
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12 and NO. Activation of PTPs following the parasite infection is summarized in 
(Figure 1.4-2). Nevertheless, Leishmania species can selectively trigger the production 
of some pro-inflammatory and inflammatory cytokines, chemokines at different time 
points during infection, which attract more host cells to the site of infection. 
 
Figure 2.2-2 Diagram illustrating the activation of PTPs following the infection  
PTP proteins (SHP-1, PTP1B and TCPTP), are usually up regulated following Leishmania 
parasite infection. Super activation of this family has a negative effect on JAK2/STAT1 cell 
signalling pathway.  The SHP-1 can react with JAK2 kinase and prevent STAT1 
phosphorylation and its translocation to the nucleus, this suppresses NO production. PTPs 
family can also interfere with the activation of TLRs via effects on their substrate family, which 
belongs to PKC such as IRAK1, IRAK2 and IRAK3 (Modified from Olivier, et. al., 2012). 
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1.4.2 Adaptive immune response to Leishmania parasite infection 
The failure of an innate immune response to Leishmania parasite infection may enable 
parasite entry into a wide range of immune cells. This can also lead to a correct 
signalling for the initiation of the adaptive immune response. Generally, a strong 
immune response leads to the activation and proliferation of required T cells which can 
stop the infection and end with memory immunity for future infections. The 
mechanisms of adaptive immune response are modulated in Leishmania infection.  
Infectious diseases that are caused by parasitic infection such as Leishmaniasis are 
characterised by the lack of adequate T cell response. However, studies using different 
strains of mice that are susceptible (Balb/c) and resistant (C57LB/6) to disease have 
identified the roles of the adaptive immunity in Leishmania spp infection. 
T lymphocytes (T cells) only recognize the antigens presented on the surface of APCs 
via MHC class I or MHC class II molecules. The two subsets of the T cells population: 
cytotoxic T cells, which identified by expression of CD8, and helper T cells, which 
express CD4 molecules, activated according to the type of MHC molecules, located on 
the surface of the APC. If the antigens were loaded into MHC class I molecules, CD8 
would be activated to kill the infected cells, while, CD4 cells would be activated as 
consequence of antigen presentation via MHC class II molecules. These cells 
subdivided into two functional groups: Th1 and Th2 T cells. In spite of its failure to 
control the Leishmania parasite infection, innate immunity has a pivotal role in 
activation of the most effective anti-parasite (intracellular) immune response. The three 
main steps required to increase the number of specific T cells are: antigen processing 
and presentation, co-stimulatory molecules and production of the related cytokines 
(Kaye and Scott, 2011), and they all start in innate immune compartments.  It has been 
reported that all T cell sub populations take part in Leishmania parasite infection, and 
the role of each subset varies according to the type APCs involved and the Leishmania 
spp, which in turn subvert them toward their advantage.   
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1.4.2.1 Cytotoxic T cells and Leishmania parasite infection 
Generally, the response of CD4+ Th1 cells has the major role in Leishmania infection 
by controlling the secretion of IFN-γ. This leads to activation of other macrophages and 
induces DC maturation as well as the activation of CD8+ cells (Kaye and Scott, 2011). 
Although the role of CD8+ cells in immunity to intracellular parasites such as 
Toxoplasma gondii and T. cruzi, and bacterial infections such as Microbacterium 
tuberculosis has been described, the role of CD8+ cells in Leishmania infection is still 
not clearly identified. In addition, the published data are still controversial and there is 
confusion in many cases. Some of the results illustrate that the role of CD8+ cells in 
parasite killing is species-dependant. For example, the role of CD8+ T cells in VL 
control has been demonstrated in an early study by (Stern, et. al., 1988). In contrast, 
other studies have shown that the CD8+ response is not important in the control of some 
Leishmania species causing CL, such as L. major (Muller, et. al., 1993). Another study 
has reported that these cells were required to control disease progression when resistant 
C57BL/6 mice were infected with a low dose of the L. major parasite (Belkaid, et. al., 
2002). Results of Faria, et. al., (2009) demonstrated that CD8+ T cells are associated 
with lesion progression in patients with CL caused by L. braziliensis infection. This 
later finding was not in agreement with the findings of Belkaid, et. al., (2002) who 
reported that CD8-/- C57BL/6 mice failed to control the L. major infection.  
Recently, more attention has been paid to CD4 cell immune responses and the 
paradoxical role of the Th1 and Th2 paradigm following exposure to Leishmania spp. 
This might be a promising line of investigation for better undersigning and protective 
immunity to Leishmaniasis, as well as for the development of effective vaccine 
candidates. 
1.4.2.2 Helper T cells and Leishmania parasite infection 
Differentiation of Th1 and Th2 immune responses is mostly related to the type of 
cytokines and its concentration in the plasma after infection (Maggi, et, al., 1992). If 
Th0 cells are stimulated by IFN-γ and IL-12, then they differentiate into Th1, whereas 
stimulation with IL-4 and IL-10 leads to Th2 differentiation (Powrie, et. al., 1993). 
 Th1 response 
Many studies have reported that resistance to Leishmania parasite infection is related 
to the induction of Th1 immune responses. In human Leishmaniasis, there is a 
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significant association between the type 1 immune response and resistance to cutaneous 
Leishmaniasis, and this associated with a high production of IFN-γ (Romao, et. al., 
2009). On the other hand, mucosal lesions and chronic CL are characterised by a 
mixture of Th1 and Th2 cytokines (Mendez, et. al., 2001). Animal models such as 
susceptible and resistant mice strains have had a great impact on current knowledge and 
understanding of the balance between Th1 and Th2 paradigms after Leishmania parasite 
infection. In susceptible Balb/c mice and resistant C57BL/6 infected with L. major 
promastigotes, the IL-4 driven Th2 response is associated with disease progression in 
Balb/c mice, whereas IL-12 driven Th1 responses are associated with parasite 
resistance in C57BL/6 mice. However, the variation between Th1 and Th2 responses 
across infections with different Leishmania spp remained unclear.  
The role of Th1 or Th2 immune response has also been investigated using IL-12-/- 
C57BL/6 mice.  These mice are unable to control the parasite infection, which was 
associated with low levels of IFN-γ mRNA expression and high levels of IL-4 mRNA 
expression (Hondowicz, et. al., 1997). Additional experiments have shown that 
treatment of resistant C57BL/6 mice with neutralizing anti-IL-12 antibodies during the 
course of Leishmania infection results in disease progression. Many studies have 
reported the role of IL-10 in the progression of Leishmania parasite infection (Belkaid, 
et. al., 2001), have illustrated that depletion of IL-10 in mice infected with L. major 
promastigotes controls parasite infection. Recent studies using enzyme-linked 
immunosorbent assay (ELISA) to study cytokine profiles in the sera of patients infected 
with Leishmaniasis have found that levels of  TNF-α, IL-12, IL-4, and IL-10 are 
increased in patients with active lesions, thereby suggesting a role of these cytokines in 
Leishmania infection (Rodriguez, et. al., 2007).  
Other studies have demonstrated that activation of the two subsets of Th helper 
lymphocytes by the administration of adjuvant mixed with GP63 isolated from                     
L donovani promastigotes results in the prevention of VL symptoms in susceptible 
Balb/c mice (Nathan, et. al., 1983; Bhowmick et. al., 2008). Therefore, the correlation 
between Th1 response and Leishmania parasite infection control seems to be species-
dependent. 
 Th2 response 
The failure of an early and adequate Th1 immune response after Leishmania infection 
is responsible for Leishmaniasis development. A considerable number of studies have 
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shown that progressive lesions are associated with a high Th2 immune response 
(Bourreau, et. al., 2003; Murray, et. al., 2005). 
For example, susceptible Balb/c mice infected with L. major and treated with anti-IL-4 
monoclonal antibodies can successfully overcome their infection (Chtelain, et. al., 
1992). Other studies have shown that the high levels of IL-4 cytokine after Leishmania 
parasite infection is related to the high number of CD4+ T cells. These cells were 
characterized by the expression of Vβ4/Vα8 T cell receptors which successfully bind 
to the Leishmania antigen LACK (Leishmania homologue of receptor for activated C 
kinase) (Launois, 1995; Melby, et. al., 2001). Donnelly, et. al., (2005) reported the role 
of LACK antigens in the stimulation of Th2 immune responses and their role in 
developing progressive lesions in susceptible Balb/c mice has been fully verified. 
Results have also shown that infected Balb/c mice with LACK knockout L. major failed 
to activate targeted transgenic T cells with Vβ4/Vα8 receptor. However, the LACK 
antigen itself is highly immunogenic and had been widely considered as a vaccine 
candidate for Leishmaniasis. Melby, et. al., (2001) investigated the capacity of LACK 
to influence the development of Leishmaniasis, and showed that immunised Balb/c 
mice that had been immunised with recombinant LACK antigen were protected from  
L. major infection. The protection was a consequence of the shifting of the immune 
response from Th2-IL-4 towards Th1-IFN-γ dependent. In contrast, in the case of 
challenging with L. donovani, LACK vaccine did not protect against VL, even though 
the immune response was the same as in the case of infection with L. major. However, 
these findings emphasis the variation of immune response to different species of 
Leishmania parasite. Therefore, an effective immune response to Leishmania parasite 
infection is dependent on the activation of both innate and adaptive immunity, as shown 
in (Figure 1.4-3). 
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Figure 2.2-3 Interactions between Leishmania parasite and host immune cells 
The graph shows there is no distinguish line between the innate adaptive and immune 
response, since the parasite can either interact with various cell types and modulate their 
cytokines production. For example, Leishmania promastigotes (1) transform into the 
amastigote stage inside infected cells (2), and they can fix complement C3b subunit 
into iC3b (3), which prevents them from opsonisation compared to the LPS (4). 
Promastigotes can also use neutrophils for safe entrance into macrophages (5). They 
are able to activate the migration of DCs to the site of the infection and down regulate 
their cytokines towards a Th1 immune response, which allows them to travel away to 
the systematic tissues (6). Most importantly they can inhibit iNOS which negatively 
downstream NO secretion (7). NK cells also will be activated following Leishmania 
infection, and secrete IFN-γ (8). Activation of adaptive immune through Th1 (9) or Th2 
(10) Leeds to parasite clearance or disease progression respectively. 
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1.5  Leishmania vaccines 
Despite all the comprehensive attempts to date, a good vaccine model has not been 
developed. Currently, treatment for Leishmaniasis is chemotherapy dependent, such as 
Amphotericin B and Pentamidine, which are compromised by unpleasant side effects 
and the high cost. Therefore, working towards vaccination may be more appropriate in 
comparison to chemotherapy treatment. A good anti-Leishmania vaccine would have 
several characteristics such as safety and stability, availability to the people in need, 
induction of good CD4 and CD8 T cells responses and be effective for both CL and 
VL. Different methods of vaccination have been used to control Leishmania infection, 
and this have given a promising result in experimental models. Although these vaccines 
failed to provide protection, they significantly increased the current knowledge of the 
complexity of immune response to the Leishmania parasite. The first generation of 
Leishmania vaccines, which include Leishmanisation and killed vaccine, and second 
generation which include genetically modified parasites, are briefly described below. 
1.5.1 Leishmanisation and killed vaccine 
Leishmanisation is a process whereby live virulent parasite is introduced to the host in 
order to produce a long lasting immunity which is associated with activation of T cells 
mediated immunity and protection against re-infection with the parasite (Nadim, et. al., 
1983). This method was widely used in the 1970s and 1980s in endemic areas such as 
Iran and the Soviet Union (Greenblatt, 1988; Khamesipour, et. al., 2005). WHO later 
banned this method in many countries, because of safety issues (some vaccinated 
patients developed non-healed lesions). Afterwards, the focus of vaccine development 
was shifted towards using a killed preparation of the parasite. This was introduced to 
the world by Brazilian scientists in the late 1930s, and this type of vaccination was 
performed by the inoculation of the host with killed promastigotes. Although, this 
method of vaccination is safer compared to Leishmanisation, this method was 
compromised by the low effectiveness of protection in endemic areas (Mayrink, et. al., 
1985). For example, a vaccine called Leishvacin derived from L. amazonensis 
(Marzochi, et. al., 1998), was used in Ecuador and Colombia and was safe, but not 
effective (Velez, et. al., 2005). In addition, the observation that vaccinated individuals 
developed Th1 immune response without controlling the infection, which also was in 
agreement with others (Gicheru, et. al., 2001), suggests that the Th1 immune response 
was less important in controlling CL. However, a good protection was achieved using 
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killed L. major against L. donovani infection in canine and hamster models (Mohebali, 
et. al., 2004). 
1.5.2 Live-attenuated vaccines 
In this method, vaccination is performed with non-pathogenic parasites, which can be 
taken up by different host cells and stimulates a long-term immune response. This 
method was more effective in controlling parasite infection compared with 
Leishmanisation and killed vaccination methods. Attenuated parasites can be produced 
by various methods, such as long term culturing under gentamicin pressure, and 
knocking out some genes (Kedzierski, et. al., 2006), and different results have obtained 
as a consequence. For example, L. major promastigote knockout dihydrofolate 
reductase-thymidylate synthetase (DHFR-TS) gene (required for a long term survival 
in the host), induces some protection in murine models infected with L. major and L. 
amazonensis, but failed to produce any protection against infection with L. major and 
L. amazonensis in infected primate models (Amaral, et. al., 2002). Although the 
attenuated parasite might be produced by a knockout virulence gene such as LPG1 gene 
(encoding a putative galactofuranosyl transferase involved in the biosynthesis of the 
virulence lipophosphoglycan) and systeine proteninase, these parasites could still 
induce the infection (Huang and Turco, 1993).  A study by Uzonna, et. al., (2004) 
showed that L. major knockout LPG2 gene (responsible for transportation of GDP 
mannose to Golgi apparatus) gave Balb/c mice protection from homologous infection, 
and that the protection induced by attenuated parasites was not related to the Th1 
immune response, as was indicated by IFN-γ production. However, a study by Carrió, 
et. al., (2011) demonstrated that immunisation of Balb/c mice with of L. infeantum 
HSP70-II knockout gene (encoding heat-shock response), induced a high level of 
protection against L. major infection. The protection was associated with high levels of 
NO concentration and Th1 immune response, as determined on the basis of an ELISA 
analysis of anti-Leishmania IgG antibody subclass. 
1.5.3 Recombinant protein vaccines 
Recombinant protein vaccine consists of protein fragments of the pathogenic organism 
that have been produced in cells engineered genetically to express  particular proteins, 
for example, bacteria and yeast. These antigens (synthesised proteins) can be 
successfully used as a vaccine model (Khamesipour, et. al., 2006). Due to their high 
immunogenicity, the immune system will raise specific required antibodies against the 
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introduced proteins, which eventually protect the host from the infection. This method 
was widely used to control many diseases including Leishmania infection. In almost all 
known Leishmania spp, GP63 protein was considered to be highly immunogenic, and 
was therefore used as  a target for vaccines against Leishmaniasis. For example, use of 
GP63 as a recombinant vaccine induced some protection in Vervet monkeys 
(Cercopithicus aethiops) challenged with L. major (Olobo, et. al., 1995). Other 
important immunogenic proteins used as recombinant vaccines are cysteine 
proteinases. Rafati, et. al., (2002), reported that recombinant CPB and CPA proteins 
mixed with poloxamer 407 as an adjuvant induced the immune response in Balb/c mice 
infected with L. major. Although recombinant CPB protein induced partial protection, 
recombinant CPA did not. In addition, the protection of infected Balb/c mice was 
associated with CD8 T cells, since depletion of these lymphocytes using depleting CD8 
antibodies in mice immunised with recombinant CPB led to disease progression. In this 
type of vaccine, a single protein is usually used, however, some studies have 
demonstrated that using more than one immunogenic protein at once induces a stronger 
degree of protection. For example, recombinant LmSTI1 and TSA protein gives good 
protection in Balb/c mice (immunised three times) challenged with freshly isolated        
L. major amastigotes, compared to recombinant TSA mixed with IL-12, which induces 
partial protection. However, immunisation with a mixture of both proteins induced 
strong protection in a murine challenged model (Campos-Neto, et. al., 2001).  
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1.5.4 DNA vaccine 
DNA vaccine are based on introducing the genetic material from the pathogen of 
interest to the mammalian host, instead of introducing the antigen itself (Liu, et. al., 
2005; Choi, et. al., 2009). Although traditional vaccines have successfully protected 
humans from some diseases, they failed to protect against many other diseases. In the 
last decade, genetic vaccines have been extensively investigated as promising future 
candidates to prevent the spread of many infectious diseases. Unlike the majority of 
traditional vaccines, DNA vaccines are becoming increasingly more reliable due to 
their unique features. Since they do not introduce any live pathogenic element to the 
immunised subject, they are considered to be safer (Sheets, et. al., 2006). In addition, 
plasmid DNA is more stable and relatively easy to prepare compared to others. This 
makes them affordable to people in developing countries (Kedzierski, et. al., 2006;      
Al-Wabel, et. al., 2007). It has been reported that DNA vaccines are highly 
immunogenic, so that they are able to stimulate both humoral and cellular immune 
responses against encoding proteins (Liu, et. al., 2005; Ganges, et. al., 2008). 
Following immunisation, plasmid DNA is taken up by host cells, and the proteins of 
interest synthesised. These then stimulate either a cellular or antibody mediated 
immune response. Once the inserted gene is translated into protein, it may follow an 
MHC class I or a MHC class II pathways or both. If the encoding protein is digested 
inside the cell cytoplasm due to proteasome enzymes, this leads to peptide circulation 
and loading onto newly sensitized MHC I molecules in the endoplasmic reticulum in 
the presence of other supportive components. MHC class I peptide complexes are then 
transported through the Golgi complex to the cell surface (endogenous pathway). The 
presentation of loading peptides on the APC surface by MHC class I stimulates 
cytotoxic T lymphocytes (CD8+), and induces a cell-mediated immune response 
(Anderson and Schneider, 2007; Choi, et. al., 2009). 
Alternatively, the proteins encoded by DNA vaccines can be released outside the 
transfected cells, and taken up by APCs as foreign antigens. These proteins will be 
digested into peptides inside the endosomes, treated as extracellular antigens and loaded 
on MHC class II molecules, to be transported into the cell surface by the Golgi complex 
(exogenesis pathway). Peptide presentation by MHC class II stimulates helper                  
T lymphocytes (CD4+), which facilitate the generation of antibodies by B cells (Liu and 
Ulmer, 2005). Moreover, plasmids derived from the bacteria are highly immunogenic, 
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as the backbone contains un-methylated cytosine-phosphate-guanosine motifs (CpG) 
which stimulates the innate immune response through TLR9 (Anderson and Schneider, 
2007; Rottembourg, et. al., 2010). The different scenarios of immune responses 
following DNA immunisation are summarised in (Figure 1.5-1).  
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Figure 2.2-1 Facts related to DNA vaccines 
Gene gun immunisation with plasmid encoding a gene of interest will be taken up by cells and 
translated into mRNA: (1). This travels to the cytoplasmic rough reticulum to produce the 
protein (2). In the Endogenous Pathway, the encoding protein (3) is digested inside the 
proteasome to peptides (4). These enter the smooth endoplasm reticulum together with newly 
generated MHC class I. Peptide-MHC class I complex travels through the Golgi complex to the 
cell surface (5). The complex can be recognized by CD8 (6). In the exogenous pathway, the 
encoding protein is secreted outside the cell and taken up by APCs (7). Endosome-lysosome 
fusion takes place (8). The protein is digested into peptides, which are loaded onto MHC class 
II in specific small compartments (9). This process ends by traveling to APC surface and the 
CD4 subset is stimulated (10). (Modified from Schirmbeck and Reimann, 2001). 
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DNA vaccines, encoding one or more Leishmania genes, have been used 
experimentally to protect animal models from developing lesions when they are 
challenged with live Leishmania parasites. Al-Wabel, et. al., (2007) have reported that 
immunisation of susceptible Balb/c mice with recombinant nucleoside hydrolase 
protected against L. major infection, and that the protection of immunised mice was 
related to enhancement of a Th1 response. In a similar study, immunisation of C57BL/6 
mice with CpG DNA along with live L. major strongly stimulates dermal, but not bone 
marrow DCs to produce IL-2 and IFN-γ (Laabs, et. al., 2009).   
 Hence, DNA vaccines are a promising approaches for preventing or eliminating 
widespread Leishmania infection in both developing and developed countries.  
The current project therefore, was designed to test and compare the immunogenicity of 
three different Leishmania genes cloned into three different plasmids:  
i. Leishmania mexicana GP63.  
ii. Leishmania donovani centrin1.  
iii.  Leishmania donovani centrin3.  
Each gene will be sub-cloned in three plasmids, which are VR1012, pcRT7/CT-TOPO 
and pcDNA3.1/Higro(-). 
1.5.4.1 Leishmania parasite GP63 protein 
The biological roles of GP63 as virulence factor have been previously addressed 
(section 1.3.3) its role as vaccine candidate will be discussed in this section. The surface 
of most species that belong to the Trypanosomatidae family is coated with 63-kDa GPI-
anchored protein known as GP63, which is present at 5x105 molecules per parasite 
(Etges, et. al., 1986). In Leishmania species that have been studied, at least one or two 
isoforms of the GP63 gene are presented in both stages of the Leishmania parasite life 
cycle: the extracellular metacyclic promastigotes and intracellular amastigotes            
(Ilg, et. al., 1993; Inverso, et. al., 1993).  
Since GP63 is presented in all Leishmania spp, it has been a vaccine target for many 
researchers (Handman, et. al., 1995). GP63 was used as a recombinant protein vaccine, 
which failed to protect immunised mice from infection with L. major, but it did give 
partial protection in immunised monkeys challenged with L. major (Olobo, et. al., 
1995). The GP63 gene was used in combination with other genes as a DNA vaccine. 
For example, the multi-antigenic plasmid DNA vaccine encoding KMP11 
(kinetoplastid membrane protein-11), TRYP (Tryparedoxin peroxidase (TRYP), or 
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thiol-specific antioxidant (TSA), LACK and GP63 L. infantum antigens failed to 
protect immunised dogs that were challenged with L. infantum promastigotes,  after 
four dose of immunisation (Rodríguez-Cortés, et. al., 2007). Interestingly, many have 
identified the effectiveness of some isoforms of GP63 as a vaccine to Leishmania 
infection, while other isoforms could lead to the exacerbation of Leishmaniasis 
symptoms (Tsagozis, et. al., 2004). 
L. major GP63 has been broadly used as a DNA vaccine, and it has been reported that 
Th1 immune response Balb/c mice could be enhanced by GP63 DNA immunisation, 
and that this to a significant reduction in lesions size and the number of parasite burdens 
(Walker, 1998). On the other hand, immunisation of susceptible Balb/c mice with 
different isoforms of GP63 cloned into VR1012 (VR1012-GP46, VR1012-GP63 and 
VR1012-CPb) as DNA vaccine, gives a partial protection from infection with                    
L. mexicana (Dumonteil, et. al., 2003). 
1.5.4.2 Leishmania parasite centrins 
Many studies have reported that Centrins, as calcium binding proteins, have 
fundamental roles associated with microtubule organising centres (CMTOC), 
(Wolfrum and Salishbury, 1998; Klink and Wolniak, 2001). Three centrin isoforms 
which vary in terms of characterisation and function are found across many species:  
i. Human centrin1 (HsCEN1).  
ii. Human centrin2 (HsCEN2) and Chlamydomonas reinhardtii centrin (CrCEN1) 
are important in centrosome segregation.  
iii. Human centrin3 (HsCEN3) and yeast centrin (CDC31) are essential in 
centrosome duplication (Selvapandiyan, et. al., 2001).  
Since the role of centrin in cell growth and multiplication has been well defined, 
Leishmania parasite centrins have attracted the attention of many parasite 
immunologists in attempts to develop attenuated Leishmania spp that could be 
promising vaccine candidates. It has been reported that the growth of Leishmania 
parasites in which the centrin gene has been knocked out was highly affected.  For 
example, the growth rate of L. donovani promastigotes knockout centrin gene was 
arrested at the G2/M stage compared to controls, and also that the growth of  the 
amastigote was strongly inhibited in infected macrophages (Selvapandiyan, et. al., 
2001; Selvapandiyan et. al.,2004). Centrins have similar roles within the life cycle of 
T. brucei (Selvapandiyan, et. al., 2007).                                                                                                     
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The efficiency of attenuated Leishmania parasites as a vaccine has been tested using 
centrin knockout Leishmania. Challenging susceptible Balb/c mice with L. donovani 
LdCEN-/-  induced Th1 immune response, compared to mice challenged with normal L. 
donovani (Selvapandiyan, et. al., 2004). The Th1 immune response was correlated with 
a high production of interferon gamma (IFN-γ), increased IgG2 immunoglobulins as 
well as production of NO in macrophages. Moreover, immunisation using LdCEN-/- 
protects against L. braziliensis induced MCL (Selvapandiyan, et. al., 2009). 
1.5.4.3 VR1012, pcDNA3.1/Hygro(-) and pcRT7/CT-TOPO plasmids 
DNA plasmids incorporating the human cytomegalovirus promoter (CMV) such as 
VR1012 and pcDNA3.1 plasmids generate better gene expression following  
transfection compared to plasmids with other viral promoters, such as the SV40 
promoter (Ali, et. al., 2009). It is well known that VR1012 and pcDNA3.1/Hygro(-) 
vectors are more effective mammalian plasmids with highly successful rates in DNA 
vaccination methods (Guo, et. al., 2000). pcRT7/CT-TOPO plasmid is widely known 
as a prokaryotic vector, but it has been shown to transfect and express genes of interest 
in mammalian cells (Asteal, 2011). These plasmids were used to develop a DNA 
vaccine candidate against Leishmania parasite infections. For instance pcRT7/CT-
TOPO encoding L. donovani centrin3 gene provided better protection of susceptible 
Balb/c mice comparing to pcDNA3.1/Hygro(-) plasmid encoding the same gene (L. 
donovani centrin3), even the empty pcRT7/CT-TOPO gave some protection of Balb/c 
mice against challenge with L. mexicana promastigotes (Asteal, 2011). 
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1.6  Aims of the study 
Vaccination is the  method of choice in controlling infectious diseases and since no 
effective vaccine is available against Leishmaniasis, this project was partly designed to 
test and compare the immunogenicity of three Leishmania genes (L. mexicana GP63, 
L. donovani centrin1 and L. donovani centrin3) cloned in 3 different plasmids 
(pcRT7/CT-TOPO, VR1012, and pcDNA3.1/Hygro(-)). The immunogenicity of newly 
prepared DNA vaccines will be evaluated in vivo by a gene gun immunisation method 
in susceptible Balb/c mice. Immune responses will be analysed in spleen, lymph nodes, 
blood and bone marrow of immunised and control mice using the following immune 
assays:  
 
I) Elispot (Enzyme-linked  immunospot) assay to measure the CTL activity in 
the immunised mice. 
II)  ELISA (Enzyme-linked immunosorbent assay) to measure levels of  IL-2, 
IL-4 and IFN-γ in the sera of cultured cells from spleens and lymph nodes 
stimulated in vitro with L. mexicana antigens, and to determine total IgG, 
IgG1 and IgG2a in blood samples 
III) Flow cytometry to estimate the number of T helper cells (CD4) and 
cytotoxic T cells (CD8) in spleens and lymph nodes.  
IV) Proliferation responses of splenocytes and lymphocytes as a result of in vitro 
stimulation with L. mexicana antigens. 
V) A novel Leishmania survival assay will be used for the first time in this 
study to measure the resistance of bone marrow derived macrophages from 
immunised Balb/c mice to L. mexicana infection.  
The second aim of this project is to study and evaluate in vivo and in vitro the effect of 
long period culturing on L. mexicana promastigote infectivity (a model developed in 
this study).   
The third aim of this project is to investigate the interactions between the virulent and 
avirulent L. mexicana promastigotes and susceptible human (U937 monocyte, 
MonoMac-6 monocytes, and U937 macrophages) as host cells. This will include: 
Firstly, study of histocompatibility complex class I (MHC I) expression in target cells. 
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Secondly, studying the modulation of gene expression of some Toll- Like Receptors 
(TLR-1, TLR-2, TLR-4 and TLR-9), Cytokines (IL-1, IL-6, IL-10, IL-12, TNF-α, and 
TGF-β) and Chemokines ( CCL-1, CLL-2, CCL-3, CCL-4, CCL-5 and CCl-22), in 
target cells following infection with virulent and avirulent L. mexicana promastigotes 
or their antigens measured by qPCR. 
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2. Materials and Methods 
2.1 Materials 
2.1.1   Molecular biology reagents and kits 
No. Product Name Company Cat. No. 
1 100bp DNA Ladder Genecraft 
GC-015-
004 
2 1kp DNA Ladder Promega G571A 
3 5X colourless Go tag R Reaction Buffer Promega M7921 
4 Alkaline Phosphatase 10X Reaction Buffer Promega M133A 
5 Alkaline Phosphatase, Calf Intestinal Promega M1821 
6 Ampicillin, sodium salt Sigma A9518 
7 AvaI Promega R6091 
8 BgIII Promega R6081 
9 Buffer B 10X Promega Roo2A 
10 Buffer E 10X Promega R005A 
11 ClaI Promega R6551 
12 EcoRI Promega R6011 
13 GelRed TM Nucleic Acid Gel Stain, in Water Biotium 41003 
14 Go Taq R DNA Polymerase Promega M3178 
15 HaellI Promega R6171 
16 Hind III Promega R604A 
17 iQ SYBR Green Supermix Bio-Rad 8880 
18 InstaGene™ Matrix kit (Bio-Rad 732-6030 
19 KAP A dNTP Mix Biosystem KN1008 
20 LB Agar High Salt, Granulated  Melford GL1706 
21 LB Broth Melford L1704 
22 Ligase Buffer, 10x Promega C126A 
23 MinElute Gel Extraction Kit (50) Qiagen 28604 
24 M-MLV Reverse Transcriptase Promega M1701 
25 M-MLV RT 5X Buffer Promega M531A 
26 Nuclease-Free Water Qiagen 129115 
27 Oligo(dT)15 Primer Promega C1101 
28 Prepaid Barcode labels MWG 94-050 
29 RNase-Free DNase Set (50) Qiagen 79254 
30 RNasin® Ribonuclease Inhibitor Promega N2111 
31 RNeasy Mini Kit (50) Qiagen 74104 
32 SalI Promega R6051 
33 Strip Tubes and Caps, 0.1 ml Qiagen 981103 
34 T4 Ligase Promega M1801 
35 UltraFlux*Flat Cap PCR Tubes SSI 3220-00 
36 Wizard R Plus SV Minpreps Promega A1330 
37 Xba I Promega R6181 
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2.1.2 Culture media and supplements 
No. Product Name Company Cat. No. 
1 Albumin from bovine serum Sigma A2153 
2 C.T.L Test ™ medium C.T.L CTL-010 
3 DPBS 0.0095M(PO4) w/o Ca and Mg Lonza BE12-167F 
4 Foetal Bovine Serum Fisher SV30143.03 
5 Fungizone Invitrogen 15290-018 
6 Geneticin® Selective Antibiotic Life 
technologies 
10131-019 
7 HEPES Buffered Saline Solution Lonza CC-5022 
8 
Kanamycin solution from Streptomyces 
kanamyceticus 
Sigma K0254 
9 L-Glutamine 200mM 100ml Lonza BE17-605E 
10 Lipofectamine® 2000 Transfection 
Reagent 
Life 
technologies 
11668027 
11 
Lipopolysaccharides from Escherichia 
coli 
Sigma L8274 
12 Non-essential amino acids (NEAA) Sigma M7145 
13 OPI Media Supplement Sigma O5003 
14 
Penicillin 5,000, Streptomycin. 5,000 
U/ml 
Lonza DE17-603E 
15 RPMI 1640 without L-glutamine Lonza BE12-167F 
16 
Schneider's Drosophila Medium, 
Modified 
Lonza 04-351Q 
17 Sodium Pyruvate Solution Lonza BE13-115E 
18 Staphylococcal enterotoxin B (SEB) Sigma S4881 
19 Trypsin/EDTA Solution 100 ml Lonza CC-5012 
20 Zeocin Selective Antibiotic Invitrogen 469270 
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2.1.3 Antibodies and kits 
No. Product Name Company Cat. No. 
1 Anti-human CD14: FITC  Biolegend 325603 
2 Anti-human CD68: FITC Biolegend 333805 
3 ELISpot Blue Colour Module R&D Systems SEL002 
4 FcR Blocking Reagent, human 
Miltenyi 
Biotec 
130-059-901 
5 F4/80 Antibody - Cl:A3-1 Serotec MCA497FT 
6 Goat anti-mouse IgG2a:FITC Serotec STAR133F 
7 Got anti-mouse IgG: HRP Abcam Ab6789 
8 Got anti-mouse IgG2a: HRP Serotec STAR133P 
9 GP63 antibody Gen Flow 96-126 
10 Greiss reagent system Promega G2930 
11 Hamster anti mouse CD11c: FITC Serotec MCA369F 
12 InstaGene™ Matrix kit Bio-Rad 732-6030 
13 Mouse anti mouse MHC class I:FITC Serotec MCA2189F 
14 Mouse IFN gamma Duoset ELISA Kit R&D Systems DY485 
15 Mouse IFN-γ ELISpot Development kit R&D Systems SEL485 
16 Mouse IgG1: FITC κ Isotype ctrl (FC) Biolegend 400109 
17 Mouse igG2b negative control: FITC Serotec MCA691F 
18 Mouse IgG2b, κ Isotype Ctrl Biolegend 400309 
19 Mouse IL-12p70 DuoSet  ELISA Kit R&D Systems DY419 
20 Mouse IL-4 DuoSet  ELISA Kit R&D Systems DY404 
21 Protein Kit Sigma B9643 
22 Rabbit anti mouse IgG1: HRP Serotec OBT1508P 
23 
Rat anti-mouse CD3:RPE-Alexxa 
Fluor®647 
Serotec MCA500P64 
24 Rat anti-mouse CD4: FITC Serotec MCA1107F 
25 Rat anti-mouse CD8: RPE Serotec MCA609PE 
26 Rat IgG2a negative control: FITC Serotec MCA1212F 
27 Rat IgG2a negative control: RPE Serotec MCA1212P 
28 
Rat IgG2a negative control: RPE-Alexxa 
Fluor®647 
Serotec 
MCA1212P6
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2.1.4 Chemicals 
No. Product Name Company Cat. No. 
1 Bovine Serum Albumin Sigma A2135 
2 2-Mercaptoethanol Sigma M3148 
3 Calcium chloride Sigma 499609 
4 Dimethyl Sulphoxide (DMSO) Sigma D2650 
5 Ethanol, absolute Sigma E7023 
6 Ethanol, anhydrous Sigma 676829 
7 Giemsa Stain, Modified Solution Sigma 48900 
8 Glycerol for molecular biology Sigma G5516 
9 Glycine Sigma G8898 
10 Gold Microcarriers Bio-Rad 165-2263 
11 Hemin Sigma H9039 
12 IsoFlow ™ Sheath Fliid Coulter 72006 
13 Isopropanol Sigma 19516 
14 Latex beads Sigma L3030 
15 MicroScint™-O 
Perkin 
Elmer 
6013611 
16 Paraformaldehyde Sigma 158127 
17 Phenol:Chloroform:Isoamyl Alcohol Sigma P3803 
18 Phorbol 12-myristate 13-acetate Sigma P1585 
19 Polyvinylpyrrolidone (PVP) Sigma PVP360 
20 Potassium acetate Sigma P1190 
21 Potassium chloride Sigma P9541 
22 Potassium hydroxide Sigma P5958 
23 Potassium phosphate monobasic Sigma P5666 
24 Sodium azide Sigma S2002 
25 Sodium hydroxide Sigma S5881 
26 Spermidine Sigma S0266 
27 Sulphuric acid (stop solution)  Sigma 339741 
28 Thymidine [6-3H] 
Perkin 
Elmer 
NET3550
01MC 
29 Trizma® base, minimum Sigma T1503 
30 Trizma® hydrochloride  Sigma T3253 
31 Trypan Blue Solution Sigma TB154 
32 Tween®20 Sigma P2287 
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2.1.5 Equipments 
No. Equipment Name Company Cat. No. 
1 -20 °C freezer  Les 2C000062 
2 4°C fridge Les 2C000062 
3 4°C Mistral 200R centrifuge MSE 5696/06/27 
4 -80°C  Freezer   Sanyo 08070722 
5 800W compact microwave Sanyo SY05/0058 
6 Autoclave Rodwell 00000 
7 Bench top vortex mixers 
Scientific 
Industries 
50HZ 
8 Block heater  Stuart SBH130D 
9 CK2  microscope Olympus 110605 
10 Class II microbiological safety cabinet Envait C14299 
11 Class II microbiological safety cabinet walker C14296 
12 CO2 water jacketed incubator 
Forma 
Scientific 
27555-
1063 
13 Confocal microscope Leica 510000141 
14 Cooled incubator LMS 9140/06LR 
15 Elispot plate readers  (CTL)  
16 EV243 consort mini power supply  Gene Flow P5-0040 
17 Fluorescence microscope BX51TF Olympus 6F22612 
18 Gallios, 10 colour flow cytometer  
Beckman 
Coulter     
1269903 
19 Gel Documentation In Genivs 1032 
20 Hotplate with stirrer, aluminium plate analogue Geneflow SB162 
21 Micro-centrifuge Heraeus 50/60HZ 
22 Microprocessor pH meter Hanna 500258 
23 Multi Sub Midi Horizontal Gel Unit Geneflow G9-0010 
24 Nanodrop® 8000 8 Sample Spectrophotometer Labtech 0388 
25 qPCR machine  Rcorbett R070571 
26 Scintillation Top Counter Packard 5069256 
27 Shaker incubator Stuart R0001040 
28 Sonicator 
Fisher 
Scientific 
183422050 
29 Spectra fluor plate reader  Tecoan 93437 
30 Tc-3000G techne gradient thermal cycler Geneflow T2-1022 
31 Transilluminator 
Genetic 
Research 
S/90/090 
32 Tubing Prep Station  Bio-Rad 1237 
33 Water bath Grant OE963900 
34 Helios gene gun Bio-Rad 165-2431 
35 Pellet pestles Sigma Z359971 
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2.1.6 Consumables 
No. Name of product Company Cat. No. 
1 0.5 ml Micro tubes  Sarstedt 72.699 
2 1.5 ml Micro tubes  Sarstedt 72.690.001 
3 10 ml syringes 
Becton 
Dickinson 
300613 
4 15 ml Tubes  Sarstedt 62.554.502 
5 2 ml Micro tubes  Sarstedt 72.695 
6 50 ml Tubes  Sarstedt 62.547.254 
7 96 well plates (flat bottom) Sarstedt 84.1835 
8 96 well plates (round bottom) Sarstedt 83.1835 
9 ELISA plates  
Fisher 
Scientific 
07-200-35    
10 Flow cytometry tubes Elkay 2052-003 
11 Insulin syringe (with needle) 30g x 8mm BD 324893 
12 MultiScreen HTS HA, 0.45 µm, sterile Millipore MSHAS45 
13 Pasteur pipettes SLS  
14 Petri dishs 92x16mm Sarstedt 82.1473 
15 Pipette tips 1000µl Pipette, blue Sarstedt 70.762 
16 Pipette tips 200µl Pipette, yellow Sarstedt 70.760.002 
17 Serological pipettes 10ml Sarstedt 86.1254 
18 Serologische pipettes 25ml Sarstedt 86.1685.00 
19 Syringe filter 0.25µl 
Sartorius 
Steidim 
10331103 
20 Tip biosphere 10µl white rack with filter Sarstedt 70.1131.21 
21 Tip biosphere 1000µl blue rack with filter Sarstedt 20.762.211 
22 Tip biosphere 20µl yellow  rack with filter Sarstedt 70.760.213 
23 Tip biosphere 200µl yellow rack with filter Sarstedt 70.760.211 
24 Tissue culture flasks T25 Vent Cap Rad Sarstedt 83.1810.00 
25 Tissue culture flasks T75 Vent Cap Rad Sarstedt 83.1813.00 
26 Tissue culture plates 24 well plate  Sarstedt 83.1836 
 
2.1.7 The source of plasmids used in this study 
No. Plasmid name Source 
1 Empty pcDNA3.1/ Hygro(-) Invitrogen 
2 pcDNA3.1/Hygro(-)-L.mexgp63 Rezvan PhD thesis, 2007 (NTU) 
3 pcDNA3.1/Hygro(-)-Ldcen3 Asteal, PhD thesis, 2011 (NTU) 
4 pCR®II-TOPO®-Ldcen1 Dr Nakhasi, FDA, USA 
5 pcRT7/CT-TOPO-Ldcen3 Dr Nakhasi, FDA, USA 
6 VR12-L.mexgp63 
Prof. Dumonteil (Laboratorio de 
Parasitologia, C.I.R, Mexico) 
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2.2  Methods 
2.2.1  Bulking of original plasmids 
A sufficient amount of each DNA plasmid is required for further analysis, therefore 
bulking up of VR1012-L.mexgp63, pcDNA3.1/Hygro(-)-L.mexgp63 and pcRT7/CT-
TOPO-Ldcen3, was performed using the standard molecular biology protocols. 
2.2.1.1 The preparation of competent Escherichia coli cells 
All Escherichia coli XILB strain competent cells used in this study were obtained from 
one single colony (Invitrogen, UK). Bulking of E. coli was performed in three days 
according to the manufacturer’s guidelines and protocols.  
Day one: one aliquot of E. coli XILB cells was thawed out on ice, and then streaked on 
two LB agar plates containing Tetracycline antibiotic (Sigma, UK) 5µg per ml. Plates 
were incubated overnight at 37ºC.  
On day two: one single colony was picked up and re-suspended in 3ml of fresh sterile 
LB broth media containing 5µg per ml Tetracycline, the suspension was then incubated 
overnight at 37ºC  with shaking at 200rpm using Stuart S150 shaking incubator. 
On day three: a 500µl of E. coli suspension from the previous step was added into 100ml 
of LB broth media plus 5µg per ml Tetracycline in a conical flask. The suspension was 
allowed to recover in a rocking incubator at 37ºC for 5 hours. E. coli cells were left to 
grow until OD600 = 0.500. Cells were then prepared for freezing as follows:  the E. 
coli cells were centrifuged at 500g for 15 minutes. Supernatant was discarded and the 
pellet was re-suspended in 30ml of TFB I buffer (30mM of KoAc, 50 mM of MnCl2, 
100mM KCl, 10mM CaCl2 and 15M Glycerol), pH was adjusted to pH 5.8 with acetic 
acid. The suspension was incubated on ice for 30 minutes,  cells were then centrifuged 
at 500g at 4ºC for 20 minutes, supernatant was removed, and the pellet was re-
suspended in 4ml of buffer TFB II (100mM MOPS, 75mM CaCl2, 10mM  KCl and 
15M Glycerol, pH was adjusted to pH 6.8 with KOH). Competent E. coli cells were 
aliquoted using sterile Eppendorf tubes under a sterile condition and stored at -80ºC.   
2.2.1.2 Bulking of original Leishmania DNA constructs  
The bulking up of VR1012-L.mexgp63 plasmid, pcDNA3.1/Hygro(-)-L.mexgp63, 
pcRT7/CT-TOPO-Ldcen3, pCR®II-TOPO®-Ldcen1,  pcDNA3.1/Hygro(-)-Ldcen3 
and empty pcDNA3.1/Hygro(-) plasmids was also performed in two days as described 
in sections 2.2.1.2.1 and 2.2.2.1.2. Kanamycin or ampicillin (Sigma, UK) were used as 
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a selective antibiotic, according to the plasmid maps (Figures, 2.2.1, 2.2.2, 2.2.3, and 
2.2.4).  
 Day one: Transformation of plasmid DNA to the competent 
cells 
A 200µl aliquot of E. coli XLIB bacteria was allowed to defrost on ice, and 1µl of DNA 
plasmid was gently added followed by incubation on ice for 30 minutes.  The mixture 
was exposed to a heat-shock in a water bath at 42°C for 3 minutes, to ensure the uptake 
of the plasmid DNA by XLIB bacteria, followed by incubation on ice for 5 minutes. A 
volume of 300µl of fresh LB broth media was then added and incubated for 30 minutes 
at 37ºC in a rocking incubator. The suspension was then transformed into fresh LB 
broth media supplemented with 15µg/ml kanamycin, a selective antibiotic (Figure 
2.2.1), and incubated overnight at 37ºC in a shaking incubator. 
 Day two: Plasmid DNA extraction 
Plasmid DNA extraction was performed using a Wizard® Plus SVMinipreps 
Purification System (Promega, UK), protocols and guidelines of manufacturers were 
followed. Briefly, the suspension of XLIB bacteria broth culture was harvested using 
sterile 1.5 ml micro-centrifuge tubes. XLIB E. coli cells were centrifuged at 8000g for 
5 minutes at room temperature. After the LB broth media was completely removed, the 
cell pellet was re-suspended in 250µl of the provided re-suspension solution. Cells were 
lysed by adding 250µl of Cell lysis buffer, plus 10µl of alkaline protease solution. After 
incubation for 3 minutes, 350µl of the Wizard® Plus SV neutralization solution was 
added and mixed well with the lysed E. coli cells. The suspension was then centrifuged 
at 8000g for 10 minutes at room temperature. The clear supernatant was transferred into 
the provided spin column, and further centrifuged for 2 minutes. This was followed by 
two washes using 750µl and 250µl respectively of the provided washing buffer. The 
ethanol was completely removed by an additional spin step for 2 minutes. Plasmid DNA 
was eluted in nuclease-free water and centrifuged for two minutes at room temperature. 
The final product was stored at -20ºC.  
The structure of VR1012, pcRT7/CT-TOPO, pCR®II-TOPO®, and pcDNA3.1/ 
Hygro(-) plasmids used in this study are shown in Figures 2.2.1, 2.2.1, 2.2.3, and 2.2.3, 
respectively.  
2) Materials and Methods 
 
55 
 
 
 
Figure 2.2-1 The structure of VR1012-L.mexgp63 plasmid map with restriction sites 
(Gift from Prof. Dumonteil, Mexico) et al., 2003) 
 
 
Figure 2.2-2 The structure of pcRT7/CT-TOPO plasmid with restriction sites 
 (http://www.biovisualtech.com/bvplasmid/pCRT7_CT-TOPO.htm) 
 
2) Materials and Methods 
 
56 
 
 
Figure 2.2-3 The structure of pCR®II-TOPO® plasmid with restriction sites 
 (http://www.addgene.org/vector-database/2289/) 
 
 
Figure 2.2-4 The structure of pcDNA3.1/Hygro(-) plasmid with restriction sites 
(http://www.biovisualtech.com/bvplasmid/pcDNA3.1_Hygro%28-%29.htm) 
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2.2.1.3 Confirmation of the presence of Leishmania genes in bulked 
plasmids by PCR Amplification 
In order to check the presence of the cloned genes (L. mexicana GP63, L. donovani 
centrin1 and L. donovani centrin3) in the bulked plasmids, these plasmids were used as 
the DNA template for a polymerase chain reaction (PCR). The PCR reaction was 
performed in a total volume of 20µl per PCR tube by adding following volumes:  
Reagent Volume (µl) 
10 µM of forward primer           01.00 µl 
10 µM of Reverse  primer 01.00 µl 
10 mM dNTPs 00.4 µl 
5u/μlGoTaq® Flexi DNA Polymerase 00.2 µl 
5X Green GoTaq® Reaction Buffer 04.0 µl 
DNA template 02.00 µl 
Nuclease-free Water 11.4µl 
Total Volume 20.00 µl per tube 
 
Table 2.2-1 List of regents and volumes used in the conventional PCR 
 
To confirm the presence of L. mexicana GP63 gene in the VR1012-L.mexgp63 and 
pcDNA3.1/Hygro (-) plasmids, pair 1 primers (Table 2.2.2), was used.  The presence 
of L. donovani centrin1 in pCR®II-TOPO® plasmid was confirmed using pair                   
5 primers (Table 2.2.2). The presence of L. donovani centrin3 in pcDNA3.1/Hygro(-)-
Ldcen3 plasmid was confirmed using pair 3 primers (Table 2.2.2). 
The PCR reactions were always carried out in duplicate using a Primus Advanced 
Thermal Cyclers PCR machine (Geneflow). The PCR reaction conditions were: initial 
denaturation at 95ºC for 5 minutes followed by 30 cycles of 95ºC for 30 seconds of 
denaturation, and annealing temperature was preformed according to each primer as 
listed in table 2.2.2. Extension step at 72ºC for 1 minute, a final extension was 
performed at 72ºC for 10 minutes, and the final hold was at 4ºC for 24 hours. The PCR 
products were then subjected to 1.5% w/v agarose gel electrophoresis separation. 
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Target gene Primer séquence (5'    3') 
MT 
ºC 
Prod. size 
(bp) 
1- L.mexgp63   
F.P. ACATCCTCACCGACGAGAAG  
R.P. CTTGAAGTCGCCACAGATCA  
60 194 bp 
2- L.mexgp63  
F.P. TCTATCTAGAATGCCCGTCGACAGC 
R.P. TCTAAAGCTTTCACGTCGGGAGCC 
65 1940 bp 
3- Ldcen 3 
F.P. ACAATCAGCCGCTTATGGAC  
R.P. AATCATTGCCTGCAGCTCTT  
58 203 bp 
4- Ldcen3 
F.P.TCTAGTCGACATGAACATCACTAGTC 
R.P.TCTAAGATCTGTAGTCGTCCTCCTCT 
65 543 bp 
5- Ldcen1 
F.P. CTGACGGATGAACAGATTCG  
R.P. AAAGCTTTCACGTCGGGAGC  
60 200 bp 
6- Ldcen1 
F.P. ATGGCTGCGCTGACGGAT  
R.P. CTACTTTCCACGCATGTGC  
61 450 bp 
 
Table 2.2-2 List of primers used for PCR amplifications 
The sequence of forward (F), reverse (R) primer, melting temperature (MT) and product size 
for each target gene. Primers were designed using an available online Primer 3PlusL 
software 
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2.2.1.4 Preparation of 1.5% w/v agarose gel electrophoresis 
A 1.5% w/v Hi-Res Standard Agarose (Geneflow, UK) was used. Gels were stained 
with 5µl of Gel-Red™ Nucleic Acid Gel Stain, 10,000X in water, melted agarose was 
poured into a casting chamber with the appropriate comb, and left to set up at room 
temperature. After 30 minutes, the samples (PCR products) were loaded into gel a long 
with 1kp DNA ladder (Promega, UK). Agarose gel electrophoresis was performed at 
80 volts for 1 hour. The gel was imaged using a gel documentation system (InGenivs, 
UK). 
2.2.2 Preparation of the new Leishmania DNA constructs 
DNA constructs underlined in the following table were newly constructed in this study 
to compare immunogenicity of three Leishmania genes: L. mexicana GP63 
(L.mexgp63), L. donovani centrin1 (Ldcen1) and L. donovani centrin3 (Ldcen3), in 
three different plasmids. 
Group 1 Group 2 Group 3 Group 4 
pcRT7/CT-TOPO-              
L.mexgp63 
pcRT7/CT-TOPO- 
Ldcen 1 
pcRT7/CT-TOPO- 
Ldcen 3 
Empty pcRT7/CT-
TOPO 
VR1012-L.mexgp63 VR1012-Ldcen1 VR1012-Ldcen3 Empty VR1012 
pcDNA3.1/Hygro(-)-           
L.mexgp63 
pcDNA3.1/Hygro 
(-)-Ldcen1 
pcDNA3.1/Hygro(-)-
Ldcen3 
Empty 
pcDNA3.1/Hygro(-) 
 
Table 2.2-3 DNA constructs used in the current study 
The underlined (red) constructs are newly prepared 
 
2.2.2.1 The construction of pcRT7/CT-TOPO-L.mexgp63 plasmid 
A new pair of primers containing the sequence of Hind III and d Xbal restriction 
sequences was designed (Table 2.2.2, underlined sequences). These new primers were 
designed to amplify the complete L. mexicana GP63 gene along with restriction sites, 
from VR1012-L.mexgp63 plasmid. PCR reaction was performed at a melting 
temperature of 65ºC and the mixture was subjected to the same conditions mentioned 
in section 2.2.1.3. 
Final PCR product (L. mexicana GP63 gene) was loaded into 1.5% w/v agarose gel 
(prepared as previously described) along with 1kp DNA ladder (Promega, UK). The 
gel was run at 80 volts for 1 hour.     
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 Isolation of the L. mexicana GP63 gene fragments  
The bands (L. mexicana GP63 gene) were cut out of the gel using a sterile scalpel and 
sterile Eppendorf tube under blue light transilluminator to avoid damaging the DNA. 
The PCR product was then purified using a Qiagen gel extraction kit according to the 
manufacturer’s protocol. Briefly: three volumes of QG buffer were mixed with one 
volume of the gel. The mixture was then incubated in water bath at 50ºC for 10 minutes 
to be dissolved completely. The mixture was mixed well with one volume of 
isopropanol (Sigma, UK). The samples were then transferred into the provided 
MinElute columns to allow the DNA to bind to their membrane by passing the sample 
through them. To optimise the binding of DNA, 500µl of QG buffer was further added 
to each MinElute column. DNA washing was performed by passing 750µl of buffer PE 
through each MinElute column. It was necessary that all the buffer PE was completely 
removed from the sample at 8000g. DNA was finally eluted in 10µl of buffer EB; 
samples were collected in new sterile collection tubes and stored at -20ºC. 
 Restriction and digestion of L. mexicana GP63 gene and 
pcRT7/CT-TOPO plasmid  
In order to increase the efficiency of the ligation step, the full length of amplified L. 
mexicana GP63 gene and the empty pcRT7/CT-TOPO were both exposed to Hind III 
and Xba l restriction enzymes (Promega, UK), in order to create corresponding sticky 
ends. The reaction was performed in a final volume of 10µl as following: 6µl of PCR 
product, 1µl of nuclease-free water (Qiagen, UK), 1µl of buffer E, 1µl of Hind III 
enzyme and 1µl of Xba l enzyme were mixed in a sterile Eppendorf tube. For plasmid 
digestion, 2µl of plasmid, 6µl of nuclease-free water, 1µl of buffer E, 1µl of Hind III 
enzyme and 1µl of Xba l enzyme were mixed in a sterile Eppendorf tube. Reaction 
volumes were centrifuged for 10 second, and then incubated in a water bath for 45 
minutes at 37ºC. Both reaction volumes were run onto 1.5% w/v agarose gel 
electrophoresis. Bands which represent the empty pcRT7/CT-TOPO and L. mexicana 
GP63 gene were cut out of the gel separately and DNA isolation was performed using 
a Qiagen gel extraction kit according to the manufacturer’s protocol as described above 
(section 2.2.2.1.1). 
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 Dephosphorylation of plasmid DNA    
Both sticky ends of digested plasmids are likely to re-ligate together, which causes 
reduction of the efficiency of the ligation process. Therefore, digested plasmids must 
be dephosphorylated to provide a highly successful ligation process. The process was 
achieved by using alkaline phosphatase, calf intestinal (CIAP) (Promega, UK). The 
reaction was performed by adding 1µl of dephosphorlation buffer and 0.5µl of alkaline 
phosphatase enzyme to 10µl of digested plasmid. The mixture was incubated in a water 
bath at 37ºC for 30 minutes.                                              
 Ligation of L. mexicana GP63 gene and pcRT7/CT-TOPO 
plasmid      
In order to insert the L. mexicana gp63 gene into pCRT7/CT-TOPO plasmid, they have 
to be mixed at a ratio of 1:3 (vector: insert) when the gene of interest is smaller than 
target plasmid, and at a ratio of 3:1 (vector: insert) when the gene of interest is bigger 
than target plasmid. The quantity of insert to be used was calculated using the following 
formula:                                                                                              
(Ng of vector) x (kb size of insert) / (kb size of vector) x molar ratio of (insert/vector)              
= ng of insert gene of interest. 
The amount of plasmid used was 100ng per microlitre. After calculation of the required 
amount from the gene of interest, this was mixed with 1µl of 10x ligation buffer and 
1µl of T4 ligase enzyme (Promega, UK) and adjusted to 10µl using nuclease free water. 
The mixture was gently mixed and incubated over night at 4ºC.          
 Transformation 
The transformation of the newly prepared DNA constructs into appropriate cells was 
accomplished as follows: 
2.2.2.1.5.1 Day 1 of transformation 
pcRT7/CT-TOPO-L.mexgp63 plasmid was transformed into XLIB E. coli bacteria as 
previously described in paragraph 2.2.1.2.1. After the heat shock, E. coli cells were 
recovered in 300µl of fresh LB broth media for at least 1 hour. This was followed by 
growing the transfected E. coli suspension on two LB agar plates containing the 
selective antibiotic (15µg ampicillin per ml) by streaking 50µl and 150µl of both, 
respectively. A third plate was similarly streaked with un-ligated plasmid (linear forms) 
as a control. The plates were inverted and incubated at 37ºC overnight. 
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2.2.2.1.5.2 Day 2 of transformation 
On the following day, at least five single colonies were separately selected and 
transferred into sterile universal tubes containing 3ml LB broth media supplemented 
with 15µg ampicillin per ml. The suspension was incubated overnight at 37ºC in a 
shaker incubator, to allow the growth of E. coli cells to produce more copies of DNA 
plasmid. 
2.2.2.1.5.3 Day 3 of transformation 
During the last day of the transformation, pcRT7/CT-TOPO-L.mexgp63 plasmid 
construct was isolated from E. coli genomic DNA using a Wizard® Plus SVMinipreps 
Purification System (Promega, UK) as has been previously described in paragraph 
2.2.1.2.2.  
 Confirmation of the newly cloned L. mexicana GP63 gene 
The success of sub-cloning of L. mexicana GP63 gene in pcRT7/CT-TOPO plasmid 
was confirmed using three methods. First: the presence of the L. mexicana GP63 gene 
was determined by restriction digestion of the newly constructed pcRT7/CT-TOPO-
L.mexgp63 with Hind III and Xba l restriction enzymes. Second: the presence of the     
L. mexicana GP63 gene was confirmed by PCR using pair 2 primers (Table 2.2.2). 
Third: the new plasmid construct was sequenced to ensure that no base miss-match 
occurred during the cloning procedure. Due to the length of the L. mexicana GP63 gene, 
three forward primers were used to sequence the whole gene:  
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Primer Number Primer séquence (5'    3') MT ºC 
1 ACATCCTCAACGAGAAG 59.4ºC 
2 GCGATGTTGTGCAATGAGAG 57.3ºC. 
3 TTAAGTTGAGCAGCGTGAGC 57.3 
 
Table 2.2-4 List of primers used to sequence L. mexicana GP63 gene 
 
2.2.2.2 The construction of pcRT7/CT-TOPO-Ldcen1   
The pcRT7/CT-TOPO-Ldcen3, and pCR®II-TOPO®-Ldcen1 plasmids were digested 
with Hind III and Xba I restriction enzymes, in order to obtain empty pcRT7/CT-TOPO 
and L. donovani centrin1. 2µl of each plasmid was digested by 1µl of each enzyme plus 
1µl buffer E in a sterile 1.5 ml Eppendorf tube. The reaction volumes were adjusted to 
10µl final volume with nuclease-free water. The digestion and restriction steps were 
carried out at 37ºC in a water bath. Fragments of the digested plasmids were separated 
by 1.5% w/v agarose gel, and the bands representing the empty pcRT7/CT-TOPO 
plasmid and L. donovani centrin1 gene were excised from the gel. DNA was extracted 
from the gel using a Qiagen gel extraction kit, according to manufacturer’s protocol as 
described previously (section 2.2.2.1.1), and the empty pcRT7/CT-TOPO plasmid was 
dephosphorylated as described in section 2.2.2.1.3. To perform the ligation step, the 
sufficient amount of DNA from the dephosphorylated vector and the insert (L. donovani 
centrin1) was calculated, using a ratio of 1:3 (vector: insert), and the ligation step was 
prepared as previously described in paragraph 2.2.2.1.4. A volume of 2µl from the new 
DNA construct (pcRT7/CT-TOPO-Ldcen1) was transformed into one aliquot XLIB     
E. coli to perform a 3-day long transformation procedure as described in sections 
2.2.2.1.5.1, 2.2.2.1.5.2 and 2.2.2.1.5.3. The presence of L. donovani centrin1 in the new 
DNA construct was confirmed using three methods, as previously described.                                  
2.2.2.3 Construction of VR1012-Ldcen1 plasmid 
EcoR restriction enzyme was used to digest VR1012-L.mexgp63 and pCR®II-
TOPO®-Ldcen1 plasmids in order to obtain empty VR1012 plasmid and L. donovani 
centrin1 respectively. Digestion, purification, and dephosphorylation of the empty 
plasmid, ligation, and transformation steps were performed as previously described in 
sections 2.2.2.1.2, 2.2.2.1.1, 2.2.2.1.3, 2.2.2.1.4, 2.2.2.1.5.1, 2.2.2.1.5.2 and 2.2.2.1.5.3, 
respectively. Since both ends of L. donovani centrin1 gene as well as VR1012 plasmid 
were digested using the same restriction enzyme, it was necessary to check that                 
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L. donovani centrin1 had the correct orientation. The correct orientation to the                  
L. donovani centrin1 gene, which cloned into VR1012 plasmid, was checked by an 
enzyme restriction analysis using Just bio online analysis software. The success of           
L. donovani centrin1 gene into VR1012 plasmid was proven using the three methods 
mentioned in section 2.2.2.1.6. 
2.2.2.4 The construction of VR1012-Ldcen3 plasmid  
Due to the absence of the preferred restriction sites, on pcRT7/CT-TOPO-Ldcen3 
plasmid required to cut off the L. donovani cenrtin3 gene, two restriction enzymes were 
chosen in order to design a new pair of forward and reverse primers containing the 
recognition sites of Sall and BgIII, respectively, pair 4 (Table 2.2.2). These new primers 
were used to amplify the target gene using pcRT7/CT-TOPO-Ldcen3 plasmid as a 
DNA template for a PCR reaction.  The amplified PCR product (L. donovani cenrtin3 
gene) was run via gel electrophoresis, and extracted using a Qiagen gel extraction kit. 
VR1012 plasmid was digested with Sall and BgIII restriction enzymes in order to create 
the complementary sticky ends. The digestion step was carried out as mentioned above. 
Empty VR1012 was removed from the gel and the DNA was dephosphorylated as 
previously described in section 2.2.2.1.3.   
The digested VR1012 plasmid and L. donovani cenrtin3 gene (PCR product), were 
mixed together at a ratio of 1:3 (plasmid: insert). T4 ligase enzyme and 10x buffer were 
added to the mixture and incubated at 4ºC overnight, as explained in section 2.2.2.1.4. 
The newly prepared VR1012-Ldcen3 DNA construct was transformed into E. coli cells 
as previously described in sections 2.2.2.1.5.1, 2.2.2.1.5.2 and 2.2.2.1.5.3. The presence 
of L. donovani cenrtin3 gene in VR1012 plasmid was confirmed as previously 
described in section 2.2.2.1.6.         
2.2.2.5 The construction of pcDNA3.1/Hygro(-)-Ldcen1 plasmid    
Hind III and Xba I restriction enzymes (Promega) were used to digest the empty 
pcDNA3.1/Hygro(-) and pCR®II-TOPO®-Ldcen1 plasmids, in order to obtain the 
linear form of the empty plasmid and L. donovani centrin1. The digested plasmids were 
subjected to 1.5% w/v agarose gel, and target DNA bands were excised as described in 
section 2.2.2.1.1. After DNA purification, the empty plasmid was dephosphorylated as 
previously described in section 2.2.2.1.3.     
Both the L. donovani centrin1 gene and pcDNA3.1/Hygro(-) plasmid were ligated with 
a ratio of 1:3 (vector: insert), transformation and confirmation steps of newly prepared 
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DNA construct (pcDNA3.1/Hygro(-)-Ldcen1) were performed as previously described 
for other constructs in this study. 
2.2.2.6 The preparation of the empty plasmids 
Restriction and digestion methods were used to prepare the empty VR1012 and 
pcRT7/CT-TOPO plasmids. VR1012-Lmexgp63 plasmid was digested with EcoRI 
restriction enzyme to remove the inserted L. mexicana GP63 gene, and pcRT7/CT-
TOPO-Ldcen3 was digested with Hind III and Xba I restriction enzymes to remove the 
L. donovani centrin3 gene. Both of the digested plasmids were subjected to 1.5% w/v 
agarose gel at 80 volts for 1 hour. The bands representing each plasmid were gel 
extracted, and the ends of each plasmid were re-ligated using T4 ligase enzyme as 
described above. The obtained products were used as DNA template to confirm the 
absence of the removed genes by PCR, L. mexicana GP63 gene and L. donovani 
centrin3 gene from VR1012 and pcRT7/CT-TOPO plasmids, respectively. 
2.2.3 Transfection of human cell line with DNA constructs 
The prepared Leishmania DNA constructs (Table 2.2.2) were transfected into the MCF-
7 (Michigan Cancer Foundation-7) human cell line to check the expression of these 
plasmids in eukaryotic cells using Lipofectamine™2000 Transfection Reagent. In the 
case of transfection with plasmids encoding L. mexicana GP63 gene, 
immunofluorescence staining was performed to check the expression of GP63 gene in 
transfected cells. Due to the lack of availability of anti-centrin antibodies, the 
expression of L. donovani centrin1 and L. donovani centrin3 was performed using 
qPCR analysis. 
2.2.3.1 Antibiotic sensitivity assay 
The MCF-7 cell line was obtained from Mr S. Reeder, JvGCRC, NTU, (ATCC- HTB-
22™) and grown in DMEM medium (Lonza, UK) supplemented with 10% v/v FCS 
and 1% v/v NEAA (Lonza, UK). In order to find the optimum cell number to be used 
in the antibiotic sensitivity assay, firstly MCF-7 cells were seeded at serial 
concentrations from 1x102 to 1x105 cells per ml per well in 24 well plates. Plates were 
incubated at 37ºC with 5% v/v CO2 incubator for 10 days. At the end of the incubation 
period, 1x103 cells resulted in gave 80% confluent. Therefore, MCF-7 cells were 
cultured in 24 well plates at the concentration of 1x103 per ml in the presence of serial 
concentrations of 500, 250, 125, 75µg per ml Geneticin (G418) in duplicate. 
Microscopic examination revealed that the lowest concentration of the antibiotic in 
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which all MCF-7 cells died in 8-10 days was 500µg per ml. A similar experiment was 
repeated in order to find the optimum toxic concentration of zeocin antibiotic. Cells 
were grown in a 24 well plate at the concentration of 1x103 in the presence of 100, 50, 
25, 12.5 and 6.25µg per ml. Plates were kept at 37ºC with 5% v/v CO2 for 10 days, the 
lower concentration at which all MCF-7 cells died was 50µg per ml. 
2.2.3.2 Transfection of MCF-7 tumour cells with DNA constructs 
MCF-7 tumour cells were transfected with pcRT7/CT-TOPO- L.mexgp63, VR10-
L.mexgp63 and pcDNA3.1-L.mexgp63 using Lipofectamine™ 2000   (Invitrogen, UK) 
according to the manufacturer’s instruction for adherent cells with slight modifications. 
Briefly, MCF-7 tumour cells were cultured at 5105 per well in 24-well plates, cells 
were allowed to adhere for 24 hours at 37ºC with 5% v/v CO2.  On the following day, 
Lipofectamine™ 2000-DNA construct complexes were prepared using serum-free 
Opti-MEM medium (Lonza, UK) to increase the efficiency of complex formation. 
Briefly, Lipofectamine™ 2000 and the required DNA were diluted in serum-free Opti-
MEM medium at 2µl/50µl and 1µg/50µl respectively, and incubated at room 
temperature for 5 minutes. The diluted Lipofectamine™ 2000 and DNA were mixed 
together and further incubated for 30 minutes at room temperature. The MCF-7 cell 
culture supernatant was removed and the Lipofectamine™ 2000-DNA was gently 
added at 100µl per well, followed by 6 hours incubation at 37ºC in an incubator with a 
5% v/v CO2, after which transfected cells were recovered in 1ml of fresh media. On the 
following day, the culture medium was replaced with 1ml of medium containing 
selective antibiotic at a concentration of 500µg or 50µg for Geneticin® (G418) or 
Zeocin, respectively. Cells were then cultured in the presence of the selective antibiotic 
for at least three passages before being  subjected to further analysis.  
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2.2.3.3 Detection of Leishmania genes in transfected cells 
 Detection of L. mexicana GP63 in transfected cells 
Immunofluorescence staining was used in this study to check for the presence of             
L. mexicana GP63 protein in cells transfected with DNA constructs encoding GP63 
gene. Briefly, after three passages in the selective media, transfected cells were cultured 
at a concentration of 5x105 for 24 hours on glass coverslips inserted into 24 well plates 
(the coverslips were dipped into 70% v/v methanol before use). On the following day, 
the culture medium was removed and cells were washed twice with 1xPBS. Cells were 
then fixed for 15 minutes at 4ºC using 500µl of 4% w/v paraformaldehyde (Sigma, 
UK). At the end of incubation period, the paraformaldehyde was removed and wells 
were washed once with 1xPBS. Coverslips were blocked with 500µl of blocking buffer 
(0.1% v/v Tween®20  and 5% w/v bovine serum albumin (BSA) in 1xPBS) for 1 hour 
at room temperature. Blocking buffer was then washed off using 1ml of washing buffer 
(0.1% v/v Tween®20 in 1xPBS). The monoclonal primary anti-GP63 antibody 
(GenWay, Switzerland) was diluted 1:500 using blocking buffer, and 300µl of diluted 
antibody was added to each well, plates were incubated over-night at 4ºC. Control wells 
were left without the primary antibody (just blocking buffer was added). On the 
following day, the coverslips were washed, using washing buffer, three times (each 
wash preformed for 10 minutes shaker). Goat-anti mouse IgG2a FITC (Serotec, UK), a 
secondary antibody, was diluted 1:1000 in blocking buffer and added to the coverslips 
(300µl per well), including the controls. Coverslips were light protected and incubated 
at 4ºC on a rocker for two hours. Finally, the coverslips were washed three times as 
above, and placed face down onto glass slide, and mounted with DAPI (Vector, UK), 
slides were visualized and imaged using fluorescence microscope (Olympus). 
 Detection of L. donovani centrin1 and L. donovani centrin3 in 
transfected cells by PCR 
Total mRNA was extracted from transfected cells (MCF-7) using a Qiagen kit, 
according to the manufacturer’s protocol. Extracted RNA was converted to cDNA 
using M-MLV (Moloney murine leukaemia virus) enzyme (Promega, UK) method 
following the manufacturer’s protocol. Obtained cDNA was used as DNA template for 
qPCR, using the following primers:  
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Table 2.2-5 L. donovani centrin primers used to detect centrin1 and centrin3 genes in 
transfected MCF-7 cell line 
 
 
2.2.4 The immunological protocols 
2.2.4.1 The preparation of soluble Leishmania antigens (SLA), and 
protein quantification 
The late log phase of L. mexicana promastigotes M379 (≤ 2x107 promastigotes per ml), 
growing in Schneider’ Drosophila medium supplemented with 10% v/v HIFCS were 
centrifuged at 2000g at 4ºC for 10 minutes. The supernatant was discarded and the pellet 
was washed five times with sterile 1xPBS. The pellet was re-suspended in sterile 1xPBS 
(500µl for 2x107 promastigotes) and exposed to five cyclic of freezing and thawing in 
liquid nitrogen. The lysate was further homogenised using a Pellet Pestles (Sigma, UK). 
The protein concentration of the product was quantified, and kept at -80ºC for further 
use. The total protein concentration of extracted protein was measured using a 
Bicinchoninic Acid Protein Assay Kit (Sigma, UK), according to the manufacturer’s 
protocol. Briefly, a Nunc-Immuno 96 Micro Well™ Plate was loaded with serial 
dilutions of BSA protein (Sigma, UK) in order to create a standard curve (Appendix 5) 
consisting of 7 concentrations using a stock of BSA (Sigma, UK) in 1xPBS solution at 
a concentration of 1mg per ml. Following thorough mixing, a volume of 25µl from each 
concentration as well as unknown samples (SLA) were plated in triplicate. A volume 
of 200µl working reagent (1:50, buffer B: buffer A, respectively) was added to each 
well. The plate was light protected and kept for 30 minutes in a 37ºC incubator. Colour 
development was measured using a Spectrophotometer at an absorbance of 570nm 
according to the manufacture’s protocol.   
Gene name Primer pair sequence  M°C Pro. size (bp) 
L. donovani 
cenrtin1 
F.P.CGATGTGCTGAAGGAGATGA 
R.P. ACGCTCTTGAACTCCTCGAA  
60 78 
L. donovani 
centrin3 
F.P. GAGAGGCATTCGAGCTGTTC 
R.P. GCATGCTGACCTTCATCTCA 
60 72 
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2.2.4.2 Gene-gun gold bullets preparation 
Plasmid constructs encoding Leishmania spp genes were coated onto 1.0µm gold 
microcarrier beads according to the manufacturer’s instructions. Briefly, in order to 
help the DNA binding to the gold, 200µl of spermidine (Sigma, UK) was mixed with 
16.6 mg of gold (Bio-Rad, UK), the solution was well mixed, and 36µg of the DNA 
construct was added. After 10 seconds sonication, 200µl of 1mM CaCl2 was added drop 
wise to the mixture while sonicating. To precipitate the DNA, the mixture was allowed 
to stand for 10 minutes at room temperature. Precipitated gold-DNA complex was 
pelleted by centrifugation 8000g for 5 minutes, and the pellet was washed three times 
with 1ml of 100% v/v anhydrous ethanol (Sigma, UK). After the last wash, the gold-
DNA pellet was re-suspended in 2ml of 0.025mg/ml polyvinylpyrrolidone (PVP) in a 
sterile 15ml conical tube. The gold PVP solution was then loaded into dried Tefzel 
tubes using a 5 ml syringe. The solution was left to settle for 30 minutes on the Prep 
Station, so the gold particles settled to the bottom of the tube. The supernatant was 
gently poured off using the attached syringe. The tube was rotated for 5 seconds and 
then left to dry by turning the N2 gas on for 20 minutes. The plastic tubing was removed 
from the Prep Station and cut using a guillotine into 1 cm (bullets) that will be loaded 
into the gene gun. DNA Bullets were kept at 4ºC until require. 
2.2.4.3 Immunisation with DNA constructs  
 Animals  
Balb/c mice were obtained from Charles River, UK and Harlan. All animals were 
handled in accordance with the Home Office Codes of Practice for the housing and care 
of animals and procedures were performed under the relevant Project Licence 40/3317, 
in the BSF unit at Nottingham Trent University. 
 DNA bullets immunisation 
A comprehensive study was designed in order to investigate the immunogenicity of the 
prepared DNA constructs according to the Table 2.2.3. 
Groups of 4 female Balb/c mice were immunised 3 times with 1µg DNA of each vector 
coated on gold particles (prepared in section 2.2.4.2), using a Gene Gun (Bio-Rad, UK) 
on a shaved area of the Balb/c abdomen according to following schedule:  
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Two controls were considered in this study, mice immunised with empty gold bullets 
(just gold without any DNA), and mice immunised with empty plasmids. Fourteen days 
after the last immunisation, all mice were killed using carbon dioxide (CO2) euthanasia. 
On the day of harvesting the following tissues where collected from each mouse. 
1) Blood samples were collected by cardiac puncture and serum prepared for the 
analysis of the presence of antibody responses (total IgG, IgG2a and IgGb) 
using Enzyme-linked immunosorbent assay (ELISA). 
2)   Spleens were collected and splenocytes prepared for the analysis IFN-γ 
secretion, proliferation assay and CD4+, CD8+ profiling using flow cytometry 
analysis. Supernatants from the functional assays were collected for the 
determination of IL-2, IL-4 and IFN-γ levels by ELISA. 
3)  Lymph nodes were collected and lymph node cells prepared for the analysis of  
proliferation and CD4+, CD8+ profiling using flow cytometry analysis. 
Supernatants from the functional assays were collected for the determination of 
IL-2, IL-4 and IFN-γ levels by ELISA. 
4)  Bones were collected to generate bone marrow-derived macrophage (BM-DM). 
2.2.4.4 Preparation of splenocytes suspension 
Spleens from immunised and control mice were harvested under sterile conditions. The 
spleen bags containing the splenocytes were flushed out using serum-free RPMI 1640 
medium using a 25g needle and 5 ml syringe. The splenocyte suspensions were 
transferred into 15ml tube and centrifuged at 800g for 5 minutes at 4ºC. The supernatant 
was aspirated, and the pellet was re-suspended in 3ml of T cell medium (RPMI 1640 
medium supplemented with 10% v/v FCS, 20mM HEPES, 50μM 2 Mercaptoethanol, 
50µM per ml penicillin-streptomycin and 0.25μg per ml Fungizone). Cells were 
counted using trypan blue solution, and cultured at different cell number concentrations 
according to the need of each assay. 
2.2.4.5 Preparation of lymphocytes suspension 
Ten lymph nodes from each mouse were collected and placed into 1.5 Eppendorf 
containing 1 ml of PBS. Under sterile conditions, the lymph nodes were washed three 
2) Materials and Methods 
 
71 
 
times with serum-free medium, and homogenised using disposal pellet pestles (Sigma, 
UK). The suspension of lymphocytes was washed twice before counting using trypan 
blue solution. Lymphocytes were cultured in RPMI 1640 medium supplemented with 
10% v/v FCS, 20mM HEPES, 50μM 2 Mercaptoethanol, 50µM per ml Penicillin-
Streptomycin and 0.25μg per ml Fungizone. 
2.2.4.6 IFNgamma Elispot assay   
The Enzyme-Linked ImmunoSpot (Elispot) assay was used in the current study to 
detect the secreted IFN-γ by splenocytes of immunised mice in response to in vitro 
stimulation with L. mexicana Soluble Antigen (SLA). The Elispot assay was preformed 
according to the manufacturer’s protocol with minor modifications. Briefly, a day 
before harvesting, MultiScreen® plates were pre-wetted with 100µl of 35% v/v ethanol 
for 1 minute. Each plate was then washed three times with sterile phosphate buffered 
saline (PBS) after tapping it against a clean tissue paper to remove any residual liquid. 
The required mouse IFN-γ capture antibody was diluted 1:60 in PBS and loaded onto 
the Elispot plate (100 µl per well), and incubated overnight at 4ºC. On the day of 
harvesting, the capture antibody solution was removed, and the plates were washed 
three times with sterile PBS and blocked with C.T.L-Test™ Medium (Cellular 
Technology Ltd, UK) for 2 hours at 37ºC in a 5% v/v CO2 incubator. Splenocytes from 
immunised mice and controls were seeded at a concentration of 1x106 in 100µl of T 
cell medium. Cells were stimulated with another 100µl per well of fresh media contain 
10µg SLA per ml. Plates were then incubated at 37ºC in an incubator with a 5% v/v 
CO2 atmosphere. After 48 hours, plates were re-stimulated with 30 and 50µg per ml 
SLA and incubated for a further 24 hours. The test was performed in triplicate for each 
concentration. A positive control was also used for each plate using Staphylococcal 
enterotoxin B (SEB) (Sigma, UK) at a concentration of 20µg per ml.  At  the end of the 
incubation period, culture medium was removed, and the Elispot plates were washed 
four times using wash buffer (0.05% v/v Tween®20 in PBS), and wells were loaded 
with 100µl of mouse IFN-γ detection antibody diluted in filtered reagent diluent (1% 
w/v BSA in PBS, pH 7.2-7.4). Plates were covered and incubated overnight at 4ºC. On 
the following day, the plates were developed using Elispot Blue Color Module (R&D 
system, UK). Briefly, the detection antibodies were completely removed from the plates 
by three washes with washing buffer, and a further three washes with 1xPBS, followed 
by three washes with distilled water.  Plates were blotted against a clean tissue paper, 
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and loaded with 100µl of Streptavidin-AP diluted 1:60 in reagent diluent, then,  
protected from the light were incubated for 2 hours at room temperature. The plates 
were then washed three times with wash buffer and distilled water, then loaded with 
provided BCIP/NBT solution (100µl per well) and incubated for 30 minutes at room 
temperature. Plates were then washed with deionized water and allowed to dry in the 
dark at room temperature. Developed spots were counted automatically using an Elispot 
reader (Cellular technology Limited, UK). 
2.2.4.7 CD4 and CD8 profiling by flow cytometric analysis 
In order to monitor the effect of the Leishmania DNA constructs on the percentage 
ratios of CD4+ and CD8+ in the spleens and lymph nodes of the immunised mice and 
controls, 106 cells of splenocytes and lymphocytes per FACS® tube were stained for 
their expression of CD4+ and CD8+ and analysed using flow cytometry. Briefly, cells 
were placed in FACS® tubes at a concentration of 1x10 cells per tube. Cells were then 
washed twice with two ml of FACS buffer (1xPBS containing 0.1% w/v BSA plus 0.1% 
NaN3) at 400g and 4°C for 5 minutes. Both rat-anti mouse CD4: FITC and rat-anti 
mouse CD8: RPE (Serotec, UK) were diluted 1:10 in FACS buffer, and 10µl of diluted 
antibody were simultaneously added to the test FACS tubes. Relevant isotopes, rat 
IgG2a negative control: FITC and rat IgG2a negative control: RPE (Serotec, UK) were 
treated similarly and added to isotype tubes. Cells were light protected and incubated 
for 20 minutes at room temperature. Cells were then washed twice with 2 ml of FACS 
buffer.  After the last wash, cells were re-suspended in 250µl of Isoton, and analysed 
using a Beckman Coulter Gallios, 10 colour flow cytometer (Beckman Coulter, UK).  The 
results were presented as percentage of positive CD4 and/or CD8 compared to the whole 
population of splenocytes or lymphocytes.  
2.2.4.8 Proliferation assay 
A proliferation assay was used in this study to analyse responses to immunization with 
the gene gun. The increase in DNA synthesis as result of splenocytes proliferation was 
measured by adding [3H]-Thymidine, a radioisotope-DNA labelling agent. Briefly 
splenocytes and lymphocytes were counted and plated at a concentration of 5x105 in 
100µl of T cells medium per well in a round bottomed 96-well plate. Cells were 
stimulated with 10µg per ml SLA in 100µl of culture media (just culture medium 
without SLA was added to the control wells). Plates were then incubated at 37°C in a 
5% v/v CO2 incubator. 72 hours later, the splenocytes and the lymphocytes were re-
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stimulated with 30 and 50µg SLA per ml and plus [3H] Thymidine 1µ Ci per well. The 
plates were further incubated for 72 hours at 37°C in 5% v/v CO2 incubator. The test 
was performed in triplicate for each concentration.  At the end of the incubation period, 
plates were harvested onto a 96 well UniFilter GF/C plate, using Filtermate Harvester 
(Packard), and left to dry for a few hours at room temperature. Newly synthesised DNA 
was measured using TopCount Nxt™ (Packard, UK). 
2.2.4.9 ELISA assays (IFN-γ, IL-4 and IL-2) 
ELISA (Enzyme-linked immunosorbent assay) approaches were used to estimate the 
concentration of IFN-γ, IL-4 and IL-2 cytokines. Splenocytes and lymphocytes (from 
spleens and lymph nodes, respectively) were cultured at a concentration of 106 per well 
per ml of T cells medium using 24 well plates. Two doses of SLA were used to stimulate 
the cells, 30 and 50µg SLA per ml. Plates were then incubated at 37ºC in 5% v/v CO2 
incubator. Supernatant (900μl) was collected from control and test wells at 2 time points 
(day 3 and day 5) of the culture. Samples were kept at -20ºC until analysis for cytokine 
levels. The levels of IFN-γ, IL-4 and IL-2 in the culture supernatant of splenocytes and 
lymphocytes were determined using commercially available Deu-Set ELISA Kits 
(R&D System, UK). The assays were carried out following the manufacturer’s 
instructions.  
2.2.4.10 Detection of anti-Leishmania IgG, IgG2a and IgG1 isotype 
antibodies   
On the day of harvesting, blood samples from immunised and control mice were 
collected as described in section 2.2.4.3.2. The blood samples were stored at 4°C for 
eight hours, and the serum was harvested from each sample by centrifugation at 8000g 
for 15 minutes. The serum was collected and stored at -20ºC. Total IgG, IgG1 and 
IgG2a was estimated by ELISA. Briefly, a flat-bottomed 96-well plate (Fisher 
Scientific, UK) was coated with 100µl per well of coating buffer (50mM sodium 
carbonate buffer, pH 9.6) containing a 5µg per ml L. mexicana SLA.  The plates were 
sealed and incubated overnight at 4ºC. After 3 washes with washing buffer (1x PBS and 
0.05% v/v Tween 20), the plates were blocked with blocking buffer (1% w/v casein in 
1xPBS) for 1 hour at 37ºC in an incubator. Plates were washed 4 times with washing 
buffer, and 100µl per well of 1:100 dilution of the serum samples in 1xPBS were added. 
They were then sealed and incubated at room temperature for 2 hours.  Plates were 
washed 4 times with shaking for 1 minute per wash using washing buffer. Goat anti-
2) Materials and Methods 
 
74 
 
mouse IgG2a: HRP (Serotec, UK), Rabbit anti-mouse IgG1: HRP (Serotec, UK), or 
Goat anti-mouse IgG (Abcam, UK) were diluted at 1:8000. 1:100000, and 1:100000 
(antibody: blocking buffer) respectively were added at a volume of 100µl per well. 
Plates were light protected and incubated at room temperature for 1 hour.  At the end 
of the incubation period, the plates were washed as described above, and 100µl of 
substrate solution (1: 1 reagent A: reagent B) was added to each well. Plates were 
incubated for 20 minutes at room temperature. The reaction was stopped by adding 50µl 
of 2.5M H2SO4, and the absorbance (OD) was measured at 570 nm by 
spectrophotometer. 
2.2.4.11 The generation of bone marrow-derived macrophages (BM-
DMs) 
Hind limbs of naïve and immunised Balb/c mice were collected on the day of harvesting 
and used to generate the adherent bone marrow-derived macrophages (BM-DMs), 
according to Inaba, et. al., (1992) protocol. Briefly, tissues and muscles were 
completely removed using scalpel and tweezers under sterile conditions. Bone-marrow 
cells were flushed out after cutting the ends of the bones. Cells were then centrifuged 
at 400g at 4ºC for 5 minutes, and the pellet was re-suspended in 2ml of fresh BM-DC 
medium. Cell counting was performed using 0.4% w/v trypan blue stain in phosphate 
buffered saline (Sigma, UK), and plated in 24 well plates at a concentration of 106 cells 
per well per ml of fresh media supplemented with 1µg per ml of Granulocyte-
macrophage colony-stimulating factor (GM-CSF), (Sigma, UK). Plates were then 
incubated at 37ºC in 5% v/v CO2 under 95% v/v humidity. On days 2 and 4, BM-DCs 
were washed by gently changing 75% of old medium (containing non-adherent DCs) 
with fresh DC medium containing GM-CSF. On day 6, adherent BM-DM were gently 
detached using Pasteur pipettes and seeded in 24 well plates at a concentration of 2x105 
cells per well.  4-6 hours later cells were pulsed with1µg Lipopolysaccharides (LPS), 
(Sigma, UK), and incubated at 37ºC in 5% v/v CO2 under 95% v/v humidity for 24 
hours.   
Before processing, the obtained macrophages were phenotypically characterised for the 
expression of specific mouse macrophage marker (F4/80) and dendritic cells CD11c 
marker by flow cytometric analysis. Using the Serotec rat anti-mouse F4/80: FITC and 
its relevant isotype IgG2b, and Hamster anti-mouse CD11c: FITC and its relevant 
isotype IgG antibodies. 
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2.2.4.12 Survival assay 
A new assay to measure the susceptibility of BM-DMs from controls and immunised 
mice to Leishmania infection was established for the first time in this study. Matured 
BM-DMs from naïve and immunised mice were infected with late log phase of virulent 
L. mexicana promastigotes at a ratio of 1:10 (cell: parasite). Infected cells were 
incubated under 95% v/v humidity at 37ºC in a 5% v/v CO2. Six hours after the 
infection, free promastigotes were removed by changing the medium, and infected cells 
were further incubated under the same conditions for 48 hours. Afterwards, infected 
macrophages were first detached using Pasteur pipettes, and then homogenized by 
passing them through a 0.25G needle at least five times in order to obtain a suspension 
of single L. mexicana amastigotes. The homogenised BM-DMs were completely 
removed by centrifugation of the homogenized cell suspension at 1000g and 4ºC for 10 
minutes. The supernatant, which contained the amastigote stage, was transferred into 
new sterile 15ml tubes, which were further centrifuged at 3000g and 4ºC (to pellet the 
amastigote stage) for 15 minutes. The supernatant was then discarded and the pellet 
was washed three times using sterile PBS re-suspended in 5 ml of Schneider’s 
Drosophila medium supplemented with 20% v/v HIFCS in a T25 tissue culture flask. 
5x105 amastigotes from each sample of infected macrophages (generated from controls 
and immunised mice), were then kept at 25ºC and monitored for promastigote stage 
recovery for up to two weeks. A 50µl of culture medium (supernatant) from each well 
for each mouse was collected at 30 minutes, 24 and 48 hours to be used for IFN-γ 
estimation using the ELISA method and for the measure of nitrite levels using standard 
Griess Reagent System according to the manufacturer’s protocol.  
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 IFN-γ and nitrite concentration 
The level of IFN-γ in culture media was measured using commercial Deu-Set IFN-γ 
ELISA Kits (R&D System, UK) according to the manufacturer’s protocol. Standard 
curve was produced for each experiment (Appendix 6). Measurement of nitrite in the 
culture medium was performed using Griess Reagent System (Promega, UK) with all 
the samples were immediately subjected to nitrite concentration analysis after 
harvesting. Briefly, 50µl of experimental sample was plated into a 96 well plate 
(Sarstedt, UK) then the test was carried out in triplicate. 50µl of the provided 
Sulfanilamide solution was added to each well, and the plate was then light protected 
and incubated at room temperature for 10 minutes. After the first incubation time,  50µl 
of NED solution was added to all samples, and the plate was also light protected and 
further incubated for an extra 10 minutes at room temperature for colour development. 
Absorbance was measured using an Asys UVM 340 Microplate Reader (Biochrom) at 
495nm. The standard reference curve (Appendix 8), for quantification of nitrite 
concentration was performed for each experiment as follows.  The provided 0.1M nitrite 
standard was diluted 1:1000 in RPMI medium in order to prepare  1ml of 100µM nitrite 
solution, then serially diluted to give 100, 50, 25, 12.5, 6.25, 3.13, 1.56 and 0.0µM 
nitrite solution.  
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2.2.5 L. mexicana infectivity and susceptible human cell lines 
2.2.5.1 Cell lines and parasite 
 MonoMac-6 cell line  
The human monocytic cell line MonoMac-6 was obtained from DSMZ-German 
(DSMZ no. ACC124).  MonoMac-6 cells were cultured in a complete RPMI medium, 
supplemented with 10% v/v FCS, 2mM L-Glutamine, 1mM Na pyruvate, 1% v/v non-
essential amino acids, 9µg/ml bovine insulin and Penicillin-Streptomycin 200µg/ml. 
Cells were maintained at a concentration of 1-5x105 cells/ ml using 25 or 75cm3 tissue 
culture flasks, under 95% v/v humidity at 37ºC in a 5% v/v CO2 incubator. Cultured 
cells were checked and maintained  regularly. 
 U937 monocytes cell line 
The human U937 monocyte cell line was a kind gift from Prof. SJ Forsythe, Pathogen 
Research Group, NTU. U937 monocyte cells were cultured according to ICLC, in 
RPMI 1640 supplemented with 10% v/v FCS, 2mM L-Glutamine and 200µg/ml of 
Penicillin-Streptomycin. Cells were grown under 95% v/v humidity at 37ºC in a 5% 
v/vCO2 incubator. Cells were sub-cultured regularly every 2-3 days to keep them at a 
concentration of 3-5x105 cells per ml. 
 W6/32HK Hybridoma cell line  
Mouse hybridoma W6/32 cell line was obtained from European Culture Collection 
(Catalogue No. 84112003). Cells were maintained in RPMI supplemented with 10% 
v/v FCS and 2mM glutamine in a T25 tissue culture flask, under 95% v/v humidity at 
37ºC in a 5% v/v CO2 incubator. In order to collect the supernatant containing anti-
human HLA (MHC I) antibodies from the culture of W6/32, cells were seeded in 5 ml 
of fresh media per T25 flask and cultured until they became 80% confluent. The old 
culture medium was replaced by 5 ml of fresh medium, and cells were incubated for at 
least 2 weeks before supernatant-containing antibodies (mouse monoclonal mouse anti- 
HLA antibodies) were collected. Supernatants were centrifuged at 400g and 4ºC for 3 
minutes, supernatant was passed through a 0.25µm filter for sterilisation, and stored at 
-80ºC. 
 Maintaining the Leishmania mexicana parasite 
The Leishmania mexicana (MNYC/BZ/62/M379) strain was obtained from Dr V. 
Yardley, The London School of Hygiene and Tropical Medicine (LSHTM). The 
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virulency of L. mexicana promastigotes was maintained by continuously passaging 
them in susceptible Bulb/c mice. Groups of three Balb/c mice were injected intra-
dermally with 2x106 stationary phase L. mexicana promastigotes in a total volume of 
50µl per mouse in sterile 1xPBS. Mice were injected in a shaved area at the back about 
1cm from the tail base. The maintenance and care of mice were according to the 
guidelines of the Home Office. Mice were killed when they developed the required 
lesion. After two passages of amastigotes in Drosophila Schneider media (Lonza, UK), 
supplemented with 10% v/v HIFCS at 25ºC, obtained promastigotes were further 
cultured and frozen in liquid nitrogen for future work. 
2.2.5.2 The genetic identification of L. mexicana parasite 
The obtained parasites were genetically confirmed as L. mexicana species, by 
Restriction Fragment Length Polymorphism analysis (RFLP), using the method of 
Schonian, et. al., (2003) method, with minor changes. First, the genomic DNA was 
extracted from late log L. mexicana promastigote culture using an InstaGene™ Matrix 
kit (Bio-Rad, UK) according to the manufacturer’s instructions.  Briefly, 200µl of late 
log parasite culture was pelleted at 2000g for 5 minutes, and the pellet was washed three 
times with sterile 1xPBS, and then re-suspended in 30µl of autoclaved nuclease free 
water. 20µl of the parasite lysate was mixed with 200µl of InstaGene™ matrix, and 
incubated at 56ºC for 30 minutes. The suspension was then vortexed and incubated at 
100ºC using a heat block for 8 minutes. The product was stored at -20ºC to be used as 
DNA template. Ribosomal internal transcribed spacer (IST1) region was amplified by 
PCR from extracted genomic DNA. The PCR reaction was set up in a 20µl final volume 
as follows: 1µl of 10µM OL1853 primer (CTGGATCATTTTCCGATG), 1µL of 10µM 
OL1854 primer (TGATACCACTTATCGCACTT), 1µl of genomic DNA, 4µl of 
5xGreen GoTaq® Reaction Buffer, 0.2µl of GoTaq® Flexi DNA Polymerase, 0.4µl 10 
mM dNTPs and 11.4µl nuclease-free water. The reaction was carried out in duplicate 
using a Primus Advanced Thermal Cyclers PCR machine (Geneflow, UK). PCR 
conditions were as following: initial denaturation at 95ºC for 5 minutes followed by 40 
cycles of 95ºC for 40 seconds denaturation, 53ºC annealing temperature for 40 seconds, 
extension step at 72ºC for 50 seconds, final extension at 72ºC for ten minutes, the final 
hold was at 4ºC for 24 hours. The obtained PCR product was digested with Hae III 
enzyme (Promega, UK) for 45 minutes at 37ºC, and the digested product was loaded 
into 2% w/v agarose gel electrophoresis for 2 hours. 
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2.2.5.3 L. mexicana promastigote growth characteristics 
 The effect of in vitro passaging on growth curves 
The L. mexicana parasite was derived from freshly harvested lesions from infected 
Balb/c mice by culturing the homogenised lesion in Drosophila Schneider media 
(Lonza, UK), supplemented with 10% v/v HIFCS (Fisher, UK) at 25ºC. L. mexicana 
promastigotes from passage 1 (P1) were further cultured at a concentration of 1x105 
cells per ml up to passage 20 (P20), the parasite was grown under an anaerobic 
conditions in unvented flasks, this was done by properly ceiling the flask with parafilms 
(the efficacy ceiling was compared with culturing the parasite under strict bacterial 
anaerobic conditions). To count the parasite, 10µl material from the culture was fixed 
with 2% w/v paraformaldehyde and counted using a Neubauer hemocytometer. The 
growth curves of the parasite at passages 1, 7 and 20 were performed using 3 cultures 
for each passage number in each experiment, which was initiated at a concentration of 
1x105 promastigotes per ml. Experiments were repeated 3 times using different frozen 
aliquots. To monitor the morphological changes that were accruing over the culture 
period, 100µl from each flask at the late log stage, at each passage number was 
subjected to cell size and flagellum length measurement using a calibrated micrometer 
slide. Parasites with straight flagellum were measured to determine the average length 
of their bodies and flagella (Appendix 16). 
 The effect of in vitro passaging on virulence-associated genes 
In order to examine and follow up the changes that occurred in the gene expression 
profiles of some of the genes related to parasite infectivity during their in vitro 
passaging, quantitative polymerase chain reaction qPCR analysis was used. The total 
mRNA from metacyclic promastigotes at P1, P7 and P20 was extracted. Briefly, 1x108 
L. mexicana promastigotes from each passage number was pelleted at 2000g for 10 
minutes, followed by five washes with sterile PBS. The washed pellet was subjected to 
RNA extraction using Qiagen kit according to manufacturer’s protocol as described in 
section 2.2.5.6.1. RNA quality and quantity were checked by 1.5% w/v agarose gel 
(Appendix 9.B), and Nano Drop®8000 Spectrophotometer (Appendix 11). Since 
mRNA is unstable and easily degraded, it was necessary to reverse transcribe (RT) the 
single strand mRNA to complementary DNA (cDNA). 
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 cDNA Synthesis 
Since mRNA is unstable and easily degraded, it was necessary to reverse transcribe 
(RT) the single strand mRNA to complementary DNA (cDNA). The synthesis of single-
stranded cDNA was performed using M-MLV reverse transcriptase (Promega, UK), 
following the manufacturer’s protocol. Each reaction was carried out in duplicate, under 
sterile conditions. 1µg of mRNA was diluted in 13µl of nuclease-free water and 
incubated at 70ºC in a block heater with 1µl (0.5µg per µl) Oligo (dT)15 primer for 5 
minutes to denature the RNA secondary structure. The mixture was incubated on ice 
for 5 minutes to allow the primers to anneal to the mRNA. A mixture of 5µl of 5x 
reaction buffer, 1µl of  10mM dNTPs, 0.7µl of 25 Units rRNasin® ribonclease inhibitor 
and 1µl of 200 units M-MLV RT was added to each tube of the annealed 
primer/template, and the total volume was adjusted to 25µl using nuclease-free water. 
The tubes were mixed and incubated at 39ºC for 80 minutes. The synthesised cDNA 
was heated up to 90°C for 5 minutes to de-activate the enzymes. Quality and quantity 
of synthesised cDNA was determined using gel electrophoresis and a Nanodrop 8000 
Spectrophotometer, respectively. The product was stored at -20ºC.  
qPCR analysis was performed using specific primers for amplification of each gene. 
Primers were designed using online Primer3Plus software according to their sequence 
given by the National Centre for Biotechnology Information (NCBI). The names, 
accession numbers of the chosen genes, Primer pair sequence, product size and melting 
temperatures are listed in (Table 2.2.6).  
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Gene 
name 
Accession 
No. 
Primer Sequence Prod. 
size 
MT 
°C 
histone 
H4 
XM-
003879078 
F.P.TCTCGAGCGACATCTACGAA 
R.P.CGCACAATATCCTCCACGTA 
110 bp 57.3 
L.dcen 
 
AF406767 F.P.ACGATGTGCTGAAGGAGATG 
R.P.CAGCATCACGCTCTTGAACT 
186 bp 60  
L.mex 
Cht1 
AY572789 F.P.TCAGGACTCGTTCCACTACG 
R.P.ACCTCGGCACTGAAGAAGAT 
72 bp 58  
L.mex 
CPB2 
AJ319727 F.P.ACGTGTTGATCGGAAGCAG 
R.P.CAGCGTGGTTCACCTCTTTA 
147 bp 60  
L.mex 
CPB2.8 
Z49962 F.P.CGTGCCTGCTCAGTGAATAC 
R.P.GATCACCTGCTCCACCATC 
116 bp 60  
L.mex 
CPC 
Z48599 F.P.GTGACAACGTCGAGATGGAG 
R.P.TACACCTGCATGGCTACCTC 
124 bp 60  
L.mex 
gp63-C1 
X64394 
 
F.P.ACCGTCTGAGAGTCGGAACT 
R.P.GTAGTCCAGGAATGGCGAGT 
113 bp 60  
L.mex   
  LPG2 
AJ278970 
 
F.P.CATTTGGTATCCTGGTGCTG 
R.P.GAGGAAGCCACTGTTTAGCC 
120 bp 58  
L.mex-α 
tubulin 
DQ450541 F.P.CTATCTGCATCCACATTGGC 
R.P.ACTTGTCAGAGGGCATGGA 
111 bp 60  
L.mex-β 
tubulin 
M23441 F.P.GCGCTTTCTTCACTGGTACA 
R.P.TGGTACTGCTGGTACTCGGA 
65 bp 60  
LACK AF363976 F.P.GGTCGTACATCAAGGTGGTG 
R.P.GACCGTAGTCGCTGTCCAC 
96 bp 60  
Sherp XM-
003875691 
F.P.GACAATGCGCACAACAAGAT 
R.P.GTCCTTGATGCTTTCAATCG 
100 bp 57.3 
 
Table 2.2-6 List of L. mexicana virulence-associated genes 
Primer pair sequence, accession number, product size and melting temperature (MT) 
of the primers used in qPCR  
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 The effect of in vitro passaging on L. mexicana GP63 protein 
expression   
The effect on GP63 protein in L. mexicana promastigotes due to in vitro culturing was 
examined by Immunofluorescence staining. The promastigotes from late log phase 
culture of passages 1, 7 and 20 were subjected to immunofluorescence staining using 
anti L. major GP63 antibody (GenWay, Switzerland). Briefly, L. mexicana 
promastigotes (1x106) from the late log stage of each passage number, and late log stage 
of L. major promastigotes was used as positive control. L. major and L. mexicana 
promastigotes from each passage number were pelleted, washed twice with 1xPBS, and 
fixed in 1% w/v paraformaldehyde for 30 minutes at room temperature. The samples 
were then treated with 0.1M glycine (Sigma, UK) for 10 minutes at room temperature. 
The parasites were then washed with 500µl of PBS, and re-suspended in 100µl of 
1xPBS. A volume of 50µl of the parasite suspension was placed on polystyrene tissue 
culture treated glass slides, and incubated overnight at 4ºC (to allow parasite 
attachment). On the following day the slides were blocked with 200µl per well of TB 
buffer (0.1% w/v BSA in 1xPBS with 0.1% v/v Triton X100) for 10 minutes. The 
primary anti-L. major GP63 antibody was diluted in TB buffer, 200µl added to each 
well (no antibody was added to control wells), and incubated over-night at 4°C. The 
primary antibody was then washed off three times with 1xPBS, 200µl per well of 
diluted goat anti-mouse IgG2a FITC (Serotec, UK) in TB buffer (secondary antibody) 
was added, and the slides were light protected and incubated for 1 hour at room 
temperature. The slides were then washed three times with 1xPBS mounted with DAPI 
(Vector, UK), examined and imaged using a fluorescence microscope (Olympus). 
 The effect of in vitro passaging on in vivo infectivity of                   
L. mexicana 
Groups of three Balb/c mice were inoculated in a shaved area at the back about 1 cm 
from the tail base with 2x106 of late log  phase L. mexicana promastigotes  at passage 
1 (P1), passage 7 (P7), or passage 20 (P20) in a total  volume of 50µl per mouse in 
sterile 1xPBS. Mice were kept under standard conditions and monitored regularly for 
lesion development. In this study L. mexicana promastigotes P1 and P20 will be called, 
for simplicity, virulent and avirulent parasites, respectively.  
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2.2.5.4 L. mexicana promastigotes-host cell interactions  
 Host cells 
In addition to the use of MonoMac-6 and U937 cell lines as monocytes (sections 
2.2.5.1.1, and 2.2.5.1.2), U937 monocytes were induced to differentiate into human 
macrophage-like cells using Phorbol 12-myristate 13-acetate (PMA, Sigma, UK) (Kim, 
et. al., 1998). In this study, the ability of LPS (Sigma, UK) to induce U937 macrophages 
was also examined. Briefly, U937 monocytes were plated in 24-well tissue culture 
plates at a concentration of 2x105 cells per well per ml, using the culture medium 
described in section 2.2.5.1.2, and validation experiments were performed to determine 
the optimum concentration to be used. Briefly, four concentrations of 1, 2 and 5 µg per 
ml of PMA or LPS were used to mature U973 cells for 48 hours.  Macrophage 
maturation was monitored by the expression of human macrophage CD14, CD68 and 
F4/80 markers using qPCR and flow cytometric analysis. 
 Characterisation of the U937 macrophage cell line 
Three methods were used to confirm the maturation of U937 monocytes into U937 
macrophages: Firstly, U937 macrophages were subjected to mRNA extraction using 
RNA kit (Qiagen, UK). The obtained mRNA was converted to cDNA, which was used 
as template for qPCR analysis to check the gene expression of the (F4/80, CD14, and 
CD68) macrophage markers.  Although the F4/80 primers were initially designed for 
mouse Emr1, they amplified the human Emr1 gene due to the high similarity between 
the two genes, (Table 2.2.7).  
Secondly, the maturation of U937 monocytes was confirmed by staining induced 
macrophages with antibodies to CD14, CD68. (Biolegend, UK) and F4/80 (Serotec, 
UK) and analysing these by flow cytometry. 
Thirdly, the phagocytic ability of matured U937 cells (macrophages) was assessed by 
a bead up-take assay compared to U937 monocytes. Here, U937 cells were cultured in 
the presence of 1, 2 and 5 µg/ml of PMA per ml for 48 hours. U937 macrophages were 
mixed with 1µl latex beads (Sigma, UK) and cells were further incubated for 24 hours. 
On the following day, cells were washed at least three times using sterile PBS and fixed 
with 2% w/v paraformaldehyde for 5 minutes. Coverslips (macrophages) or smears 
(monocytes) were mounted with DAPI (Vector, UK), up-taken beads by U937 
macrophages and U937 monocytes were counted using a Leica TCS SP2 confocal 
microscopy. 
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Gene 
Name 
Accession 
Number 
Primer pair Sequence 
Product 
size 
MT 
°C 
CD14 NM-000591 
F.P. CACAGGTTCCTGCTCAGCTA 
R.P. AGCTGGAAAGTGCAAGTCCT 
144 bp 60 
CD68 NM-01040059 
F.P.GCGGTGGAGTACAATGTGTC 
R.P.GTGGACAGCTGGTGAAAGAA 
144 pb 60 
F4/80 NM-010130 
F.P.TTGGCCAAGATTCTCTTCCT 
R.P.TCACTGCCTCCACTAGCATC 
127 bp 58 
 
Table 2.2-7 Primers of human macrophage markers 
Gene names, accession numbers, primer pair sequence, product size and melting temperature 
(MT°C) of the primers used for characterisation of U937 macrophages 
 
 In vitro infection of U937 monocytes and U937 macrophages 
cell lines with L. mexicana 
U937 monocytes and U937 macrophages cells were infected with the late log phase of 
L. mexicana promastigotes at a ratio of 1:30 (target: parasite). Briefly, target cells were 
plated in 24 well plates at a concentration of 2x105 per well using fresh medium. The 
required virulent or avirulent L. mexicana promastigote numbers were washed 3 times 
in sterile 1xPBS and used to infect target cells, which were incubated at 37°C, 95% v/v 
humidity in a 5% v/v CO2 incubator. 
 L. mexicana promastigote infectivity 
After 2 hours of incubation, host cells were separated from the host cells by slow 
centrifugation at 400g for 5 minutes. The numbers of un-attached (free) virulent and 
avirulent L. mexicana promastigotes were quantified using a Neubauer 
Hemocytometer.  
 Inhibition of L. mexicana promastigote growth by conditioned 
medium 
Human target cells (U937 monocytes or U937 macrophages) were plated and infected 
as described in section 2.2.5.4.3. The medium from controls and cells infected with 
virulent or avirulent parasites for 2 or 24 hours was collected and centrifuged at 2500g 
for 10 minutes to remove infected cells and the parasites. The supernatant was sterilised 
by passing it through a 0.25µm filter and used to investigate the inhibition effect on 
parasite growth. Virulent or avirulent L. mexicana promastigotes were cultured in 5 ml 
of conditioned media at a concentration of 1x105 per ml for three days. At the end of 
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incubation period, the number of promastigotes per ml was evaluated using a Neubauer 
hemocytometer. 
 Live imaging and Giemsa staining 
Live imaging of infected target cells was performed using a Nikon eclipse TS100 
microscope connected to Nikon digital net camera DN100 at different time points at 
40x magnification. Free (un-attached) virulent or avirulent promastigotes, and released 
amastigotes were counted in four fields using at least six wells for every experiment. In 
other experiments, U937 monocytes and U937 macrophages were infected with late log 
phase virulent or avirulent L. mexicana promastigotes at a ratio of 1:10 (cell: parasite). 
After 2, 24 and 48 hours of infection at 37°C, infected cells where washed and fixed 
using 2% v/v paraformaldehyde for 5 minutes at room temperature. 20µl of the 
suspension of infected cells and controls was used to prepare microscope slides. After 
drying at room temperature, slides were stained in 5% w/v Giemsa for 3 minutes 
followed by an extensive wash with distilled water. The infected cells were visualized 
at 40x or 100x magnification.    
2.2.5.5 Flow cytometric analysis of MHC class I expression in human 
cell lines 
Flow cytometry analysis was used to determine the MHC class I expression in human 
cell lines after in vitro infection with L. mexicana promastigotes. The procedure was 
carried out over two days. On day 1, the target cells were infected with L. mexicana 
promastigotes; on day 2, infected cells were stained with specific antibodies. 
 Infection of target cells with L. mexicana parasites 
In order to investigate the effect of different growth stages of L. mexicana on the MHC 
class I expression in infected human cells,  MonoMac-6 and U937 monocytes cell lines 
were infected with virulent or avirulent parasites at different stages in their growth 
curve (Table 2.2.8), at a ratio of 1:10 (target: parasite). Infected cells were incubated in 
95% v/v humidity at 37ºC in a 5% v/v CO2 incubator for 24 hours.   
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Growth phase name No. of L. mexicana promastigotes 
Early log phase ≥ 5 x 106 cells per ml 
Mid log phase ≥ 1 x 107 cells per ml 
Late log phase ≤ 2.5 x 107 cells per ml 
 
Table 2.2-8 Phases of the L. mexicana growth curve 
 (Adapted from Protocols for handling and working with Leishmania species, Mottram, 2008) 
 Staining with antibodies for flow cytometry analysis 
To determine the MHC class I expression by flow cytometry analysis, staining of 
infected cells was performed in a two-step protocol, firstly, staining with primary 
antibodies, secondly: staining with secondary antibodies. Briefly, the supernatant of the 
mouse W6/32 HK hybridoma cell line was used as a primary antibody. Infected cells 
were harvested and centrifuged for 3 minutes at 400g and 4ºC and treated with 2% w/v 
paraformaldehyde for 5 minutes at room temperature, to kill the parasites. Infected cells 
were washed three times with 2ml of FACS buffer (1xPBS containing 0.1% w/v BSA 
plus 0.1% NaN3) at 400g and 4°C for 3 minutes, and the number of infected cells was 
adjusted to a concentration of 2x105 per FACS® tube. Cells were then treated with FcR 
Blocking Reagent (Miltenyi, UK), for 15 minutes at room temperature. This was 
followed by washing with 2ml of FACS buffer at 400g and 4°C for 3 minutes. 
Extracellular staining of MHC class I was performed by re-suspending the cells (test 
tubes) in 50µl supernatant of W6/32HK hybridoma cell line as primary antibody 
prepared in section 2.2.5.1.3, and incubated for 15 minutes at room temperature. Cells 
were then washed in FACS buffer three times and stained with a 5µl per tube of diluted 
(1:100) rat-anti mouse:FITC (Serotec, UK) as a secondary for 15 minutes at room 
temperature. Stained cells were washed twice with 2 ml of FACS buffer, and the pellet 
was re-suspended into 300µl of Isoton. The samples were later analysed using Gallios, 
10 colour flow cytometer (Beckman Coulter, UK) 
 Study of L. mexicana growth stages infectivity 
To study the growth stage infectivity, L. mexicana at early and late log phases were 
scanned for their virulence-associated gene expression using qPCR. Briefly, a number 
of 1x108 L. mexicana promastigotes from early and late log phases (the number of 
promastigotes was either ≥5x106 or ≤1x107 per ml, respectively) were centrifuged and 
subjected to mRNA extraction followed by cDNA synthesis. Expression of the 
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following genes was determined: L. mexicana GP63, L. mexicana LPG2, L. mexicana 
CPC, L. mexicana CPB2, L. mexicana CPB2.8 and L. mexicana CHT1. The accession 
numbers, primer sequences, product sizes and melting temperature for each primer are 
listed in table 2.2.4. In other experiments, L. mexicana promastigotes from early and 
late log phases were used to infect the target cells as described above, and monitored 
for amastigote performance. 
 The effect of infection of target cells with high dose of                   
L. mexicana promastigotes on MHC class I expression 
Late log stages of virulent and avirulent L. mexicana promastigotes were used to infect 
U937 monocytes at a ratio of 1:20, 1:30, 1:50 and 1:70 for 24 hours as described above. 
Infected cells were stained for the expression of the MHC class I and analysed by flow 
cytometer.    
 Treatment of infected cells with Fungizone 
In order to prove whether the induced down-regulation of MHC class I expression by 
L. mexicana promastigotes infection was reversible or not, infected cells with virulent 
and avirulent parasite were treated with Fungizone (Lonza, UK), an anti-Leishmania 
reagent that caused the death of the parasites by increasing their plasma membrane 
permeability. A validation experiment was carried to determine the optimum 
concentration of Fungizone used in this study. Briefly, 106 L. mexicana promastigotes 
per ml of medium containing serial dilutions of 2, 4, 6, 8 and 16µg per ml Fungizone, 
were incubated at 25ºC. Cell viability was examined under a light microscope every 30 
minutes. The dose of 4 µg per ml of Fungizone was found to be the optimum 
concentration to kill L. mexicana promastigotes in 60 minutes. Host cells (U937 
monocyte and U937 macrophages) were cultured at a concentration of 2x105 per well 
in 24 well plates and infected with the virulent and avirulent late log phase of L. 
mexicana at a ratio of 1:30 (cell: parasite). Cells were divided into 4 groups: the first 
group was used as a control, the second group was fixed two hours after infection with 
2% w/v paraformaldehyde, the third group was treated with 4 µg per ml Fungizone 2 
hours after the infection and further incubated for 24 hours, and a fourth group was 
infected for 24 hours. Infected cells were incubated in 95% v/v humidity at 37ºC in a 
5% v/v CO2 incubator. The following day, controls and infected cells were subjected to 
MHC class I expression as described above. In other experiments, target cells were 
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ether treated with 4 µg per ml Fungizone 24 hours after virulent and virulent parasites 
infected, or infected for 48 hours. The expression of target markers was analysed by 
flow cytometry. All flow cytometry data were analysed using Beckman Coulter Kaluza 
software.  . 
2.2.5.6 The effect of L. mexicana promastigotes infection on the gene 
expression profile of susceptible human cell lines 
In order to determine the effect of L. mexicana infection or their antigens on the gene 
expression profile of human monocyte and macrophage cells, target cells were either 
infected with a ratio of 1:30 (cell: promastigotes) late log phase of virulent and avirulent 
L. mexicana promastigotes, or stimulated with 10µg per ml virulent or avirulent               
L. mexicana antigens (SLA). Total mRNA was extracted from controls as well as from 
infected or stimulated U937 monocytes, U937 macrophages, and MonoMac-6 cell.  
 Preparation of infected target cells for RNA extraction 
Before RNA extraction, infected cells were harvested and free parasites were removed 
by centrifugation. Adherent U937 macrophages were harvested using trypsin solution. 
500µl of trypsin solution was added to each well, plates were kept for 5 minutes at 37°C 
in 5% v/v CO2. The detached U937 macrophages, U937 monocytes, and MonoMac6 
(infected or stimulated and controls), were collected, washed with PBS, and subjected 
to RNA extraction.     
 RNA extraction using Qiagen kit and cDNA synthesis 
Total mRNA was extracted using a Qiagen kit, according to the manufacturer’s 
protocol. A number of 5x106 each target cells were infected with virulent or avirulent 
L. mexicana promastigotes or stimulated target cells with or their SLA, were washed 
three times with sterile PBS and the cell pellet was re-suspended in 350µl of buffer RLT 
and vortexed, cells were then homogenised using a Pellet Pestle (Sigma, UK) for 30 
seconds. Homogenised cells were mixed with 350µl of 75% v/v ethanol (Sigma, UK), 
and transferred into the provided spin column. Columns were then centrifuged at 8000g 
for 30 second at room temperature. To avoid DNA contamination, samples were 
subjected to a DNA digest step using RNAase-Free DNase Set (Qiagen, UK). RNA was 
allowed to bind to a silica membrane using 350µl of buffer RW1 and incubated for 3 
minutes. The buffer RWI was discarded by centrifuging the columns for 2 minutes at 
8000g. 80µl of buffer RDD was gently loaded onto the silica membrane and columns 
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were incubated for 15 minutes at room temperature. Buffer RDD was removed with 
350µl of buffer RW, and this was spun at 8000g for 1 minute. The columns were 
removed and placed into new 2ml collection tubes and cleaned by two wash steps using 
500µl of buffer RPE at 8000g. The bound RNA was eluted in Rnase-free water (30 µl 
per column) for 5 minutes. To increase the RNA yield, the last step was repeated.  RNA 
was collected in a sterile 1.5 Eppendorf and kept at -80oC for further investigations. 
RNA quality and quantity were checked by 1.5% w/v agarose gel (Appendix 9.A), and 
Nano Drop®8000 Spectrophotometer (Appendix 10), respectively. The synthesis of 
single-stranded cDNA was performed using the M-MLV reverse transcriptase method 
(Promega, UK), following the manufacturer’s protocol as described in section 2.2.5.3.3. 
 Quantitative Real-Time PCR (qPCR) analysis 
The quantitative polymerase chain reaction (qPCR) technique was used to analyse and 
compare the modulation of target cell gene expression profile as result of infection with 
virulent and avirulent L. mexicana or their antigens. A 0.5µl of cDNA from control, 
infected and stimulated cells, was used to prepare the qPCR reaction in a final volume 
of 12.5µl, as stated in the following table: 
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Reagent volume 
10µM forward primer 0.5 µl 
10µM reverse  primer 0.5 µl 
2x iQ™SYBR Green Supermix (Bio-Rad) 6.75 µl 
cDNA template 0.5 µl 
Nuclease-free water 4.25 µl 
Total volume 12.5 µl 
 
Table 2.2-9 The volume of each reagent used to prepare the master mix of qPCR 
 
All qPCR reactions were prepared in duplicates using strip tubes and caps from 
Corbett® Rotor-Gene®. The gene expression profile of the toll-like receptor (TLR-1, 
TLR-2, TLR-4 and TLR-9), Chemokines (CCL-1, CCL2, CCL-3, CCL-4, CCL-5 and 
CCL-22), and cytokines (TNF-α, IL-1, IL-6, IL-10, IL-12β, and TGF-β), in control, 
infected, or stimulated target cells were investigated. Gene accession numbers, primer 
pair sequences and product sizes are shown in Table (2.2.10). Three housekeeping 
genes used in this study are: beta-2-microglobulin (B2M), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and beta actin (ACTB).  
All reactions were performed using a Rotor ™ 6000 Real Time PCR machine (Corbett 
Research). Reaction conditions were as follows: initial denaturation step at 95ºC for 10 
minutes followed by 40 cycles of denaturation at 95ºC for 30 seconds, annealing  
(depending on the primers MT, table 2.2.10) for 30 seconds and an extension step at 
72ºC for 20 seconds. A ramp temperature between the melting temperature and 72ºC 
was used to obtain the melting curves. 
The comparative threshold method (Ct) was used in order to quantify the results 
obtained by qPCR. In this method, Ct values of genes of interest were compared with 
the Ct values of endogenous housekeeping genes. For each gene of interest the relative 
expression was calculated as 2-ΔΔCT. 
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Table 2.2-10 List of genes and primers sequence used to determine the host cells immune 
response 
Genes, primer pair sequences, accession numbers, product sizes and  
melting temperatures (MT) of the primers used in qPCR 
Target 
gene 
Accession 
number 
Primer pair sequence MT°C 
Prod. 
size 
ACTB NM-001101 
F.P.GGCATGGGTCAGAAGGATT 
R.P.AGAAGGTGTGGTGCCAGATT 
59 136 bp 
B2M NM-004048 
F.P-CATCCAGCAGAGAATGGAAA 
R.P-CCAGTCCTTGCTGAAAGACA 
60 144 bp 
CCL-1 NM-002981 
F.P.ATGCAGGTACCCTTCTCCAG 
R.P.AACACAGGATTGCCCTCAG 
60 74 bp 
CCL-2 NM-002982 
F.P.GCAGAAGTGGGTTCAGGATT 
R.P.TGGGTTGTGGAGTGAGTGTT 
60 63 bp 
CCL-22 NM-002990 
F.P.GGCGTGGTGAAACACTTCTA 
R.P.GGCACAGATCTCCTTATCCC 
60 100 bp 
CCL3 NM-002983 
F.P.CCCGGTGTCATCTCCTAAC 
R.P.GCTCCAGGTCGCTGACATA 
60 91 bp 
CCL-4 NM-002984 
F.P.AGTCTGTGCTGATCCCAGTG 
R.P.TGTCTCATGGAGAAGCATCC 
60 128 bp 
CCL-5 NM-000579 
F.P.CGGTGTCGAAATGAGAAGAA 
R.P.TAGGGAGCCCAGAAGAGAAA 
58.3 86 bp 
GAPDH J02642 
F.P.ATCATCCCTGCCTCTACTGG 
R.P.GTCAGGTCCACCACTGACAC 
60 122 bp 
IL-10 M57627 
F.P.GATGCCTTCAGCAGAGTGAA 
R.P.ACCCTTAAAGTCCTCCAGCA 
60 93 bp 
IL-12B NM-002187 
F.P.GCCGTTCACAAGCTCAAGTA 
R.P.GCCGAGAATTCTTTAATGGC 
58.3 112 bp 
IL-1β NM-000576 
F.P.AAGCTGAGGAAGATGCTGGT 
R.P.CGTTATCCCATGTGTCGAAG 
60 115 bp 
IL-6 NM-000600 
F.P.TCAGCCCTGAGAAAGGAGAC 
R.P.CCATCTTTGGAAGGTTCAGG 
60 94  bp 
TGF-β NM-00066 
F P ACAATTCCTGGCGATACCTC 
R P ACAACTCCGGTGACATCAAA 
60 85 bp 
TLR-1 NM-003263 
F.P.ACTTATTTGGAATGGCCCAA 
R. P .TTTGCTTGCTCTGTCAGCTT 
58.3 95 bp 
TLR-2 NM-003264 
F.P.CTTCACTCAGGAGCAGCAAG 
R.P.GTCCTGTGACATTCCGACAC 
60 135 bp 
TLR-4 U88880 
F.P.TGGACCTGAGCTTTAATCCC 
RP.GTCTGGATTTCACACCTGGAT 
58.3 100 bp 
TLR-9 AF245704 
F.P.CCAGCTACATCCCGATACCT 
R.P.GTTCTCACTCAGGTCCAGCA 
60 136 bp 
TNF-α M10988 
F P.CCCATGTTGTAGCAAACCCT 
R P. TGAGGTACAGGCCCTCTGAT 
60 99 bp 
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2.3 Statistical analysis    
The experiments in this study were undertaken at least three times unless it is stated. 
Results are expressed as means ± SEM. Data were analysed using Prism 6.0 (GraphPad 
Software). Statistical significance was performed using two-way ANOVA, a 
nonparametric Mann-Whitney U test, or a Student’s t-test. 
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3. Immunisation with Leishmania DNA 
constructs  
3.1   Introduction 
Most of the available chemotherapy to treat Leishmaniasis, are associated with 
considerable resistance and side effect problems, therefore an effective vaccine is still 
the best available option. Recently, DNA vaccination of many diseases, including 
Leishmaniasis has been widely investigated in the last few decades. 
The control of Leishmania parasite infection is a complicated and cumbersome issue, 
and is greatly affected by the genetic background of the host immune system, the 
Leishmania spp, and even the sand fly, which delivers the parasite into the host. For 
example, the resistance of C57BL/6 mice to L. major infection is correlated to the Th1 
immune response, which characterized by a high production of IFN-γ.  In contrast, the 
susceptibility of Balb/c mice to the same parasite is correlated to the Th2 immune 
response, which is characterized by a high IL-4 and IL-10 production (Louis, et. al., 
1998). The role of CD4+ and CD8+ T cells in protection against Leishmania spp has 
been determined through their production of IFN-γ, which in turn activates the 
production of NO in infected macrophages (Bogdan and Röllinghoff, 1998; Woelbing, 
et. al., 2006). The Th1/Th2 paradigm in resistance and susceptibility to Leishmania 
infection, respectively, has been shown to be species-dependent (McMahon and 
Alexander, 2004; Alexander and Bryson, 2005). This increases the challenge of 
producing a homologous Leishmania vaccine. The results of many trials to develop a 
protective vaccine against Cutaneous and Visceral Leishmaniasis have shown to be 
mostly dependent on the vaccine type, and the delivery method. For example, Petters 
et. al., (2009), have reported that vaccination with autoclaved L. major antigen and CpG 
oligodeoxynucleotides was protective against needle challenge but, failed to protect 
against infection with sand fly challenge. 
Recently, it has been also demonstrated that the protection induced by using DNA 
vaccine might be vector-dependant, since pcRT7/CT-TOPO-Ldcen-3 induced better 
protection than pcDNA3.1-Ldcen-3 (Asteal, 2011). Centrin is a calcium binding 
cytoskeletal protein which is essential for duplication and segregation of centrosomes 
(Selvapandiyan, et. al., 2007). The physiological role of the centrin protein in 
Leishmania spp has been reported by Selvapandiyan, et.  al., (2001) who illustrated that 
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there was high expression of centrin protein during the exponential phase of the parasite 
growth, and that there is  less expressed at the late log stage, which indicates the 
importance of these proteins in parasite growth. This was further confirmed in the work 
of Selvapandiyan and colleagues (2004) who knocked out the centrin gene of the             
L. donovani promastigote, and demonstrated that  parasite growth was affected. The 
immunogenicity of some Leishmania genes such as centrins and GP63, which are 
represented in almost all studied Leishmania spp in DNA vaccines was investigated in 
this study.  
The capacity of DNA vaccines to protect against VL as well as CL has been determined, 
as were their effects in different experimental models. The variable results obtained 
were influenced by the type of delivery and the antigen used. The L. donovani LACK 
gene has been cloned into the pcDNA3.1 plasmid, and shown to stimulate IFN-γ 
secretion from lymph node cells of immunised Balb/c mice, but not to protect against 
systematic infection of L. donovani (Melby, et. al., 2001). In contrast, the same plasmid 
(pcDNA3.1) encoding L. major LACK (pcDNA3.1-LmLACK) using the same method 
of immunisation, protects immunised mice against L. major (Gurunathan, et. al., 1997). 
Melby, et. al., (2001), have reported that the failure of pcDNA3.1-LdLACK to protect 
against L. donovani challenge, in comparison to pcDNA3.1-LmLACK, protection 
against L. major was not due to the difference in the amino acid sequence of the LACK 
in L. donovani and L. major. 
 In another study the immunogenicity of the VR1012 plasmid encoding L. mexicana 
GP63, CPB, LACK, and L. amazonensis GP46 was analysed in Balb/c mice. Although 
all constructs induced a humoral immune response, only VR1012-GP46, VR1012-
GP63 and VR1012-CPB produced some protection as characterized by lesion size and 
parasite burden. Combining three genes together has been shown to produce better 
protection in immunised mice (Dumonteil, et. al., 2003). As shown above variation in 
the outcome of DNA vaccine immunisation, and these could be strongly related to the 
delivery plasmid, or to the cloned antigen.  
Therefore, the first aim of this study was to prepare and compare the immunogenicity 
induced by different plasmids encoding different Leishmania genes using gene gun 
immunisation of susceptible Balb/c mice.  
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The work flow 
The experiments of this chapter were carried out according to the following schedule:
 
1) Preparation of Leishmania DNA constructs 
2) Immunisation schedule 
3) Immune analysis following vaccination 
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3.2  Cloning of Leishmania genes in DNA constructs 
Three different plasmids containing 3 Leishmania genes (L. mexicana GP63,                     
L. donovani centrin1 and L. donovani centrin3) were successfully cloned into three 
different plasmids (pcRT7/CT-TOPO, VR1012 and pcDNA3.1/Hygro(-)) in order to 
generate nine Leishmania DNA constructs. Three of those were already available in our 
laboratory, and the presence of target gene in each of them was confirmed as described 
below. 
3.2.1 Confirmation of Leishmania genes in plasmid constructs 
The VR1012-L.mexgp63 plasmid (kindly obtained from Prof. Dumonteil, C.I.R, 
Mexico), was bulked up by the transformation of E. coli bacteria, and the presence of 
the L. mexicana GP63 gene was confirmed by PCR using  pair 1 primers                     
(Figure 3.2.1.A). pcDNA3.1/Hygro(-)-L.mexgp63, which was prepared by a previous 
PhD student (Rezvan, PhD thesis, 2007, NTU), was also bulked and the presence of the 
L. mexicana GP63 gene was confirmed by PCR using pair 1 primers (Figure 3.2.1.B). 
Similarly, the presence of Ldcen1 in pCR®II-TOPO®-Ldcen1 plasmid was confirmed 
by PCR (Figure 3.2.1.C). The L. donovani centrin3 gene was successfully amplified by 
PCR from pcDNA3.1/Hygro-Ldcen3 DNA construct which was also prepared by a 
previous PhD student (Asteal, PhD thesis, 2011, NTU), using pair 3 primers (Figure 
3.2.1.D). 
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Figure 3.2-1 Confirmation of the presence of Leishmania genes in bulked DNA 
constructs by PCR 
(A and B) the L. mexicana GP63 gene was amplified from VR1012-L.mexgp63 and pcDNA3.1/ 
Hygro(-)-L.mexgp63 plasmids, respectively, using pair 1 primers (Table 2.2.2), lane 11kp DNA 
ladder, lane 2 amplified L. mexicana GP63 gene (200bp). (C) 200bp PCR product of L. 
donovani centrin1 from pCR®II-TOPO®-Ldcen1 plasmid (lane 2) using pair 5 primers (Table 
2.2.2). (D) PCR amplification of L. donovani centrin3 gene (200bp) in pcDNA3.1/Hygro(-)-
Ldcen3 plasmid (lane 2) using pair 3 primers (Table 2.2.2).  
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3.2.2 Construction of pcRT7/CT-TOPO-L.mexgp63 plasmid 
Due to the lack of matched restriction enzymes that can cut the full length of the                
L. mexicana GP63 gene, and correspondingly digest the target pcRT7/CT-TOPO 
plasmid, new primers (Pair 2, table 2.2.2), were designed in order to amplify the target 
gene by PCR. Forward and reverse primers containing restriction sites for Hind III and 
Xba I restriction enzymes, respectively were designed. The new primers were 
successfully amplified 1940pb of L. mexicana GP63 gene by PCR (Figure 3.2.2.A). 
Two enzymes Hind III and Xba I were used to digest the amplified L. mexicana GP63 
gene and pCRT7/CT-TOPO (Plasmid map figure 2.2.2), in order to create the sticky 
complementary ends (Figure 3.2.2.B). On completion of the cloning process, three 
methods were used to prove the presence of the newly cloned L. mexicana GP63 gene 
in the pcRT7/CT-TOPO plasmid: 
 Firstly, digestion and restriction of the newly constructed pcRT7/CT-TOPO-
L.mexgp63 DNA construct using Hind III and Xba I restriction enzymes (Figure 
3.2.2.C). 
Secondly, the full length of L. mexicana GP63 was amplified by PCR using the newly 
prepared DNA construct as DNA template (Figure 3.2.2.D). 
Thirdly, the newly cloned gene was confirmed by sequencing (Source BioScience, 
UK).  Due to the length of L. mexicana GP63 gene, three sets of primers were used to 
fully sequence the target gene. The result shows that no miss-match occurred during 
the sub-cloning process of the new pcRT7/CT-TOPO-L.mexgp63 DNA construct 
(Appendix 1). 
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Figure 3.2-2 Construction of pcRT7/CT-TOPO-L.mexgp63 plasmid 
(A) The full length of L. mexicana GP63 gene was amplified by PCR from VR1012-L.mex 
gp63 DNA plasmid using pair 2 primers (Table 2.2.2). Lane 1 1kp DNA ladder, lane 2 amplified 
L. mexicana GP63 gene (1494bp). (B) Digestion and restriction of the PCR product                      
(L. mexicana GP63 gene, lane 2, 1494bp), and pcRT7/CT-TOPO plasmid (lane 3, 2700bp), 
with Hind III and Xba I restriction enzymes, linear form of the digested plasmid was gel 
extracted. (C) The confirmation of the presence of L. mexicana GP63 gene in newly prepared 
pcRT7/CT-TOPO-L.mexgp63 construct using the restriction enzymes method, pcrT7/CT-
TOPO-L.mexgp63 was digested by Hind III and Xba l restrictions enzymes. Lane 11kp DNA 
ladder, band 2 digested pcRT7TOPO-L.mexgp63 plasmid, band 3 L. mexicana GP63 gene 
(1494bp). (D) Confirmation of the presence of L. mexicana GP63 gene in newly prepared 
pcRT7/CT-TOPO-L.mexgp63 by PCR (1494bp), the complete L. mexicana GP63 gene was 
amplified from pcRT7/CT-TOPO-L.mexgp63 plasmid (band 2) using pair 2 primers (Table 
2.2.2).  
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3.2.3 Construction of pcRT7/CT-TOPO-Ldcen1 plasmid 
 L. donovani centrin1 was initially cloned into pCR®II-TOPO®- Ldcen1 plasmid. In 
order to cut off Ldcen1 from pCR®II-TOPO® and prepare empty pcRT7/CT-TOPO 
(plasmid map figure 2.2.3 and 2.2.2) respectively, both DNA constructs were digested 
with the same restrction enzymes (Hind III and Xba I) to create sticky complementary 
ends  (Figure 3.2.3.A). After gel purification, both the empty pcRT7/CT-TOPO plasmid 
and L. donovani centrin1 gene were ligated and transformed into E. coli complement 
cells as previously described in sections 2.2.1.2.1 and 2.2.1.2.2. The cloning of the L. 
donovani centrin1 gene into pcRT7/CT-TOPO plasmid was confirmed by PCR and 
sequencing (Figure 3.2.3.B and Appendix 2). 
 
Figure 3.2-3 Construction of pcRT7/CT-TOPO-Ldcen1 plasmid 
 (A) pcT7/CT-TOPO-Ldcen3 and pCR
®
II-TOPO
®
-Ldcen1 plasmids were digested with Hind 
III and Xba I restriction enzymes. Lane 11kp DNA ladder and band 2 represent empty 
pcRT7/CT-TOPO plasmid (2700bp). Band 3 represent excised L. donovani centrin1 gene from 
pCR®II-TOPO®-Ldcen1 plasmid (500bp). (B) Confirmation of the presence of L. donovani 
centrin1 gene in newly prepared pcRT7/CT-TOPO-Ldcen1 DNA construct by PCR. The 200bp 
PCR product (Lane 2) was amplified using pair 3 primers (Table 2.2.2).  
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3.2.4 Construction of VR1012-Ldcen1 plasmid   
VR1012-L.mexgp63 DNA construct was first digested with EcoR I restriction enzyme 
to remove the L. mexicana GP63 gene. L. donovani centrin1 was also cut off from the 
pCR®II-TOPO®-Ldcen1 DNA construct using the same restriction enzyme (Figure 
3.2.4.A). Both the gene of interest and the target plasmid were subjected to the ligation 
step followed by transformation, as described in sections 2.2.2.1.4, 2.2.1.2.1, and 
2.2.1.2.2. The newly cloned L. donovani centrin1 gene into VR1012 plasmid was 
confirmed by PCR (Figure 3.2.4.B) and sequencing.  
 
Figure 3.2-4 Construction of VR1012-Ldcen1 plasmid 
(A) Agarose gel electrophoresis illustrates the digestion of VR1012-L.mexgp63 and pCR®II-
TOPO® Ldcen1 with EcoR I restriction enzyme. Lane 1 1kp DNA ladder, band 2 represent 
excised L. donovani centrin1 gene (500bp). Lane 3 represent the empty VR1012 plasmid 
(6600bp). (B) Confirmation of the presence of L. donovani centrin1 gene in newly prepared 
VR1012-Ldcen1 DNA construct by PCR, a 200bp L. donovani centrin1 PCR produce (Lane 2) 
was amplified using pair 5 primers (Table 2.2.2).   
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3.2.5 Construction of VR1012-Ldcen3 plasmid 
Due to the lack of required restriction enzyme sites, a set of new primers which have 
the sequence of Sall and BgIII enzymes forward and reverse primer, respectively was 
designed (Table 2.2.2). The new primers were used to amplify a full length of L. 
donovani centrin3 gene by PCR (Figure 3.2.5.A). The fully amplified PCR product (L. 
donovani centrin3) and VR1012 plasmid were digested with Sall and BgIII restriction 
enzymes to create the complementary sticky ends. After gel purification, VR1012 
plasmid and L. donovani centrin3 gene were ligated at a ratio of 1:3 (plasmid: insert). 
The new product was transformed into E. coli complement cells to produce more 
copies. The new VR1012-Ldcen 3 DNA construct was subjected to a further step to 
confirm the presence of the L. donovani centrin3 gene (Figures 3.2.5.B, and Appendix 
3). 
 
Figure 3.2-5 Construction of VR1012-Ldcen3 plasmid 
 (A) The full-length L. donovani centrin3 was amplified from the pcRT7/CT-Topo-Lcen3 
plasmid by PCR using pair 4 primers (Table 2.2.2). Lane 1 1kp DNA ladder, Lane 2 represent 
amplified L. donovani centrin3 gene (500bp). (B) Confirmation of the presence of newly cloned 
L. donovani centrin3 gene into VR1012 plasmid. Two sets of primers (Pair 2 and 3 in Table 
2.2.2) were used to amplify 200bp (2) and 500bp (3), respectively. Lane1 1kp DNA ladder, lane 
2 and 3 represent the 200bp and 500bp L. donovani centrin3 gene PCR product, respectively.   
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3.2.6 Construction of pcDNA3.1/Hygro(-)-Ldcen1 plasmid 
The pCR®II-TOPO®-Ldcen1 plasmid was digested with Hind III and Xba I restriction 
enzymes (see the plasmid map figures 2.2.2 and 2.2.4), to remove L. donovani centrin1, 
and pcDNA3.1/Hygro(-) plasmid was also digested with Hind III and Xba I restriction 
enzymes (Figure 3. 2. 6. A). The target plasmid (pcDNA3.1/Hygro(-)) and  L. donovani 
centrin1 gene were ligated at a ratio of 1:3 (plasmid: insert). The new DNA construct 
was bulked up by E. coli transformation, and cloning success was confirmed by 
digestion and restriction (Figure 3.2.6. B), PCR, and sequencing. 
 
Figure 3.2-6 Construction of pcDNA3.1/Hygro(-)-Ldcen1 plasmid 
(A) Digestion of pCR®II-TOPO®-Ldcen1 and empty pcDNA3.1/Hygro(-) plasmids  with 
Hind III and Xba I restriction enzymes.   Lane 1 kp DNA ladder, lane 2 is the digested L. 
donovani centrin1 gene (500bp), and lane 3 represent the digested pcDNA3.1/Hygro(-) plasmid 
(5600bp). (B) Confirmation of the presences of Ldcen1 in newly prepared pcDNA3.1/Hygro(-
)-Ldcen1 DNA construct by restriction and digestion. The newly prepared pcDNA3.1/Hygro(-
)-Ldcen1 DNA construct was digested with Hind III and Xba I restriction enzymes. Lane1 1kp 
DNA ladder, lane 2 represents the digested L. donovani centrin1 gene (500bp) from 
pcDNA3.1/Hygro(-)-Ldcen1 plasmid. 
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3.2.7 Transfection of MCF-7 tumour cells 
To investigate whether the constructed plasmids were able to express Leishmania genes 
in mammalian cells, MCF-7 tumour cells were transfected with the prepared DNA 
constructs encoding Leishmania genes using Lipofectamine 2000, according to the 
manufacturer’s recommended protocol (details are in the Methods section, 2.2.3). After 
three passages in the selective medium, mRNA was extracted from the transfected cells 
and converted into cDNA. The presence of the L. donovani centrin1 and L. donovani 
centrin3 genes in the transfected cells was determined by qPCR analysis. The qPCR 
results clearly show the presence of a significant amount of RNA message for                   
L. donovani centin1 and L. donovani centin3 induced by 3 different plasmids, 
respectively Figure 3.2.7. A. B. The expression of L. mexicana GP63 protein in 
transfected cells was also determined by immunofluorescence antibody staining. 
Images presented in (Figure 3.2.7.C) clearly show the expression of GP63 protein 
(white arrows), whereas no GP63 protein was detected in the control cells. 
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Figure 3.2-7 Transfection of MCF-7 cell line with prepared DNA constructs 
MCF-7 tumour cells were transfected with DNA constructs encoding L. donovani centrin1 gene 
(Panel A), or DNA constructs encoding L. donovani centrin3 gene (Panel B) using 
Lipofectamine™ 2000. Graphs clearly showed that both genes were significantly expressed in 
transfected compared to un-transfected cells. The results represent the average of three 
independent experiments. Data are presented as mean + SEM.. Panel (C) shows the 
immunofluorescence staining using anti L. mexicana GP63 protein in the transfected MCF-7 
cells. The images clearly show the expression of GP63 protein (arrowed) detected by incubating 
the transfected cells with primary anti-L. major GP63 antibody, followed by incubation with 
goat anti-mouse IgG2a: FITC. The experiment was repeated twice. 
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3.3  Immunogenicity of Leishmania DNA constructs 
As has been mentioned in the Methods section, different tissues were collected from 
mice after gene gun immunisation with Leishmania DNA constructs, and were 
subjected to various immune assays to assess immune responses as described below:  
3.3.1 IFNgamma Elispot assay 
The IFN-γ secretion as result of L. mexicana SLA stimulation, after the immunisation 
with Leishmania DNA constructs was checked using an IFNgamma Elispot assay. 
Whole splenocytes population were collected two weeks after the last immunisation. 
Splenocytes were seeded at a concentration of 1x106 cells per well in Elispot plates and 
stimulated with 10µg per ml SLA.  Plates were incubated at 37ºC in 5% v/v CO2 for 48 
hours. Splenocytes were then re-stimulated with 30 and 50 µg per ml SLA and further 
incubated for 24 hours. The results, shown in Figure 3.3.1 A, B, C, clearly show that 
immunisation with the Leishmania DNA constructs induced significant IFN-γ secretion 
in response to stimulation of splenocytes with L. mexicana SLA, which was dose-
dependent since using a high dose of SLA in the second stimulation caused a significant 
increase in IFN-γ secretion by stimulated cells. 
The results in Figure 3.3.1.D show that no significant secretion of IFN-γ was detected 
in mice immunised with empty plasmids. However, a slight increase in the IFN-γ 
secretion of splenocytes from mice immunised with empty plasmids was observed. 
The IFNgamma Elispot results show that using different plasmids encoding the same 
gene did not significantly alter the immunogenicity of the DNA constructs. However, 
the immunogenicity was affected by the Leishmania gene type. L. donovani centrin3 
cloned in the three different plasmids induce more IFN-γ secretion. 
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Figure 3.3-1 IFN-γ secretion determined by Elispot Assay in splenocytes of mice 
immunised with DNA constructs following in vitro stimulation with L. mexicana SLA 
Splenocytes from immunised mice with plasmids encoding L. mexicana GP63 gene (A),             
L. donovani centrin1 gene (B), L. donovani centrin3 gene (C) and control mice (D) were 
cultured at a concentration of 106 cells per well in coated Elispot plate, and stimulated with 
10µg per ml SLA. 48 hours later, splenocytes were stimulated again with 30 and 50µg per ml 
SLA for 24 hours. The plate was then developed and number of spots counted by an Elispot 
reader. The test was performed in triplicate for each SLA concentration, and the negative 
control (cells) was left without antigen (SLA). Two controls were used: splenocytes from mice 
immunised with empty plasmids or immunised with empty bullets. The SEB positive control 
induced 200 spots. Data are represented the average of three independent experiments for each 
DNA construct. **P<0.01, ***P<0.001 (Two way ANOVA/GgaphPad Prism). The 
comparison was performed between plasmids encoding Leishmania genes and empty plasmids. 
Data are presented as mean + SEM. 
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3.3.2 Proliferation of splenocytes in response to SLA stimulation 
Balb/c mice were immunised by gene gun three times with DNA constructs as described 
in the materials and methods section (2.2.4.3.2). Two weeks after the last immunisation, 
the mice were sacrificed and the splenocytes plated into 96 well plates at a concentration 
of 5x105 per well in a total volume of 200µl of T cell medium and stimulated with 10µg 
SLA on the day of harvesting (day zero). After 72 hours, splenocytes were re-stimulated 
using two doses (30 and 50 µg per ml) SLA. Cell proliferation was estimated by 
thymidine uptake assay. Optimization experiments illustrated that the optimum T cell 
proliferation required a double in vitro stimulation with SLA (10µl per ml on day zero, 
followed by 30 or 50µl per ml on day three). 
Results in (Figure 3.3.2.A) illustrate the proliferation of the splenocytes from mice 
immunised with the three plasmids encoding the L. mexicana GP63 gene. Generally, 
the proliferation of splenocytes from mice immunised with plasmids encoding this gene 
was significantly higher, when compared to mice immunised with empty plasmids as a 
control. Moreover, although the proliferation of immunised mice splenocytes was 
significant using 10+30µg SLA compared to the control splenocytes, the stimulation 
with 10+50µg SLA induced more proliferation. The graph also shows that the highest 
proliferation rate was obtained in mice immunised by pcRT7/CT-TOPO-L.mexgp63, 
followed by pcDNA3.1/Hygro(-)-L.mexgp63 plasmid.  
Figure 3.3.2.B shows the proliferation of splenocytes in mice immunised with the three 
plasmids encoding L. donovani centrin1. Similarly, the proliferation of splenocytes 
from plasmids encoding centrin1 immunised mice was high following in vitro 
stimulation with 10+50µg SLA compared to mice immunised with empty plasmids. 
The results also indicate that immunisation with the VR1012-Ldcen1 plasmid resulted 
in a higher proliferation rate compared to immunisation with the pcRT7/CT-TOPO-
Ldcen3 and pcDNA3.1/Hygro(-)-Ldcen3 constructs. Unlike immunisation with 
plasmids encoding L. mexicana GP63 and L. donovani centrin1, there was no 
significant difference between the proliferation of splenocytes from immunised mice 
with pcRT7/CT-TOPO-Ldcen3 and pcDNA3.1/Hygro(-)-Ldcen3 constructs and mice 
immunised with empty plasmids (Figure 3.3.2.C). However, there was a significant 
difference in splenocytes proliferation from mice immunised with VR1012-Ldcen3 
compared to control cells (splenocyte from mice immunised with empty VR1012 
plasmid). 
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Results in Figure 3.3.2.D, show there was no difference in the proliferation of 
splenocytes harvested from immunised mice with empty plasmids and empty bullets. 
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Figure 3.3-2 Proliferation of splenocytes stimulated with SLA 
The immunogencity of DNA construtcs was estimated by thymidin up-take proliferation assay. 
On day zero, splenocytes from mice immunised with plasmids encoding L. mexicana GP63 (A), 
L. donovani centrin1 (B), and L. donovani centrin3 (C) genes, were cultured at a concentration 
of 5x105 cells per well in T cell medium using 96 well plates. Cells were first stimulated with 
10µg per ml SLA for 72 hours, then re-stimulated with 30 and 50µg per ml SLA, and plates 
were further incubated for 72 hours and labelled with 1µl Ci [3H]-Thymidine per well. Plates 
were harvested and counted. (D) Proliferation of splenocytes from mice immunised with empty 
plasmids or empty bullets. The results represented the avareage of three independent 
experiments for each DNA constructs. *P<0.05,**P<0.01,***P<0.001 (Two way 
ANOVA/GraphPad Prism). The comparison was preformed between plasmids encoding 
Leishmania genes and empty plasmids. Data are presented as mean + SEM. 
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3.3.3 Proliferation of lymph node lymphocytes in response to SLA 
stimulation 
Ten lymph nods from each mouse were collected on the day of harvesting (Appendix 
4), and lymphocytes were flushed out using serum-free medium. Cells were cultured 
and treated as described for splenocytes. Interestingly, a similar pattern of results to that 
of splenocyte proliferation was observed. Results illustrated that there was not much 
difference in the proliferation of lymphocytes from mice that had been immunised with 
the three plasmids encoding the L. mexicana GP63 gene (Figure 3.3.3. A). Results of  
Figure 3.3.3. B shows the proliferation of lymphocytes from mice immunised with three 
plasmids encoding L. donovani centrin1. The pcDNA3.1/Hygro(-)-Ldcen1 construct 
resulted in the highest proliferation rate at the two tested SLA doses, while the lower 
proliferation rate was obtaind in mice immunised with pcRT7/CT-TOPO-Ldcen1. 
However, the proliferation of lymphocytes from immunised mice was still higher than 
that of lymphocytes from mice which had been immunised with empty plasmids. Figure 
(3.3.3.C) shows that immunisation with VR1012-Ldcen3 and pcDNA3.1/Hygro(-)-
Ldcen3 induced a significant proliferation compared to that of empty plasmids 
following stimulation with 10+30 and 10+50µg SLA per ml. Although immunisation 
with pcR7/CT-TOPO-Ldcen3 induced high proliferation, statistical analysis showed no 
significant differences when compared to the control (immunised with empty 
plasmids). Two controls (immunised with empty plasmids and empty bullet) were also 
included in these experiments, and the results clearly show a slight increase in the 
lymphocyte proliferation of mice immunised with empty plasmids compared to empty 
bullets. However, the statistical analysis showed there were no significant differences 
(Figure 3.3.3.D). 
 
 
 
 
 
 
 
3) Leishmania DNA constructs immunogenicity   
 
113 
 
 
 
Figure 3.3-3 Proliferation of lymph node lymphocytes stimulated with SLA 
On day zero, lymph node lymphocytes from mice immunised with plasmids encoding                   
L. mexicana GP63 gene (A), L. donovani centrin1 (B),  and L. donovani centrin3 gene (C) genes 
were cultured at a concentration of 5x105 cells per well in T cell medium using a 96 well plates. 
Cells were first stimulated with 10µg per ml SLA for 72 hours, re-stimulated with 30 or 50 
10µg per ml SLA, and further incubated for 72 hours with 1µl Ci [3H]-Thymidine per well. 
Cells were then harvested and counted. Two control mice immunised with empty plasmids and 
empty bullets were also included (D).  The results represent the average of three independent 
experiments for each DNA construct. *P<0.05, **P<0.01, ***P<0.001 (Two way 
ANOVA/GraphPad Prism). The comparison was preformed between plasmids encoding 
Leishmania genes and empty plasmids. Data are presented as mean + SEM. 
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3.3.4 The CD4 and CD8 profile in immunised mice. 
In this study, the effect of immunisation with the different Leishmania DNA constructs 
on the  percentage of CD4+ and CD8+ T cells in spleens and lymph nodes was 
investigated using flow cytometry. Cells from spleens and lymph nodes were harvested 
two weeks after the last immunisation, and cell suspensions prepared as described in 
sections 2.2.4.4 and 2.2.4.5, were stained with anti-mouse CD4+ and CD8+ antibodies 
and analysed by flow cytometry. The results illustrate that immunisation has caused an 
alteration in the percentage of CD4+ and CD8+ cells depending on the source of T cells 
and the encoding gene. In general, more variations in CD4+ and CD8+ cell profiles were 
obseved in spleens compared with lymph nodes. Results in Figure 3.3.4. A, show that 
immunisation with three different plasmids encoding L. mexicana GP63 caused a 
significant increase in the percentage of the CD4+ population. Similar results were 
obtained using pcRT7/CT-TOPO and VR1012 plasmids encoding L. donovani centrin1. 
Figure 3.3.4. B illustrates that the CD8+ cell percentage was also increased, after the 
immunisation, but not significantly. This was assocciated more with the use of 
pcRT7/CT-TOPO plasmid encoding the three Leishmania genes, compared with 
VR1012 and pcDNA3.1/Hygro(-) plasmids.  
Similarly, in the lymph nodes, immunisation with the plasmids encoding  L. mexicana 
gp63 triggered the most significant increase in the CD8+ population, but  a significant 
increase was only observed after immunisation with pcRT7/CT-TOPO plasmid 
encoding L. donovani centrin1 (Figure 3.3.4.C). Interestingly, the results in Figure 
3.2.4.D, show that there are no differences in the percentage of CD8+ in control and 
immunised mice. 
 
 
 
 
 
 
 
 
  
3) Leishmania DNA constructs immunogenicity   
 
115 
 
 
Figure 3.3-4 Profiles of CD4 and CD8 in spleens and lymph nodes of immunised and 
control mice by flow cytometry analysis 
On the day of harvesting, splenocytes (A, B) and lymph node cells (C, D) were stained using 
FITC anti-mouse CD4+ and RPE anti-mouse CD8+ according to the manufacturer’s protocol. 
The data represent the percentage of CD4 and CD8 in splenocyte populations of three 
independent experiments for each DNA construct.*P<0.05 using the Mann-Whitney U test. The 
comparison was performed between plasmids encoding Leishmania genes and empty plasmids. 
Data are presented as mean + SEM.. 
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3.3.5 Antibody response in immunised mice 
To estimate the level of total IgG, IgG1 and IgG2a isotypes following immunisation 
with the different Leishmania DNA constructs, blood samples of immunised and 
control Balb/c mice were collected two weeks after the last immunisation (the day of 
harvesting), and subjected to ELISA analysis (section 2.2.4.10). The results clearly 
show an overall increase in the level of IgG1 in mice immunised with the plasmids 
encoding Leishmania genes compared to those immunised with empty plasmids 
(controls). Figure 3.3.5.A, shows that the immunisation of Balb/c mice with the three 
plasmids encoding L. mexicana GP63 and L. donovani centrin3 genes induced high 
levels of IgG1 isotype compared to control mice. Figure (3.3.5.B) shows that the levels 
of IgG2a were also high in the serum of immunised mice compared to control groups. 
pcDNA3.1/Hygro(-)-L.mexgp63 was the only construct that induced a significant 
increase in IgG2a isotype, compared to pcRT7/CT-TOPO-L.mexgp63 and          
VR1012-L.mexgp63. The results also show that pcRT7/CT-TOPO encoding either L. 
donovani centrin1 gene or L. donovani centrin3 gene has induced a significant increase 
in IgG2a isotype, compared to other constructs encoding the same genes. The results 
illustrated no differences in levels of the total IgG isotype following immunisation with 
the different DNA constructs encoding Leishmania genes and mice immunised with 
empty plasmids (Figure 3.3.5.C). 
 
 
 
3) Leishmania DNA constructs immunogenicity   
 
117 
 
 
 
3) Leishmania DNA constructs immunogenicity   
 
118 
 
 
Figure 3.3-5 Antibody responses in the sera of immunised mice 
Serum was obtained from blood samples on the day of harvesting. Specific anti Leishmania 
antibodies were determined by loading sera from control and immunised mice into plates coated 
with 5µg SLA per ml, as described in the Materials and Methods section. The results clearly 
show IgG1 (A) antibody response was higher in mice immunised with the DNA constructs 
compared to empty plasmids. Anti-L. mexicana IgG2 (B) was also high in immunised compared 
to control mice. However, analysis shows there were no differences in total IgG antibody 
response between test and control groups (C). The presented data are the average of three 
independent experiments for each DNA construct. * P<0.05, **P <0.01 using the Student's t-
test. The comparison was performed between plasmids encoding Leishmania genes and empty 
plasmids. Data are presented as mean + SEM.  
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3.3.6 Survival assay 
This assay was developed to assess the effects of immunisation on the ability of 
macrophages to control the parasite infection. The bone marrow derived macrophages 
BM-DMs were prepared from the hind limbs of naïve and immunised animals. During 
6 days of culture in the presence of mouse GM-CSF, non-adherent cells were gently 
removed by washing on day 2 and 4. The attached cells were then matured by adding 
one ml of fresh medium containing LPS at a concentration of 1µg per ml and incubated 
at 37°C for 24 hours to induce BM-DMs maturation. Flow cytometry analysis showed 
that 76.68% of adherent  cells expressed F4/80, 3.61% expressed CD11c and 64.26% 
expressed MHC class I. These results indicate that macrophages can be successfully 
derived in vitro from bone marrow (Figure 3.3.6). To conduct the survival assay, the 
macrophages from naïve and immunised mice were infected with the late log stage of 
L. mexicana promastigotes for 6 hours then non-attached parasites were removed, and 
the infected cells were further incubated for 48 hours. Results show that amastigotes 
can be produced in infected macrophages generated from naïve mice immunised with 
empty bullets, or empty plasmids as well as macrophages generated from mice 
immunised with Leishmania DNA constructs (Figure 3.3.7. A). However, these 
amastigotes behaved differently when they were cultured in a 25°C incubator in order 
to retrieve the promastigote stage. Results show amastigotes isolated from the infected 
macrophages of immunised mice with plasmids encoding L. donovani centrin1 or 
centrin3 failed to transform into the promastigote stage, compared with empty plasmids 
(Figure 3.3.7.B, C).  Results also show that the amastigotes isolated from macrophages 
of mice immunised with empty bullets or plasmids successfully produced the 
promastigote stage (Figure 3.3.7.D). Further analysis was carried out to evaluate 
whether the concentration of nitrite and IFN-γ have any role on amastigote 
transformation. Supernatant samples were collected at different time points from 
macrophages infected with L. mexicana promastigotes and subjected to NO and IFN-γ 
estimation using Griess’ reagent and the ELISA method respectively. Results in Figure 
3.3.8.A, show that nitrite concentration was significantly lower in macrophages 
generated from control and mice immunised with plasmids encoding L. donovani 
centrin1 and L. donovani centrin3 at 24 and 48 hours respectively following parasite 
infection. Interestingly, the results of ELISA analysis showed there were no differences 
in IFN-γ concentration between cells and infected cells supernatant (Figure. 3.3.8. B). 
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Figure 3.3-6 The expression of macrophage markers on the surface of bone marrow-
derived macrophages (BM-DMs) 
Bone marrow cells were flushed out of the hind limbs of immunised and control mice using 
serum-free medium. Cells were cultured in the presence of 1µg per ml GM-CSF at 37ºC in a 
CO2 incubator. The cells were washed with fresh DC medium every two days. On day 6 adhered 
cells were further stimulated by incubation with 1µg LPS overnight. Cells were immunostained 
with cell surface markers and analysed by flow cytometry.  
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Figure 3.3-7 Survival assay 
Balb/c BM-macrophages were infected with L. mexicana promastigotes for 48 hours. 
Amastigotes were isolated by homogenising the infected cells. Graph (A) shows there was no 
difference in the number of amastigotes which were isolated from infected macrophages of 
mice immunised with empty bullets, empty plasmids, or plasmids encoding L. donovani 
centrin1, (similar results were obtained from macrophages generated from mice immunised 
with plasmids encoding L. donovani centrin3). Graphs B and C show the number of recovered 
promastigotes obtained from cultures of amastigotes isolated from macrophages of mice 
immunised with empty plasmids versus plasmids encoding L. donovani centrin1 or L. donovani 
centrin3, respectively, in Schneider's medium supplemented with 20% v/v HIFCS over a period 
of two weeks.  Graph (D) show there was no difference in recovered promastigotes obtained 
from cultures of amastigotes isolated from macrophages of naïve (empty bullets) or empty 
plasmids immunised mice. The results represent the average of three experiments for each DNA 
construct. ***P <0.001 using the Student's t-test. The comparison was performed between 
plasmids encoding Leishmania genes and empty plasmids. Data are presented as mean + SEM. 
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Figure 3.3-8 NO and IFN-γ analysis in infected macrophages  
Bone marrow macrophages generated from immunised mice were infected with L. mexicana 
promastigotes. Supernatant from infected and non-infected cells was collected at 24 and 48 
hours. Collected samples were analysed for nitrite and IFN-γ concentrations (A) and (B), 
respectively. The graphs are the average of three experiments for each DNA construct. *P <0.05 
using the Student's t-test. Data are presented as mean + SEM. 
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3.4   Discussion 
One of the objectives of this study was to construct three Leishmania genes in three 
different plasmids, and use them as a delivery vehicle to compare their immunogenicity. 
Each of the L. mexicana gp63, L. donovani centrin1 and L. donovani centrin3 genes 
were sub-cloned into pcRT7/CT-TOPO, VR1012, and pcDNA3.1/Hygro(-) plasmids. 
Both VR1012 and pcDNA3.1/Hygro(-) contain kanamycin and ampicillin-resistance 
genes, respectively, and they are eukaryotic expression plasmids, due to the presence 
of cytomegalovirus CMV promoter (Garmory, et. al., 2003). Although the pcRT7/CT-
TOPO plasmid was known as a bacterial expression vector, it has a T7 promoter. 
However, the ability of this plasmid to express encoded genes in mammalian cells has 
been demonstrated by Asteal (2011). Sub-cloning of Leishmania genes into the chosen 
DNA plasmids was performed by a series of steps which started by growing  E. coli 
competent cells, and bulking of original vectors containing target genes. In direct 
cloning, the target gene was cut out of the original plasmid using suitable restriction 
enzymes producing sticky ends to increase the ligation efficiency. In the indirect 
cloning, the target gene was amplified by PCR using a specific primer with the required 
restriction enzyme sequence.  The recognition sites of the chosen restriction enzymes 
should not present in the sequence of any of the target genes. To achieve high ligation 
efficiency, the empty plasmids were dephospholorated to prevent self-ligation. The 
samples (genes and plasmids) were mixed with T4 DNA ligase enzyme and incubated 
overnight to ensure proper incorporation of the insert (target gene) into the target 
plasmid. All selected Leishmania genes were successfully cloned into the chosen 
plasmids. It has also been shown that no base miss-matching was detected during the 
gene cloning as determined by sequencing. The transfection results of the MCF-7 cell 
line illustrated the ability of Leishmania DNA constructs to induce gene expression and 
protein synthesis in transfected cells compared to non-transfected cells (Figure 3.1.7), 
and these results confirmed the previous finding reported by Rezvan (2007) and Asteal 
(2011). Further experiments illustrated that there is no significant difference between 
the level of expression of the target genes between human MCF-7 cell line and murine 
CT-26 cell line (data not shown).  
Among the different immunisation methods, gene gun immunisation has been widely 
used (Sakai, et. al, 2000, Dumonteil, et. al., 2003).  Two immunisation methods, gene 
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gun, and intramuscular inoculation immunisation, were compared (Rezvan, 2007). The 
results showed that immunisation of Balb/c mice with 100µg of pcDNA3.1-L.mexgp63 
DNA construct by intramuscular inoculation and the same construct coated on gold 
particles and delivered using gene gun method, a good immune response was induced 
using the both methods. Although the DNA concentration used in the gene gun method 
was considerably less compared to the amount used for intramuscular inoculation, 66% 
and 33% of immunised mice were lesion-free for gene gun and intramuscular 
immunisation, respectively. Therefore, the gene gun immunisation method was chosen 
in the current study to immunise susceptible Balb/c mice.  
Different vaccines can induce different immune responses, which vary according to the 
method of administration and immunisation schedule (Liu, et. al., 2005), and different 
Leishmania species required different immune responses. It is believed that the Th1 
immune response is the key factor in the control of Leishmania spp infection, therefore, 
this type of immune response is the ultimate requirement of a good vaccine to 
Leishmaniasis (Sacks and Noben-Trauth, 2002). IFN-γ secretion was evaluated in this 
using Elispot assay, and the results clearly showed significant differences in the number 
of IFN-γ spots secreted by splenocytes harvested from immunised mice with 
Leishmania DNA constructs compared to splenocytes harvested from controls. 
However, the results illustrated that there were no difference using different plasmids 
encoding the same gene. In addition, the levels of secreted IL-2, IL-4, and IFN-γ were 
also evaluated in the supernatant of splenocytes stimulated with L. mexicana SLA using 
ELISA method, and obtained results showed no differences between controls and 
immunised mice (Appendix 7). 
The selection of crude SLA preparation for stimulation in proliferation and Elispot 
experiments, but not peptides was based on the findings of our previous work where 
four potentially immunogenic GP63 peptides were predicted using SYFPEITHI 
software (TPH, A3, A4, A5, A6) and tested by immunisation of Balb/c mice and             
in vitro stimulation, and none of these four peptides were immunogenic (Rezvan, 2007). 
To search for a suitable immunogenic peptide for each of the three genes using similar 
approaches will take a considerable time if it is at all successful. 
To evaluate Th1/Th2 immune responses after immunisation using the gene gun method, 
specific antibody responses were estimated by ELISA method to evaluate Th1 and Th2 
responses in immunised Balb/cmice. The results of this study showed that there were 
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no differences in the total IgG response, however, there was a significant difference in 
the levels of IgG1 and IgG2a isotopes in response to immunisation with DNA 
constructs has been reported that the Th1 may reflect the inability of this assay to detect 
small changes in the total IgG levels versus its isotypes. It is known that the Th1 
immune response is characterised by large increases in the levels of IgG2a, IgG2b and 
IgG3 subclasses, whereas the Th2 immune response is associated with the production 
of IgG1 and IgE (Su and Stevenson, 2002). Results from this study show that both 
Leishmania specific IgG2a and IgG1 antibody isotypes were detected in the serum of 
mice immunised with the different plasmids encoding different Leishmania genes.  This 
has revealed that Leishmania DNA constructs and the method used in this study have 
succeeded in activating the immune response. The rise of the IgG response is usually 
associated with protection against infections, but Leishmania parasites can also use it 
to evade the immune response. Coating of Leishmania amastigotes by IgG antibodies 
and binding to macrophages through FCR II enhances the production of the cytokines 
associated with Th2 immune responses such as IL-10 (Kane, et. al., 2001; Buxbaum, 
et. al., 2005). The role of IL-10 in disease progression has been demonstrated in the IL-
10 knockout mice model, which become resistant to L. mexicana infection, and these 
mice showed a high level of IFN-γ, compared to wild type mice, which developed 
chronic lesions (Buxbaum, et. al., 2005). Chu, et. al., (2010) reported that IgG1 and 
IgG2a/c can enhance the production of IL-10 from infected macrophages in vitro, 
through the macrophages FcγRIII and FcγRI receptors, respectively, and their results 
also demonstrated that mice lacking IgG1 were more resistant to L. mexicana infection. 
This confirmed the fact that the FcγRIII receptor is associated with progression of 
Leishmania infection. In contrast, FcγRI is associated with infection control.     
Although the result of this study showed the rise of Th1 immune response, as measured 
by the increase in IgG2a antibody isotype response, the results also demonstrated an 
increase in Th2 immune response which was characterised by increased IgG1 level, this 
was in agreement with reports by Liu, et. al., (2005). 
In spite of the intensive investigations on the role of CD4/CD8 T cells in Leishmania 
infection control, there is still contradiction in the published findings. Flow cytometry 
results from this study showed both CD4+ and CD8+ populations were increased after 
two weeks from the last immunisation in splenocytes compared to the controls. 
However, in lymph nodes while there was a slight increase in the CD4+ population, 
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there were no differences in CD8+ population profile. For the intracellular pathogens 
(such as viruses and Leishmania spp), antigens will be mostly taken up, processed, and 
represented through MHC class I and MHC class II, which induce and activate CD8+ 
to kill infected cells and CD4+ to produce cytokines. In the case of DNA immunisation, 
the synthesised antigens will processed via into the MHC class I or MHC class II 
pathway, as a consequence of which CD8 or CD4 T cells will be stimulated, 
respectively. 
In the current study, the cell-mediated immune response was measured using a 
proliferation assay in response to relevant Leishmania antigens (SLA). Optimisation 
experiments were first conducted in order to find the optimal cell number and antigen 
concentration for the best results, which showed that splenocytes harvested from 
spleens of immunised mice, specifically proliferated as a response to a second 
stimulation with L. mexicana SLA, compared to controls. Interestingly, the results of 
this study, illustrate that the proliferation rate of cells harvested from the spleens was 
higher compared to cells harvested from lymph nodes of immunised mice. This 
observation highlights the importance of APCs and their role in processing of antigens 
and representing them on their surface, which eventually stimulates splenocyte 
proliferation. This may be related to the fact that cells population taken from the lymph 
nodes contain less macrophages compared to cells population from spleens, that have 
an important role in antigen processing, presentation (Phillips, et. al., 2010). 
In this study, a novel macrophage-resistance assay has been developed to assess 
immunity against L. mexicana infection. To the best of our knowledge, this “survival 
assay” has been used for the first time to investigate the ability of macrophages from 
immunised mice to resist L. mexicana amastigote transformation. The results of this 
assay clearly illustrate the potential of Leishmania DNA constructs, since amastigotes 
isolated from immune macrophages were not able to transform to the promastigote 
stage compared to non-immune macrophages (isolated from control mice or mice 
immunised with empty plasmids). Although this has been performed on macrophage 
progenitor cells, which demonstrated resistance to infection in vitro, this needs to be 
confirmed using mature macrophages from immunised animals by peritoneal lavage. 
In addition, more investigations are needed to determine the effect of Leishmania DNA 
constructs on the amastigote stage in infected macrophages, since the results of this 
study showed that there is no difference in IFN-γ and NO secretions of infected 
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macrophages in immunised mice compared to controls. It is also worth investigating 
other Leishmania species such as L. donovani, which target the bone marrow 
macrophages as a final host. 
Collectively, this investigation has addressed the complexity of the immune response 
to Leishmania parasite infection, which seems not only species dependent, and or the 
genetic background of the host cells, but it also dependent on the vaccine type and 
immunisation schedule. 
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4. L. mexicana promastigote growth 
characterisation 
4.1   Introduction 
Understanding the biological complexity of Leishmania parasite is essential for its 
control (Wheeler, et. al., 2011). The life cycle of Leishmania spp is complex, and 
consists of two different stages promastigote and amastigote, that survive and multiply 
inside the sand fly and mammalian host, respectively. 
Metacyclogenesis is the process whereby Leishmania parasites transform from 
infective procyclic promastigotes into infective metacyclic promastigotes, this process  
naturally takes place in sand fly vectors. It has been reported that metacyclogenesis is 
characterized by an increase in the parasite ability to infect and survive in mammalian 
hosts. 
Metacyclogenesis has also been shown to occur is cultures of promastigotes in vitro, 
and is associated with morphological changes in size, shape, length and changes in the 
surface molecules  such as LPG and GP63 (Muskus and Marín, 2002). 
 Early studies have reported that metacyclogenesis of avirulent L. major was unusually 
delayed, compared to promastigotes which recovered from late-stationary-phase 
cultures, which were able to infect Balb/c mice (Silva and Sacks, 1987) The loss of 
virulence which is associated with frequent subculture could also induce 
metacyclogenesis delay. A study by the same group reported that over 90% PNA 
positive (the lectin peanut agglutinin a method used as metacyclogenesis indication)- 
promastigotes was obtained during passage 1, which was down regulated to 10% PNA- 
promastigotes at passage 94.  
Growth conditions can also affect parasite metacyclogenesis. A study by Bates and 
Tetley, 1993, reported that culturing L. mexicana at pH 5.5 in Schneider's Drosophila 
medium supplemented with 20% v/v FCS produced homogeneous stationary phase, and 
they were resistant to complement-mediated lysis and  highly infective to peritoneal 
macrophages in vitro. However, growing the L. mexicana promastigotes at pH 7.0  in 
Schneider's Drosophila medium supplemented with 20% v/v FCS produced 
morphologically mixed populations of stationary phase and were less infectious when 
they tested in vitro. 
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 It is well established that many parasites such as Plasmodium and Leishmania species 
have evolved a number of mechanisms that allow them to misdirect the human immune 
system (Dey, et. al., 2013). Moreover, the size and genetic complexity of the different 
stages of these parasites allows them to induce a variety of antigens (proteins) that can 
be detected by the human immune system, and some parasites can also develop into 
different stages even inside the final host.  
The L. mexicana life cycle is a complex process (Figure 1.2.2).  A part of it occurs 
inside the midgut of an infected sand fly, where procyclic promastigotes replicate and 
transform into human-infective metacyclic promastigotes, which are found in the upper 
gut of the sand fly vector. A second part occurs inside the mammalian host (Bates, 
2007). In the current study, it was possible to reproduce the growth of several 
Leishmania spp outside the sand fly using different types of growth media and 
supplements under laboratory conditions.  Reports show that the procyclic forms inside 
the sand fly correspond to promastigotes in the in vitro exponential phase of growth, 
and that the metacyclic form represents the stationary phase of the in vitro culture, 
which is described as the infectious stage for experimental applications (Sacks and 
Perkins, 1984;   Sacks and Perkins, 1985).  
Despite many attempts, including the use of attenuated parasites, or subunits vaccines, 
(Daneshvar, et. al., 2003), research has failed to develop an effective Leishmania 
vaccine to date. The immunogenicity of several attenuated Leishmania spp, has been 
reported, such as L. tropica (Handman, et. al., 1983), and L. major (Kimsey, et. al., 
1993).  Attenuated parasites can be prepared using different methods, such as the 
knockout of some virulence genes. For example, Alexander, et. al (1998) produced 
attenuated L. mexicana promastigotes by knockout of the cysteine protenase genes. 
Another method is to induce attenuation by exposing the parasite culture to antibiotics 
such as Gentamicin at a known concentration for period of time (Moreira, et. al., 2012). 
The mechanism of how this antibiotic affects parasite virulence is not known. However, 
in bacteria, it has been reported that the Gentamicin affects growth by interfering with 
protein synthesis through the misreading of mRNA, which results in synthesis of 
unwanted or abnormal protein that ultimately caused the bacterial death (Daneshvar, et. 
al., 2003). Whether or not this occurs in Leishmania is uncertain. 
In the current study, the effect of laboratory conditions on the growth of L. mexicana 
promastigotes was investigated, and their attenuation was carried out naturally by serial 
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in vitro passaging of virulent L. mexicana (P1) in growth medium without antibiotics. 
Although phenomenon of losing virulence because of in vitro passaging has been 
previously reported (Mitchell, et. al., 1984). In this study changes in the virulence 
associated gene expression profile (Oliver ea. al., 2012), parasite infectivity and ability 
to transform into amastigotes in the host cells have been thoroughly investigated.  
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The work flow 
The experiments of this chapter were carried out according to the following schedule: 
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4.2  Results  
4.2.1 Leishmania mexicana identification 
A standard ITS1 PCR restriction fragment length polymorphism (RFLP) technique was 
used to confirm species identity of L. mexicana used in this study. In this method the 
internal transcribed spacer 1 (ITS1) gene encoding for18S rRNA and 5.8S rRNA was 
first amplified by PCR, then digested with HaeIII restriction enzyme. Results in Figure 
4.2.1 show that bands from the digested PCR product were identical to that published 
by Schonian, et. al., (2003). 
 
Figure 4.2-1 RFLP analysis to identify L. mexicana species 
Parasite DNA was extracted form P1 and used as a template to amplify ITS1 (ribosomal internal 
transcribed spacer 1) region, the PCR product (ITS1) digested with Hae III restriction enzyme. 
Digested products were separated in 2% w/v agarose gel for 2 hours. The experiment was 
repeated twice as shown in picture (A). The results were comparable with those published by 
Schonian et. al., (2003). Picture (B) L. mexicana is marked ** 
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4.2.2 L. mexicana promastigote growth characterisation 
As with other parasite species, L. mexicana can be grown in the laboratory and used for 
in vitro investigations, however, due to the effect of different conditions on the parasite 
infectivity, it is important to determine the growth characteristics of the target species. 
L. mexicana promastigotes were obtained from freshly harvested lesions from infected 
Balb/c mice as described in the methods section. The harvested parasites were passaged 
in vitro for specific periods of time to investigate the effect of growth on their infectivity. 
4.2.2.1 The effect of in vitro passage on L. mexicana infectivity in vivo  
In order to investigate the effect of in vitro passage on L. mexicana promastigote 
virulence, susceptible Balb/c mice at 6 to 8 weeks of age were inoculated I.D with 2x106 
L. mexicana promastigotes of different passage numbers in a shaved area on the back 
about 2cm from the tail base. Mice were monitored for lesion development. Results 
demonstrate that passaging the parasite in vitro has caused a gradual loss of in vivo 
infectivity. Virulency of L. mexicana promastigotes has been reduced at passage 7, and 
completely lost at passage 20 (Figure, 4.2.2). 
 
Figure 4.2-2 In vivo infectivity of different passage numbers of L. mexicana promastigote    
Groups of three Balb/c mice aged 6-8 weeks were injected I.D with 2x106 L. mexicana 
promastigotes at passage 1, 7 and 20. Mice were monitored for lesion development. Data are 
presented as mean + SEM, and the graph represents three different experiments. 
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4.2.2.2 The effect of in vitro passage on L. mexicana population growth 
To evaluate the effect of in vitro passage on L. mexicana promastigote growth, parasites 
at passages 1, 7 and 20 were cultured anaerobically in Schneider Drosophila medium 
(Lonza, UK), supplemented with 10% v/v HIFCS medium at 25°C, with daily counting 
using a Neubauer haemocytometer. The exponential growth phase of L. mexicana 
promastigotes at all passages was very short and only lasted for few days. It was also 
noted that there was no stationary phase of L. mexicana promastigotes at any tested 
passage number. Although there were no significant differences in the growth curve 
pattern between the different passage numbers, there was a clear difference in the total 
parasite number at the growth peak, which increased over time from 31 million at P1 
to 60 million at P20. In contrast the overall growth curve span, was longer at P1 
compared with P20 (Figure 4.2.3). 
 
Figure 4.2-3 In vitro growth curves of L. mexicana promastigotes at P1, P7 and P20 
Each growth curve was obtained from daily counting of three sets of cultures which initiated at 
a concentration of 1x106 organisms in 10 ml of Schneider Drosophila medium (Lonza, 
UK), supplemented with 10% v/v HIFCS in T25 flasks at 25°C for the experimental course. 
Graphs represent at least three independent experiments. Data are presented as mean + SEM. 
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4.2.2.3 The effect of in vitro passage on the morphology of L. mexicana 
promastigote  
Another interesting phenomenon was reported in this study, where passaging of L. 
mexicana promastigotes in vitro has revealed morphological changes (Figure 4.2.4, top 
panel). Therefore, it was decided to estimate their body size and flagella length. The 
promastigotes at late log phase of passages 1, 7 and 20 were measured using a calibrated 
micrometer slide. Results show a significant increase in cell body size, which was 
positively related to passage number, however there was no significant difference in 
flagellum length among L. mexicana promastigotes from different passage numbers 
(Figure 4.2.4 lower panel).  
 
Figure 4.2-4 The effect of prolonged in vitro culture on L. mexicana morphology 
A million promastigotes from P1 and P20 L. mexicana promastigotes at late log phase were 
washed with sterile PBS and stained with 5ng per ml CFSE. Cells were visualised using a 
fluorescence microscope with a 100x objective (Top panel). The graph shows a significant 
increase in the cell size, but no difference in flagellum length, as it measured using a calibrated 
slide, (Lower panel). Graphs represent data from at least three independent experiments, 
*P<0.05, ***P<0.001 using the Student's t-test. Data are presented as mean + SEM.  
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4.2.2.4 The effect of in vitro passaging on the virulence of L. mexicana 
To evaluate the effect of in vitro culturing on the expression of virulence-associated 
genes, total mRNA was extracted from the late log growth phase at passages P1, P7 and 
P20, and converted into cDNA, which was used for qPCR analysis. Results clearly 
illustrate a significant down regulation of the expression of GP63, LPG2, CPC, CPC2, 
CPC2.8, Ldcen, and LACK genes (Figure 4.2.5. A). CHT1 gene was also down 
regulated as result of in vitro passage. However, the level of the expression of this gene 
was restored at passage 20. Further experiments were conducted to determine the effect 
of in vitro passaging on expression of some parasite-related proteins. 
Immunofluorescence staining using anti-GP63 monoclonal antibodies demonstrated 
that the expression of GP63 protein on the surface of L. mexicana promastigotes was 
decreased as a result of in vitro passaging. The pictures showed the green colour 
(represent GP63 protein), disappeared over time from P1 to P20 (Figure 4.2.5.B). 
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Figure 4.2-5 Gene expression of virulence-associated genes in L. mexicana promastigotes 
at P1, P7 and P20 
Total mRNA was extracted from promastigote late log growth phase for each passage number, 
total RNA was converted to cDNA which was used as a template for qPCR analysis. The qPCR 
was performed by specific primers for each gene of interest using a Rotor ™ 6000 Real Time 
PCR machine (Corbett Research. Qiagen, Germany). Results were normalized to two 
housekeeping genes (L. mexicana-β tubulin, L. mexicana-α tubulin). Results represent 
three independent experiments. *P<0.05 sing the Mann-Whitney test (Panel A). Data are 
presented as mean + SEM.  One million promastigotes of P1, P7, and P20 were stained for 
GP63 protein localization using anti-GP63 monoclonal antibodies. The pictures illustrate a 
decrease in the expression of GP63 as a result of in vitro culturing, which correlates with the 
intensity of the green colour (Panel B).  
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4.2.3 Host cell-L. mexicana promastigote interaction 
In order to investigate the effect of in vitro passaging on L. mexicana promastigote 
infectivity, the infectivity of the promastigotes at passage 1 (virulent), and passage 20 
(avirulent) was measured in vitro in U937 monocyte and U937 macrophages.  
4.2.3.1 Characterization of U937 macrophages 
The U937 monocyte target cells were maintained as described in the Materials and 
Methods (section 2.2.5.1.2). Both PMA and LPS (Sigma, UK) were used separately, at 
concentrations of 1, 2 and 5µg per ml as macrophage maturation agents to select the 
optimum concentration that could be used to induce U937 monocytes into U937 
macrophages. Results in Figure 4.2.6. A, clearly show that the use of PMA has 
produced more adhered U937 macrophages compared with LPS.  In addition, the lower 
concentration, 1µg per ml PMA, gave a high number of adhered cells in comparison to 
higher concentrations. Therefore, U937 macrophages obtained from treatment with 1µg 
PMA were used for further analysis. Phase contrast imaging using confocal microscopy 
also shows morphological changes of U937 cells after treatment with 1µg PMA. The 
pictures in Figure 4.2.6.B, demonstrate a big cytoplasm and small nucleus in matured 
macrophages, in contrast to the immature U937 monocyte, which has a big nucleus and 
small cytoplasm.  
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Figure 4.2-6 Characterisation of U937 macrophages 
(A) Maturation of U937 monocyte cells with different concentrations of PMA and LPS. U937 
monocytes were seeded in 24 well plates at a concentration of 2x105 per ml, stimulated with 
the required concentration of PMA or LPS, and incubated at 37ºC for 48 hours. The culture 
medium was removed and the centres of the wells were visualized and captured using a Nikon 
Eclipse TS100 microscope connected to a Nikon digital net camera DN100 at 10x 
magnification. (B) Morphological changes were observed using a confocal microscope, target 
cells were stained with DAPI. The pictures represent different images from two independent 
experiments.   
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The obtained U937 macrophages from U937 monocytes were further assessed for the 
expression of macrophage markers (CD14, CD68 and T4/80) using qPCR, which was 
further confirmed by flow cytometry analysis. Total mRNA was extracted from 
matured cells using 1µg per ml PMA and U937 monocytes (used as a control), and 
converted into cDNA which was used to check the expression of target macrophage 
markers. Results in Figure 4.2.7.A illustrate that there was a significant expression of 
the three chosen macrophage markers on the U937 macrophages compared with U937 
monocytes. qPCR results were further confirmed by using flow cytometry analysis, 
which also showed that 36.48%, 54.78% and  80.54% of U937 macrophages expressed 
CD14, CD68 and F4/80, in comparison to 1.64%, 3.12% and 1.78% of U937 monocytes, 
respectively (Figure 4.2.7.B).  
Macrophage maturation was also confirmed using the latex beads uptake assay to 
determine the engulfing capability of matured U937 macrophages. The confocal 
microscopy results clearly show that there was average of three beads per cell when 
1µg per ml PMA was used to mature the U937 monocytes into U937 macrophages, 
compared with only one or no beads per cell when 2µg or 5µg per ml PMA was used 
(data not shown). 
Collectively, the results demonstrate that using the PMA at a concentration of 1µg per 
ml was the optimal concentration to induce U937 monocyte maturation to U937 
macrophages, which induced more U937 macrophages expressed a high level of all the 
tested macrophage markers compared with U937 monocytes, and induced high 
engulfing capability. 
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Figure 4.2-7 The expression of U937 macrophages markers 
 (A) RNA was extracted from U937 monocytes and U937 macrophages, and converted into 
cDNA for qPCR analysis. Results showed a significant expression of T4/80, CD40 and CD68 
markers; the bars represent three independent experiments. (B) Shows histogram of flow 
cytometry analysis of U937 macrophage markers. U937 macrophages and U937 monocytes 
were stained for the expression of target markers.  Data are derived from at least 3 independent 
experiments, *P<0.05 was calculated using the Mann-Whitney test. Data are presented as mean 
+ SEM. 
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4.2.4 Interaction of L. mexicana with U937 monocytes and U937 
macrophages 
In order to study parasite infectivity, host cells (U937 monocytes and U937 
macrophages) were seeded in 24 well plates at a concentration of 2x105 cells per well. 
Target cells were infected with the late log growth phase of virulent and avirulent L. 
mexicana promastigotes at a ratio of 1:30 (cell: parasite) and incubated at 37°C in a 
humid atmosphere in a 5% v/v CO2 incubator. Cells were monitored at different time 
points by microscopic examination using a Nikon Eclipse TS100 microscope connected 
to a Nikon digital net camera (DN100). A number of cellular changes in the two hours’ 
infected culture were observed, reflecting differences between infection of the target 
cells with virulent (P1) and avirulent (P20) L. mexicana promastigotes. The results 
clearly show the inability of avirulent parasites to infect target cells (Figure 4.2.8, B), 
where they formed clusters of promastigotes which remained around the target cells. In 
contrast the virulent L. mexicana promastigotes remained as single cells (Figure 4.2.8, 
A), were evenly distributed around the target cells, and no parasite clusters were 
observed following virulent parasite infection. Furthermore, the number of free 
parasites (promastigotes) isolated from U937 macrophages and U937 monocyte 
cultures infected with avirulent L. mexicana promastigote after 2 hours infection was 
significantly higher compared with those infected with virulent parasites (Figure 4.2.8. 
C and D), respectively. Free parasites remaining outside target cells were estimated by 
counting following slow centrifugation. The higher number of free avirulent                       
L. mexicana promastigotes remaining outside the host cells may be due to the inability 
of these parasites to infect the target cells. 
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Figure 4.2-8 Interaction of virulent and avirulent L. mexicana promastigotes with host 
cells 
U937 macrophages were infected at a ratio of 1:30 (cells: parasite) with virulent (A) and 
avirulent (B) L. mexicana promastigotes, respectively for 2 hours. Picture (B) shows the 
formation of clusters (indicated by the arrow) produced by avirulent parasites in comparison 
to the virulent parasite, which remained as single cells adhered to and around the target cells, 
picture (A). The pictures represent more than three experiments using different cell lines, and 
show the number of free virulent and avirulent L. mexicana promastigotes harvested from 
infected U937 macrophages (C) and U937 monocytes (D) after infection for 2 hours. Host cells 
were removed by slow centrifugation, free parasites were counted per ml using a Neubauer 
hemocytometer. The bars represent 3 independent experiment * P<0.5 using the Student's t-test. 
Data are presented as mean + SEM. 
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4.2.4.1 Infection of U937 monocytes and U937 macrophages with          
L. mexicana for 24 hours 
The results of infection of target cells with virulent and avirulent L. mexicana 
promastigotes for 24 hours have shown considerable differences in parasite infectivity. 
Images in (Figure 4.2.9.A) show U937 macrophages infected with virulent and 
avirulent L. mexicana promastigotes for 24 hours. The pictures illustrate that virulent 
parasites successfully produced amastigotes, which were detected outside the infected 
cells as the arrow indicates. However, avirulent promastigotes failed to produce 
significant numbers of amastigotes, and only few of them were detected outside 
infected cells, the majority of parasites remaining outside the target cells as 
promastigotes. Amastigote numbers in cultures of U937 macrophages infected with 
virulent and avirulent L. mexicana promastigotes were determined by counting at 2, 5 
and 24 hours post infection. Results 4.2.9.A, clearly show a significant number of 
amastigotes detected after 5 and 24 hours of infection, following the infection with 
virulent parasites. The amastigote number was highest at 24 hours after infection in 
comparison to those infected with avirulent L. mexicana promastigotes. 
A similar trend in results was also observed in the U937 monocyte cell line infected 
with virulent and avirulent L. mexicana parasites (Figure 4.2.9.B).  Interestingly, the 
number of free amastigotes in the U937 monocyte culture infected with both virulent 
and avirulent parasites was less at 24 hours infection compared with that at 5 hours 
infection. These results were reproduced using a MonoMac-6 monocyte cell line 
infected with virulent and avirulent L. mexicana promastigotes (data not shown). 
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Figure 4.2-9 Infection of U937 macrophages and U937 monocytes with virulent and 
avirulent L. mexicana 
Target cells were infected with virulent and avirulent parasites at a ratio of 1: 30 (cell: parasites). 
Four random microscopic fields from a total of 6 wells per cell line for each experiment were 
captured using a Nikon Eclipse TS100 microscope connected to a Nikon digital net camera 
DN100 at different time points (200X magnification). Pictures (A and B) were captured at 24 
hours following infection.  Graphs (A) and (B) represent the number of amastigotes per 
microscopic field in infected U937 macrophages, and U937 monocytes, respectively. Bars 
represent the three independent experiments for each cell line, **P<.01, ***P<.001 using the 
Student's t-test. Data are presented as mean + SEM. 
4) L. mexicana promastigote growth characterisation 
 
  147 
 
 
Similar patterns of results were observed when target cells were infected with virulent 
and avirulent parasites for 48 hours. Figure 4.2.10.A, illustrates that the avirulent 
parasites were able to enter the U937 macrophages, but were unable to produce 
amastigotes, in comparison to the massive production of amastigotes in cells infected 
with virulent parasites. 
To investigate whether virulent and avirulent L. mexicana promastigotes can equally 
infect target cells, a classic method of Giemsa staining and microscopic examination to 
determine the percentage of infected cells was used. Target U937 macrophages were 
infected with the virulent and avirulent late log phase of L. mexicana promastigotes at 
a ratio of 1:10 (cell: parasite) for 2, 24 and 48 hours. Infected cells were harvested, 
smeared onto glass slides and stained with 5% w/v Giemsa stain as described in the 
Materials and Methods section. The percentage of infected cells when virulent parasites 
were used steadily increased from 36%, to 50% to 86% at time points 2, 24 and 48 
hours, but the percentage of cells infected with avirulent L. mexicana promastigotes 
was 21%, 22% and 38% at 2, 24 and 48 hours (Figure 4.2.10.B). Unlike U937 
macrophages, the number of infected U937 monocytes with virulent and avirulent 
parasites was much less at 48 hours, compared with 24 hours infection (Figure 4.2.10.C).  
Interestingly, in addition to the differences in promastigote numbers after two hours 
infection with virulent and avirulent parasites (Figure 4.2.11, top panel), avirulent 
parasites failed to transform from promastigotes to amastigotes at 24 and 48 hours. The 
results clearly show that there were few amastigotes per cell in infected U937 
macrophages in comparison with the virulent infection (Figure 4.2.11, lower panel). 
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Figure 4.2-10 Interaction of L. mexicana promastigotes with U937 monocytes and U937 
macrophages 48 hours post infection 
Target cells were infected with virulent and avirulent L. mexicana promastigotes at a ratio of 1: 
30 (cell: parasites). Pictures (A) show inability of avirulent L. mexicana promastigotes to form 
amastigotes, in comparison to virulent parasites. The number of infected cells using Giemsa 
staining shows an increase in the number of infected U937 macrophages over time (B). In 
contrast, the number of infected U937 monocytes was less at 48 hours infection (C). Data are 
derived from at least 3 independent experiments, *P<0.05 was calculated using the Mann-
Whitney test. Data are presented as mean +SEM. 
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Figure 4.2-11 Interaction of host cells with virulent and avirulent L. mexicana 
promastigotes at different time points 
U937 macrophages were infected with virulent and avirulent L. mexicana promastigotes 1:10 
(cell: parasite), infected cells were stained with 5% w/v Giemsa stain at 2, 24 and 48 hours. The 
number of virulent L. mexicana promastigotes per cell after 2 hours infection was consistently 
higher in comparison to the number of avirulent promastigotes per cell (A and B, respectively).  
At 24 and 48 hours, virulent promastigotes were able to transform into amastigotes (C and E, 
extreme examples of infection). In contrast, avirulent L. mexicana promastigotes failed to 
transform into amastigotes (D and F).  ***P <0.001 using the Student's t-test. Bars represent 
numbers of the amastigotes stage in 100 infected U937 macrophages with virulent and avirulent 
parasites in two independent experiments. Data are presented as mean + SEM. 
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4.2.4.2 The effect of conditioned medium on L. mexicana promastigote 
growth 
The use of a conditioned medium, derived from U937 monocytes infected for 2 hours 
with virulent or avirulent parasites, significantly inhibited the growth of avirulent but 
not virulent L. mexicana promastigotes (Figure 4.2.12). The inhibition of avirulent 
parasite growth was irrespective of whether the conditioned medium was derived from 
infected U937 monocytes with virulent or avirulent parasite (B and C). A control 
conditioned medium derived from non-infected U937 monocytes, did not inhibit the 
growth of either virulent or avirulent L. mexicana promastigotes. Although the same 
pattern of effect on L. mexicana growth of conditioned medium derived from infected 
U937 macrophages, was observed (D, E and F), the results clearly show that the 
conditioned medium derived from infected U937 macrophages was more supportive to 
the growth of virulent parasites. 
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Figure 4.2-12 Effect of conditioned medium on L. mexicana promastigote growth 
Conditioned medium was produced by infecting target cells for 2 hours. (A) Number of 
promastigotes after being cultured for 3 days in a conditioned medium of control U937 
monocytes. (B) Number of virulent and avirulent promastigotes after being cultured for 3 days 
in conditioned medium from U937 monocytes infected for 2 hours with virulent L. mexicana. 
(C) Number of virulent and avirulent promastigotes after being cultured for 3 days in 
conditioned medium from U937 monocytes infected for two hours with avirulent L. mexicana. 
*P<0.05 using the Student's t-test. D. E and F show the effect of the conditioned medium from 
control and infected U937 macrophages on the growth of virulent and avirulent L. mexicana 
promastigotes.  Data are presented as mean + SEM. 
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4.2.4.3 Host cell lysis induced by parasite infection and A2 expression 
The current study has demonstrated that, in spite of the increase in the number of 
amastigotes after 24 hours of infection in cultures of host cells infected with virulent, 
but not avirulent parasites, there was no significant difference in numbers of host cells 
at this time. However, at 48 hours a significant loss in host cell numbers was observed 
following infection with virulent but not with avirulent parasites (Figure 4.2.13.A). This 
was further confirmed by the expression of a specific amastigote protein A2 in infected 
cells, which reflects the parasite load in infected host cells. The qPCR results illustrate 
that the expression of the A2 gene in U937 macrophages increased from 132 fold at 2 
hours, to 360 fold at 24 hours, and dropped to a 201 fold at 48 hours of infection with 
virulent parasites, compared to 0.09, 0.19, 2.16 fold expression at 2, 24 and 48 hours 
following the infection with avirulent parasites (Figure 4.2.13.B). The same pattern of 
A2 gene expression was observed in U937 monocytes infected with virulent parasites 
(Figure 4.2.13.C). The expression of the A2 gene in U937 monocytes was 73, 152, 32 
fold, and 0.015, 0.09, 0.04 fold at 2, 24, and 48 hours when cells were infected with 
virulent and avirulent L. mexicana, respectively. 
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Figure 4.2-13 Infected host cell lysis and amastigote A2 expression 
U937 monocytes were infected with virulent and avirulent L. mexicana promastigotes at a ratio 
of 1:10 (cell: promastigotes). Cells were counted using trypan blue at 2, 24, 48 hours post 
infection. **P<0.01 using the Student's t-test. The bars in (A) represent three independent 
experiments. In each experiment six replicates were used. In other experiments, cells were 
infected for 2, 24, and 48 hours and subjected to mRNA extraction. Synthesised cDNA was 
used to check the expression of the specific A2 amastigote gene. (B) illustrates A2 expression 
in infected U937 macrophages and (C) shows A2 gene expression in infected U937 monocytes. 
Data are derived from 3 independent experiments, *P<0.05 was calculated using the Mann-
Whitney test. Data are presented as mean + SEM. 
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4.2.4.4 Effect L. mexicana infection on the phagosome maturation 
markers 
The results of this study show a significant difference between virulent and avirulent              
L. mexicana infection on the expression of Rab7 and Rab9 markers. There is an over 
expression of Rab7 in U937 macrophages infected with avirulent parasite at all-time 
points, compared with infection with the virulent parasite (Figure 4.2.14.A). The results 
also demonstrate that, the expression of Rab9 was up regulated following infection of 
target cells with the avirulent parasite, but only at 2 and 24 hours of infection. 
Unexpectedly, Rab9 was up regulated, but not significantly, at 48 hours in host cells 
infected with the virulent parasite (Figure 4.2.14.B). 
 
 
Figure 4.2-14 The expression of phagosome maturation markers in infected U937 
macrophages 
 U937 macrophages were infected at a ratio of 1:10 (cell: parasites), with virulent and avirulent 
L. mexicana promastigotes.  Infected cells were then incubated at 37°C and 5% v/v CO2. 
Control (non-infected cells) and infected cells were subjected to RNA extraction after 2, 24, 
and 48 hours; synthesised cDNA was used as a DNA template in qPCR analysis. (A) Represents 
the expression of Rab7, (B) represents the expression of Rab9, at different time points. Bars 
represent three independent experiments. *P<0.05 using the Mann-Whitney U test. Data are 
presented as mean + SEM. 
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4.3  Discussion 
The challenges of Leishmania vaccine development are associated with the complexity 
of the immune response to Leishmania spp, which is directly linked to the biological 
complexity of the two stages of the parasite’s life cycle.  In this study, the biology of     
L. mexicana promastigotes growth was analysed. Attenuated L. mexicana 
promastigotes were produced naturally by continuous in vitro passaging in Schneider 
Drosophila medium (Lonza, UK), supplemented with 10% v/v HIFCS media, without 
any antibiotics. The infectivity of L. mexicana promastigotes at passages 1, 7 and 20 
was analysed by intradermal inoculation of Balb/c mice. This study demonstrated that 
L. mexicana parasite infectivity was lost during continuous culture in vitro. The loss of 
virulence was detected at P7, while complete loss was obtained at P20 (Figure 4.2.2). 
Subsequently, parasites at passage one have been called “virulent”, while the parasites 
at passage 20 are called “avirulent”. These results were in agreement with the findings 
of Segovia, et. al., (1992) who reported the loss of virulency in 12 clones isolated from 
a single L. major strain after in vitro culturing for two months, and that these clones 
were unable to form lesions in injected Blab/c mice. The loss of infectivity was also 
reported in L. donovani following long term culture in vitro, which was also 
characterized by the high expression of egalactosyl transferase, an  enzyme that was 
absent in infectious L. donovani promastigotes (De and Roy, 1999). 
The qPCR results of avirulent parasites showed extreme down regulation of almost all 
tested virulence associated genes. GP63, LPG, and cysteine proteases, which have an 
important role in parasite-host cell interaction, attachment, internalisation, and survival 
within the host cells (reviewed in the introduction section 1.3). To the best of our 
knowledge, this study is the first to report a correlation between promastigote size and 
virulency loss. The results (Figure 4.2.4) clearly show that there is an inverse 
relationship between promastigote body size and its virulency status. In contrast, no 
changes were observed in this study in the flagellum length among the different passage 
numbers, although it was noted that the virulent parasites were highly motile in the 
culture, in comparison to the avirulent promastigotes. Interestingly, there was no 
difference in the growth curve patterns between virulent and avirulent parasites but 
there was a difference in the number of parasites at peak growth. Although the centrin 
gene was down regulated at passages 7 and 20, the parasite was still growing well 
(Figure 4.2.3). This was not in agreement with previous findings by           
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Selvapandiyan, et. al., (2001; 2004), who illustrated that the growth of L. donovani was 
highly disrupted as a result of centrin gene knockout. The difference could be explained 
by the adaptation time required for the parasite to grow under laboratory conditions. 
Another possibility is that, in this model when parasites were left to grow for long 
periods of time, this affected the overall gene expression profile. This may different 
from the gene knockout studies where particular genes were deleted from the parasite. 
Since in vitro passage of L. mexicana has caused infectivity loss of the parasites, which 
was characterised by a dramatic delay in lesion appearance at the site of inoculation of 
Balb/c mice, the Leishmania parasites needed to be passaged regularly in laboratory 
animals to maintain their virulency status.  Moreira, et. al., (2012),  showed similar 
findings, where a rapid loss of L. infantum virulence was reported when parasites were 
continuously grown in axenic culture, which consequently affected their capability to 
infect macrophages, meaning that they failed to infect susceptible mice.  
It has been reported that Leishmania promastigotes enter the phagosomes of phagocytic 
cells such as DCs, neutrophils and macrophages. However, they can only multiply 
within macrophages, so these cells are considered to be the ideal host for the 
intracellular stage of Leishmania spp (Laufs, el. al., 2002). The results of the current 
study have demonstrated that U937 monocytes were also able to host virulent, but not 
avirulent, L. mexicana promastigotes.  In addition these parasites were able to produce 
the amastigote stage, so infectivity of Leishmania species in monocytes might be cell 
type and Leishmania spp dependent, and also most importantly on the virulency status 
of the parasites used. 
In order to be able to survive and proliferate inside the acidic conditions of the 
phagosomes, Leishmania spp and other intracellular microorganisms have to suppress 
phagosome maturation, therefore these pathogens have developed survival mechanisms 
which are poorly understood (Burchmore and Barrett, 2001). The current study has 
demonstrated that avirulent L. mexicana promastigotes were unable to meet the two 
important survival requirements inside host cells. Firstly, the inability of avirulent 
parasites to produce the amastigote stage and proliferate inside infected U937 
macrophages (Figure 4.2.9), compared to virulent parasite where amastigotes stage 
developed in vitro after 5 hours  at  37ºC as  of infection target cells as illustrated in 
Figure 4.2.9A. There is no publishing data of a similar type of results. However, it has 
been reported that, in order to obtain L. donovani amastigotes, THP-1 cells have to be 
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infected for 48 hours (De Muylder, et. al., 2011). Secondly, the inability of avirulent L. 
mexicana promastigotes to delay or alter phagosome maturation, which was assessed 
by the high expression of matured phagosome markers Rab7 and Rab9, when compared 
to virulent parasites (Figure 4.2.13, A and B). 
Phagosomes and lysosomes are important components in the control of pathogen 
infection. Inside the phagosomes, foreign antigens will be captured, and degraded by 
lysosomal enzymes. Leishmania parasites have developed many mechanisms to avoid 
being lysed and degraded by these enzymes at early stages of entering the host cell. The 
qPCR analysis demonstrated a significant down regulation of expression of these 
molecules in target cells infected with virulent (P 1) compared to avirulent (P 20)             
L. mexicana. This may enhance the killing of avirulent parasites by the phagosome–
endosome fusion compared to virulent parasites. A study by Desjardins and Descoteaux 
(1997) using knockout LPG2 L. donovani illustrated the direct role of LPG2 in                 
L. donovani promastigotes in phagosome–endosome fusion.   
In this study, the expression of a phagosome maturation (which reflects parasite 
clearance due to phagosome-lysosome fusion) marker was used to address differences 
between virulent and avirulent L. mexicana promastigotes. The down regulation of 
Rab7 and Rab9 (apart from 48 hours post infection) in U937 macrophages infected with 
virulent parasites, may explain the virulent parasite’s ability to transform to the 
amastigote stage, in comparison to avirulent parasites.  
This study has also demonstrated the inability of amastigotes isolated from infected 
U937 macrophages infected with virulent parasites for 48 hours, to proliferate when 
cultured under the same conditions but in the absence of their target cells. This may 
emphasise the need for acidic conditions for amastigote proliferation, and is confirmed 
by the ability of Leishmania amastigotes to proliferate inside the acidic parasitophorous 
vacuole of infected cells. The pH also has an essential role in transformation of 
promastigotes into amastigotes. 
In addition to the role of promastigote surface molecules such as GP63 and LPG, which 
facilitate promastigote-macrophage adhesion and intracellular survival respectively, the 
presence of glucose in culture media also affects infectivity in macrophages. It has been 
reported that L. mexicana expresses three isoforms of glucose transporter genes 
(LmGT), and the knockout of these genes in promastigotes reduced their ability to infect 
macrophages and thus prevented their differentiation into the amastigote stage 
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(Burchmore, et. al., 2003).  In addition to the glucose, other monosaccharaides with six 
carbon atoms (hexoses), are required for amastigote survival, through their roles in the 
phosphate pathway that maintains parasite redox balance and generates precursors for 
DNA and RNA biosynthesis (Maugeri, et. al., 2003). Another study by Naderer, et. al., 
(2006) illustrated the ability of L. major to use an alternative pathway in the case of 
glucose deficiency inside the phagosomes. It was also reported that deletion of fructose-
1, 6-bisphosphatase (FBP) enzyme in L. major, an enzyme responsible for 
gluconeogenesis (a metabolic pathway that results in the generation of glucose from 
non-carbohydrates) did not affect their ability to infect macrophages, and 
transformation to the amastigote stage, but did inhibit their ability to multiply. 
The growth of avirulent L. mexicana promastigotes was inhibited, and the 
promastigotes were unable to survive and proliferate in conditioned medium derived 
from host cells infected with virulent or avirulent parasites. In contrast, this conditioned 
medium supported the growth of virulent parasites (Figure 4.2.11). These data shed 
more light on the importance of different soluble materials released by infected cells to 
control parasite growth, as reviewed in Ali, et. al., (2013). 
The current study has also demonstrated a significant increase in amastigote numbers 
at 24 hours of infection with virulent L. mexicana, without much decrease in host cell 
numbers. However, 48 hours of infection induced a significant decrease in target cell 
numbers, suggesting cell lysis. In addition, the expression of a specific amastigote 
protein A2 in infected target cells was significantly increased from a low level at 2 
hours infection to reach its maximum expression at 24 hours. However, this expression 
was down regulated at 48 hours post infection. This seems to correlate well with the 
rate of infected cell lysis at 48 hours. This study has also demonstrated the inability of 
the amastigotes isolated from infected cells to proliferate, compared to the axenic 
amastigotes,  which  were generated in the laboratory (the late log growth phase of 
virulent and avirulent L. mexicana promastigotes cultured in Schneider Drosophila 
medium (Lonza, UK), supplemented with 20% v/v HIFCS and Hemin (Sigma, UK) at 
32.5°C, 5% v/v CO2. The results were in agreement with a study by Burchmore, et. al., 
(2001), who reported that Leishmania amastigote proliferation was performed in the 
presence of acidic conditions inside an intracellular compartment called the 
parasitophorous vacuole, and that the pH also had an essential role in transformation of 
promastigotes into amastigotes. 
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Although the number of avirulent promastigotes was considerably less at the three 
tested time points,  48 hours infection clearly showed a high number of promastigotes 
per macrophage, which failed to progress to the amastigote stage (Figure 4.2.11). These 
results indicate an important fact, that the parasite’s infectivity should be measured not 
only by infection of the target cells with the promastigotes, but also most importantly 
by the successful amastigote stage performance inside infected macrophages.  
In conclusion, this model has produced virulent and avirulent L. mexicana 
promastigotes. The loss of virulency was characterised by in vivo failure to infect 
susceptible Balb/c mice, and also in vitro inability of avirulent parasites to transform 
into the pathogenic amastigote stage, which can survive and proliferate inside 
susceptible human cell lines. The methods used in this study to demonstrate 
mechanisms of virulency loss in Leishmania could be applied to other parasite species 
to produce attenuated forms that might be used as vaccine candidates.  
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5. MHC class I expression following               
L. mexicana promastigote infection 
5.1  Introduction 
Antigen presenting cells (APCs) have an important role in immune responses against 
infection, through the processing of foreign antigens and presentation via MHC class I 
and MHC class II.  Nevertheless, many intracellular pathogens, like those that cause 
tuberculosis, Leishmaniasis, and Chagas’ disease have developed specific strategies to 
survive inside macrophages to avoid the immune response (Desjardins and Descoteaux, 
1998; Overath and Aebischer, 1999). Consequently, the ability of pathogen-infected 
APCs to activate T cells response through antigen presentation is reduced (Alexander 
and Russell, 1992; Alexander, et, al., 1999). 
Leishmania parasites as an intracellular pathogen can successfully hide and protect 
themselves by being inside APCs such as macrophages and DCs. Interestingly, even 
inside the APCs these organisms have an extra protection by being in small 
compartments called parasitophorous vacuoles inside host APCs, in particular 
macrophages (Prina, et. al., 1990; Russell, et. al., 1992). The presence of PVs inside 
the infected APCs has been shown in some studies not to affect cell surface expression 
of the MHC class I and MHC class II, however only MHC class II but not MHC class 
I molecules were detected on the PVs surfaces (Olivier, et. al., 2005). The mechanisms 
by which the Leishmania parasite manipulates antigen presentation via MHC molecules 
is poorly understood. Variable data have been reported on Leishmania antigen 
presentation, which seems to be parasite species and host cell dependent. It has been 
reported that murine macrophages infected with the metacyclic promastigotes of             
L. major or L. amazonensis present very low LACK antigen. However, when they are 
infected with the amastigote stage of these parasites, they present no parasite antigen at 
all (Courret, et. al., 1999). This illustrated promastigote susceptibility and amastigote 
resistance to the host cell’s defense mechanisms. 
Both L. amazonensis amastigote infected and non-infected bone marrow macrophages 
from Balb/c mice and C57BL/6 mice have been found to express more MHC class I on 
the cell surface, and MHC class II, was mainly found to be associated with the PV 
membranes (Lang, et. al., 1994). 
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A recent study reported that L. donovani caused a down regulation of MHC class I and 
MHC class II through the effect on phagolysosome (the combination of phagosomes 
and lysosomes) biogenesis. This was due to the presence of GP63, which affect 
processing of degraded parasites inside the PVs, and presentation on MHC class I or 
class II molecules to T cells (Matheou, et. al., 2013). 
Although macrophages are the main host for Leishmania species, other cells such as 
DCs and monocytes, which take part in an anti-Leishmanial immune response, can also 
act as Leishmania spp hosts (Gorak, et. al., 1998). A number of studies have 
investigated the antigen presentation potential of Leishmania-infected APCs, but results 
have been contradictory.  For example, a study by Kima, et. al., (1997) reported that a 
specific CD8 cell line was generated against GP46/M-2, a L. amazonensis antigen. In 
further experiments, those CD8 cells were shown to recognize mammalian cells 
transfected with plasmid encoding GP46/M-2, as well as macrophages infected with     
L. amazonensis, which presented GP46/M-2 on their MHC class I molecules. The 
activation of CD8 was eliminated after treatment of the infected cells with brefeldin A 
to block antigen presentation, and this finding revealed the role of MHC class I in 
Leishmania infection control. In another study by Meier, et. al., (2003), infection with 
Leishmania parasites inhibited T cell activation, which was not related to MHC class II 
expression on the surface of infected macrophages. It was also demonstrated that 
infection with L. donovani decreased the macrophages ability to present parasite 
antigens (Sundar, et. al., 1997). Since the MHC class I molecule is a key factor in 
parasite recognition and elimination by the immune system, this study has investigated 
the effect of infection of host cells with L. mexicana promastigotes on MHC class I 
expression. Due to the significant role of monocytes in the entry of microorganisms, 
including Leishmania spp into host cells, two monocyte cell lines (U937 and 
MonoMac-6) in addition to U937 macrophages were used to investigate the effect of 
three important variables: virulence states, growth phases of the parasite, and the 
infection load, on the expression of MHC class I in susceptible human cell lines. 
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The work flow  
The experiments of this chapter were carried out according to the following schedule: 
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5.2  Results  
5.2.1 In vitro growth of L. mexicana promastigotes  
The L. mexicana promastigote growth curve was divided into three stages, based on 
their density in the culture (parasites per ml) and these stages were used to study MHC 
class I expression in infected host cells. There was a gradual increase in parasite number 
during the first few days in culture (early log phase ≥5 x106 promastigotes per ml), 
which was followed by a steep increase in the density of the parasite number per ml 
(mid log stage and ≥1x107 per ml). A maximum L. mexicana promastigote growth in 
culture was identified at the late log phase, where the number of parasites reached 
2.5x107 per ml or above. There was a sharp decrease in cell number when the parasite 
reached the peak of growth (Figure 5.2.1.A). Results in this study show that the range 
of the growth curve was dependent on the initial number of parasites in the inoculum 
that was used to initiate the growth curve cultures. For instance, the growth curve period 
lasted 10 and 25 days when cultures were started with a concentration of 1x106 per ml 
(Appendix 13), and 1x105 (Figure 5.2-1), respectively.  The results clearly show that 
there was no stationary phase (horizontal line) in the L. mexicana growth curve under 
anaerobic conditions, which used in this study. The stationary phase in this study were 
recognized by parasite number (where the population peaked) in the culture according 
to Mottram, 2008 (personal communication), and a slight modification to the original 
protocol as presented in Figure 5.2.1.B. 
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Figure 5.2-1 In vitro growth curve of L. mexicana promastigotes 
 (A) Fresh cultures of L. mexicana promastigotes (passage 1) were initiated at a concentration 
of 1x105 promastigotes per ml in culture medium. Parasite samples (10µl) were fixed in 2% w/v 
paraformaldehyde and counted daily. The graph represents 3 independent experiments. Data 
are presented as mean + SEM. The growth curve of L. mexicana promastigotes in this study 
was divided into three different phases according to the number of promastigotes per ml as is 
shown in the Table (B). The early, mid and late log growth phases were used to investigate the 
MHC class I expression in infected host cells (U937 monocyte and MonoMac-6 cells) with                      
L. mexicana promastigotes. 
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5.2.2 Effect of L. mexicana promastigote infection on MHC class I expression 
in susceptible human cell lines 
In this study the effect of infection with L. mexicana promastigotes on the expression 
of MHC class I was investigated using susceptible human U937 monocyte and 
MonoMac-6 monocytic cell lines. Target cells cultured in 24 well plates at a 
concentration of 2x105 cells per ml per well were infected with different ratios of            
L. mexicana promastigotes taken at different points of the growth curve for 24 hours at 
37ºC in a 5% v/v CO2 atmosphere. 
5.2.2.1 Effect of infection with early growth phase of L. mexicana 
promastigotes on MHC class I expression 
Results clearly show that infection with avirulent and virulent L. mexicana 
promastigotes reduced the proportion of infected cells that expressed MHC class I, from 
92.62% of non-infected U937 monocytes, to 33.41% and 29.84% of cells that have been 
infected with virulent and avirulent parasites, respectively. Meanwhile, the infection of 
MonoMac-6 cells with avirulent and virulent L. mexicana reduced the proportion of 
cells expressing MHC class I expression from 78.48% of control cells to 37.14% and 
45.51% respectively (Figure 5.2.2). Further analysis of the median fluorescence 
intensity (MFI) revealed similar patterns of effects to those that were observed by 
analysing the percentage of MHC class expression. 
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Figure 5.2-2 Effect of infection with early log L. mexicana promastigotes on MHC class I 
expression. 
Flow cytometric histograms illustrating MHC class I expression in non-infected (control) and 
infected U937 monocyte (top panel) and MonoMac-6 cell line (lower panel). Target cells were 
seeded in 24 well plates at a concentration of 2x105 cells per well, and infected with virulent 
and avirulent early log phase L. mexicana promastigotes at a ratio of 1:10 (cell: parasite) for 24 
hours at 37°C. Cells were fixed with 2% w/v paraformaldehyde and stained for MHC class I 
expression. Data are derived from at least 3 independent experiments for each cell line* P<0.05, 
** P<0.01 using the Student's t-test.  Data are presented as mean + SEM. 
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5.2.2.2 Effect of infection with mid log phase of L. mexicana 
promastigotes on MHC class I expression 
Interestingly, although the parasite at mid log phase were supposed to be more mature 
compared to the previous phase, their capacity to reduce the proportion of infected cells 
expressing MHC class I following infection was reduced. Results showed that 92.52% 
of non-infected U937 monocytes expressed MHC class I expression, whereas only 
80.76% and 79.50% of cells infected with virulent and avirulent parasites expressed 
MHC class I respectively (Figure 5.2.3, top panel). Similarly, infection with the mid 
log phase had a minimal effect on the proportion of MonoMac-6 cells expressing MHC 
class I (80.72% of control cells, but 69.69% and 68.63% of cells following the infection 
with virulent and avirulent parasites respectively, Figure 5.2.3, lower panel). Although 
the analysis of the percentage of MHC class I positive cells did not show a difference 
in MHC class I expression between control and infected cells, the MFI analysis reveals 
a significant down regulation of MHC class I expression following infection of U937 
monocyte,  but not following infection of MonoMac-6 cells. The down regulation of 
MHC class I expression was more pronounced following infection with avirulent 
parasites. 
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Figure 5.2-3 Effect of infection with mid log L. mexicana promastigotes on MHC class I 
expression. 
Flow cytometric histograms illustrating MHC class I expression in non-infected (control) and 
infected U937 monocyte (top panel) and MonoMac-6 cell line (lower panel). Target cells were 
seeded in 24 well plates at a concentration of 2x105 cells per well, and infected with virulent 
and avirulent mid log phase L. mexicana promastigotes at a ratio of 1:10 (cell: parasite) for 24 
hours at 37°C. Cells were fixed with 2% w/v paraformaldehyde and stained for MHC class I 
expression. Data are derived from at least 3 independent experiments for each cell line,*P<0.05, 
using the Student's t-test.  Data are presented as mean + SEM.  
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5.2.2.3 Effect of infection with late log phase of L. mexicana 
promastigote on MHC class I expression 
Infection of host cells with either late log phase virulent or avirulent L. mexicana 
promastigotes at a ratio of 1:10 (cell: parasites) had a limited effect on the proportion 
of cells expressing MHC class I. 88.94% of control U937 monocytes expressed MHC 
class I, compared to 77.98%, and 78.51% of cells infected with virulent and avirulent 
parasites, respectively. Similarly, 77.92% of control MonoMac-6 cells expressed MHC 
class I, compared to 54.26%, and 53.1% of cells following infection with virulent or 
avirulent L. mexicana (Figure 5.2.4). Infection had no influence on the intensity of 
MHC class I expression on U937 monocytes, whereas the intensity of MHC class I 
expression on the MonoMac-6 cell line was significantly down regulated following 
infection with virulent (but not avirulent) L. mexicana promastigotes.   
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Figure 5.2-4 Effect of infection with late log L. mexicana promastigotes on MHC class I 
expression. 
Flow cytometric histograms illustrating MHC class I expression in non-infected (control) and 
infected U937 monocyte (top panel) and MonoMac-6 cell line (lower panel). Target cells were 
seeded in 24 well plates at a concentration of 2x105 cells per well, and infected with virulent 
and avirulent late log phase L. mexicana promastigotes at a ratio of 1:10 (cell: parasite) for 24 
hours at 37°C. Cells were fixed with 2% w/v paraformaldehyde and stained for MHC class I 
expression. Data are derived from at least 3 independent experiments for each cell line,* 
P<0.05, using the Student's t-test.  Data are presented as mean + SEM. 
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5.2.3 Analysis of L. mexicana promastigote infectively at early and late log 
growth phases 
The unexpected finding of down regulation MHC class I expression in target cells 
(U937 and MonoMac-6 monocytes), induced by early log phase infection compared to 
mid and late log phases,  has raised the question as to whether those findings were 
related to changes in the infectivity of L. mexicana promastigotes at different growth 
phases in culture. Therefore, total mRNA was extracted from both early and late log 
phases using the Qiagen kit. RNA was converted to cDNA, which used for qPCR 
analysis to determine the virulence associated gene expression in early and late log 
phases of virulent L. mexicana promastigote growth. The results in (Figure 5.2.5.A) 
clearly show that the expression of GP63, LPG2, Cht1, CPC, CPC2 and CPC2.8 genes 
was significantly higher (P>0.05) in the late log phase compared to early log phase. 
 Moreover, parasite infectivity at the log phase (metacyclic) was further confirmed by 
analysis of the expression of Small Hydrophilic Endoplasmic Reticulum-associated 
Protein-Sherp (accession number XM-003875691) and histone H4 (accession number 
XM-003879078) genes which have been used to evaluate metacyclogenesis in 
promastigotes (Moreira, et. al., 2012). mRNA was extracted from the early and late log 
stage of virulent (P1) and avirulent (P20) L. mexicana cultures. One microgram of each 
RNA sample was converted into cDNA, which was then used for qPCR analysis. The 
results (Figure 5.2.5.B) clearly show histone H4 was highly expressed in the early log 
(exponential) phase compared to late log (stationary) phase, while the Sherp gene was 
significantly expressed more in the late (stationary) phase of the virulent parasite 
compared to the early (exponential) phase. Similarly, the Sherp gene was expressed 
more in the late log stage of the avirulent parasite compared to the early log phase, but 
the difference was not significant. 
In addition to the above results, the infectivity of L. mexicana during early and late log 
phases was also confirmed by infection of target cells with both growth stages of the 
parasites. The results showed the failure of L. mexicana promastigotes at early log stage 
to produce the amastigote stage in infected host cells (Figure 5.2.5.C). 
In addition, Giemsa staining illustrated that more U937 monocytes and macrophages 
were infected using the parasite at the late log stage compared to the number of infected 
cells using the parasite at early log stage (data not shown). Taking all those results 
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together, L. mexicana promastigotes at the late log phase was considered as being the 
infectious stage, which was further investigated in this study. 
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Figure 5.2-5 Gene expression profile and infectivity L. mexicana promastigotes at early 
and late log phases 
(A) The expression of virulency associated genes in the early and late log growth phases. 
mRNA was extracted from promastigotes at early and late log growth phases of promastigotes, 
and converted to cDNA to be used as DNA template for qPCR reactions. (B) the expression of 
Sherp and H4 genes in early and late log growth phases of virulent and avirulent L. mexicana 
promastigotes. Results were normalized with L. mexicana-β tubulin and L. mexicana α-tubulin 
housekeeping genes. Data are derived from 3 independent experiments. *P<0.05 using the 
Mann–Whitney U test. Data are presented as mean + SEM. (C) U937 macrophages infected 
with virulent L. mexicana promastigotes at early (Left), and late log phase (Right). Target cells 
were infected with both stages of growth at a ratio of 1:10 (cell: parasites) for 24 hours at 37°C, 
and infected cells were monitored and visualized for production of amastigote stages.   
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5.2.4 Effect of infection with late log L. mexicana promastigotes on MHC 
class I expression using 1:20 ratio 
Increasing the dose of infection from 1:10 to 1:20 (cell: parasites) significantly reduced 
the proportion of U937 monocytes and MonoMac-6 cell lines expressing MHC class I. 
Unexpectedly, infection with avirulent L. mexicana promastigotes had a more 
pronounced effect than infection with virulent parasites in both cell lines. Results 
showed that infection with virulent and avirulent parasites reduced the proportion of 
U937 monocytes expressing MHC class I from 91.75% to 60.07%, and 34.18% 
respectively. In contrast, infection with virulent and avirulent L. mexicana 
promastigotes reduced the proportion of MonoMac-6 cells expressing MHC class I 
molecules from 80% in non-infected to 53.78% and 24.27% respectively (Figure 5.2.6). 
Similar results were obtained when the intensity of MHC class I expression was 
examined (on the basis of the MFI) on U937 and MonoMac-6 cells following the 
parasite infection. Infection significantly down regulated MHC class I expression, and 
the magnitude of this effect was more pronounced following infection with avirulent 
parasites.   
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Figure 5.2-6 Effect of infection with late log L. mexicana promastigotes on MHC class I 
expression using 1:20 ratio 
Flow cytometric histograms illustrating MHC class I expression in non-infected (control) and 
infected U937 monocyte (top panel) and MonoMac-6 cell line (lower panel). Target cells were 
seeded in 24 well plates at a concentration of 2x105 cells per well, and infected with virulent 
and avirulent late log phase L. mexicana promastigotes at a ratio of 1:20 (cell: parasite) for 24 
hours at 37°C. Cells were fixed with 2% w/v paraformaldehyde and stained for MHC class I 
expression. Data are derived from at least 3 independent experiments for each cell line,*P<0.05, 
**P<0.01 using the Student's t-test.  Data are presented as mean + SEM. 
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5.2.5 Effect of infection with high doses of late log phase of L. mexicana 
promastigotes on MHC class I expression 
In order to investigate the effect of high infection doses using virulent and avirulent     
L. mexicana promastigotes at late log phase on the proportion of cells expressing MHC 
class I, U937 monocytes were infected with three doses of 1:30, 1:50 and 1:70 (cell: 
parasites). After 24 hours infection, cells were stained for MHC class I expression and 
analysed by flow cytometry. Results showed complete down regulation of MHC class 
I expression by U937 monocytes infected with the three tested doses (Figure 5.2.7). 
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Figure 5.2-7 Effect of infection with high doses of late log phase of L. mexicana 
promastigotes on MHC class I expression  
Flow cytometric histograms illustrating MHC class I expression in non-infected (control) and 
infected U937 monocytes. Target cells were seeded in 24 well plates at a concentration of 2x105 
cells per well, and infected with late log phase of virulent and avirulent L. mexicana 
promastigotes at a ratios of 1:30, 1:50, and 1:70 (cell: parasite) for 24 hours at 37°C. Cells were 
fixed with 2% w/v paraformaldehyde and stained for MHC class I expression. Data are derived 
from at least 3 independent experiments for each cell line. ***P<0.001, using the Student's t-
test.  Data are presented as mean + SEM.  
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5.2.6 Effect of Fungizone on MHC class I expression restoration in                    
L. mexicana infected U937 monocytes 
It was unclear whether MHC class I down regulation was reversible when the infection 
was eliminated by treatment with an anti-Leishmania agent. Fungizone at a 
concentration of 4µg per ml was optimal to kill Leishmania parasites, and also was not 
toxic to the target cells, as shown by MTT assay (data not shown). The results clearly 
show that short-duration (2 hours) infection of U937 monocytes with virulent and 
avirulent L. mexicana promastigotes significantly down regulated the expression of 
MHC class I molecules. However, treatment of infected cells with Fungizone 2 hours 
after infection resulted in a restoration of MHC class I expression (Figure 5.2.8.A).  
The same pattern of results was obtained when U937 monocytes were infected for 
longer times (24 hours) and treated with Fungizone (Figure 5.2.8.B). In this experiment, 
target cells were infected with the virulent and avirulent parasites and treated with 
Fungizone for up to 24 hours. Interestingly, the results show that the level of restoration 
of MHC class I expression in cells infected with avirulent L. mexicana promastigotes 
was significantly higher compared to the restoration of MHC class I in cells infected 
with virulent promastigotes. 
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Figure 5.2-8 Effect of Fungizone on restoration of MHC class I expression in infected 
U937 monocytes  
Target cells were infected at a ratio of 1:30 (cell: parasites), at different time points when cells 
were treated with 4µg per ml Fungizone. A and B Flow cytometric histograms illustrate MHC 
class I expression in non-infected (control) and U937 monocytes infected with virulent at 
avirulent parasites for 2 and 24 hours, and then treated with Fungizone after 2 and 24 hours 
post-infection, respectively. Cells were fixed with 2% w/v paraformaldehyde and stained for 
MHC class I expression. Data are derived from at least 2 independent experiments for each cell 
line,*P<0.05, ** P<0.01, *** P<0.001 using the Student's t-test.  Data are presented as mean    
+ SEM. 
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5.2.7 Effect of Fungizone on MHC class I expression restoration in U937 
macrophages infected with L. mexicana promastigotes 
In general, the effect of infection of U937 macrophages with virulent and avirulent        
L. mexicana promastigotes on MHC class I expression was similar to that of U937 
monocytes, but with some differences. While the infection of U937 monocytes with 
virulent and avirulent parasite caused almost complete down regulation of MHC class 
I, this was not the case with U937 macrophages. Here, treatment of infected cells with 
Fungizone two hours after infection caused restoration of MHC class I expression 
(Figure 5.2.9.A) and treatment of U937 macrophages with Fungizone after 24 hours 
post infection resulted in a significant MHC class I expression (Figure 5.2.9.B).   
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Figure 5.2-9 Effect of Fungizone on restoration of MHC class I in expression infected 
U937 macrophages 
Target cells were infected with L. mexicana promastigotes at a ratio of 1:30 (cell: parasites), 
after different time points infected cells were treated with 4µg per ml Fungizone. A and B Flow 
cytometric histograms illustrate MHC class I expression in non-infected (control) and infected 
U937 macrophages with virulent and avirulent parasites for 2 and 24 hours, and then treated 
with Fungizone after 2 and 24 hours post infection, respectively. Cells were fixed with 2% w/v 
paraformaldehyde and stained for MHC class I expression. Data are derived from at least 2 
independent experiments for each cell line. **P<0.01, ***P<0.001 using the Student's t-test. 
Data are presented as mean + SEM. 
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5.2.1 Spontaneous restoration of MHC class I expression in host cells 
infected with L. mexicana promastigotes 
Further experiments have shown that MHC class I expression has been partially 
restored in U937 monocytes infected with virulent and avirulent L. mexicana 
promastigotes for 48 hours. This has happened spontaneously without treatment with 
Fungizone. The recovery of MHC class I expression was observed in both U937 
monocytes infected with virulent and avirulent parasites, however, the recovery of 
MHC class I expression was greater in cells infected with avirulent compared to cells 
infected with virulent L. mexicana, as illustrated in (Figure 5.2.10. A).  
In U937 macrophages infected with virulent L. mexicana for 48 hours, there was no 
restoration of MHC class I expression, compared to the significant MHC class I 
recovery in U937 macrophages infected with avirulent parasite (Figure 5.2.10.B).  
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Figure 5.2-10 Spontaneous restoration of MHC class I expression in host cells 
U937 monocytes and U937 macrophages were infected with virulent and avirulent L. mexicana 
promastigotes at a ratio of 1:30 (cell: parasites) for up to 48 hours. Target cells were then fixed 
with 2% w/v paraformaldehyde and stained for MHC class I expression. Data are derived from 
at least 3 independent experiments for each cell line. ** P<0.01 using the Student's t-test.  Data 
are presented as mean + SEM. 
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5.3 Discussion                                                                                              
Although the down regulation of MHC class I molecules and neutralization of CTLs 
activities following infection with intracellular pathogens is well-established following 
virus infection, there is not much information about the effect of Leishmania infection 
on MHC class I expression (Rappocciolo, et. al., 2002; Yossef, et. al., 2012). Available 
data are provide various and contradictory findings, which may reflect the complexity 
and sensitivity of type of studies. 
Virus have developed different mechanisms to avoid the antigen presentation by MHC 
class I and class II. These mechanisms vary according to the virus type.  For example 
infection of human fibroblast with varicella-zoster virus (VZV) has caused significant 
down regulation of the surface major histocompatibility complex (MHC) class II 
molecules which can be reversed by pre-treatment with IFN-gamma (Abendroth, et. al. 
2000) 
The down regulation of MHC class I might be due to the virus products. For example, 
HIV-1 Nef and Tat products have been associated with down regulation of MHC class 
I Ag presentation. Nef is a protein that is unnecessary for HIV-1 replication, (Kestier, 
et. al., 1991), but Nef increases the pathogenicity of HIV in several ways, including 
down-modulation of cell surface MHC class I molecules (Schwartz, et. al., 1996; Le 
Gall, et, al., 1998).  
The experiments described in this chapter were thus designed to investigate and 
compare the effects of virulent and avirulent L. mexicana promastigotes, which reflect 
the parasite’s infectivity at different growth stages on down regulation of MHC class I 
in infected target cells. Since MHC class I molecules can be found on the plasma surface 
of most nucleated cells (Peter, 2011) the human monocyte cell line U937 monocyte and 
MonoMac-6 monocytes and U937 macrophages were used as a model in this study to 
investigate the quantitative expression of MHC class I molecules following infection 
with L .mexicana promastigotes, using flow cytometry analysis. 
To the best of our knowledge, this is the first comprehensive study to investigate the 
MHC class I expression using different human cell lines infected with different growth 
stages of L. mexicana promastigotes, therefore, there was little information with which 
to compare the data obtained from this study.  
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The experiments in this chapter were designed to evaluate the effect of parasite 
infection on MHC class expression in whole cell population after 24 hours of infection, 
and the expression data were expressed as a percentage of positive cells and MFI in 
separate graphs. Interestingly, apart from the infection of U937 cell line with mid log 
phase virulent and avirulent L. mexicana, the MFI analysis gave similar pattern of 
results as that of the total percentage of MHC class I expression. The results have shed 
some light on the importance of the passage number and status of the promastigote 
growth phase, which if controlled may minimize contradictions in the results. 
Although both cell lines used in this study were of a monocytic lineage, results have 
shown different expression patterns of MHC in response to parasite infection, which 
may reflect differences in response to foreign antigens. Similar variations between 
different cell lines in response to the same antigen were also reported by Rappocciolo, 
et. al., (2002), where NBL-6 and EEL cell lines infected with EHV1 differentially down 
regulated MHC class I on their surface.  Unexpectedly, results of the present study show 
the ability of early log L. mexicana promastigotes to down regulate MHC class I 
expression on the surface of infected U937 monocytes and MonoMac-6 cell lines. 
These results contradict previous findings, which reported the infectivity of Leishmania 
promastigotes only observed at their late growth phase (Wozencraft, and Blackwell 
1987). In a study by Moreira, et. al., (2012), the effect of purified and non-purified 
(procyclic and metacyclic promastigotes isolated using a Ficoll density purification 
assay) L. infantum promastigotes on the expression of MHC class II molecules and the 
co-stimulatory antigen CD40 was compared. Their results showed that infection of 
target cells with non-purified promastigotes at passages P4, P21, and P31 induced 
different levels of down regulation of these markers. However, these differences were 
not seen when purified promastigotes were used.  
In the current study, different parasite growth stages have been identified in vitro for 
both virulent and avirulent parasites, based on parasite number per ml according to the 
protocol by Mottram, 2008 (personal communication), as illustrated in Table 5.2.1.B. 
Further investigation using the published method by Moreira, et al., (2012), was carried 
out to confirm the enrichment of metacyclic promastigotes when the parasite number 
reached ≤ 2x107 or above compared to its expression when the promastigote density 
was less. The results showed a high expression of the L. mexicana Sherp gene, which 
has been reported to be up regulated in metacyclic promastigotes (Knuepfer, et. al., 
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2001). Furthermore, L. mexicana histone H4 expression, which has been characterized 
as a procyclic promastigote gene in L. infantum (Soto, et. al., 1997) was highly 
expressed when promastigote density was less than 2x107, compared to its expression 
when the parasite number was higher. 
The results (Figure 5.2.5) also demonstrated that the expression of Sherp gene at the 
metacyclic stage was greater in virulent parasites compared to avirulent parasites. This 
may be another reason explaining previous reports on the inability of avirulent parasite 
to induce the infection (due to failure to reach the metacyclic stage). The analysis of 
virulency associated genes determined by qPCR confirmed expression up regulation of 
GP63 and LPG2 genes. These play an important role in parasite attachment to the host 
cells as well as inhibition of the innate immune response by interfering with the 
complement system pathway (Isnard, et. al., 2012) at the late log phase compared to 
the early phase of parasite growth. The expression of CPC, CPC2 and CPC2.8 genes 
has followed the same pattern. The above genes have an important role in parasite 
survival inside the host cells. Results also showed that an infection with early log phase 
promastigotes failed to transform into the amastigote stage after 24 hours infection 
compared to infection with parasites at late log phase (Figure 5.2.5. A). 
This study has illustrated that the stationary phase (defined above as the population 
peak) can be observed when the parasite was growing in the absence of oxygen, and 
also the virulence associated genes were highly expressed when parasites were grown 
anaerobically (Appendix 15). More investigation on the effect of different conditions, 
such as presence or absence of oxygen, in different types of medium on the associated 
gene expression profile and parasite infectivity is required.  
This study has demonstrated that the down regulation of MHC class I in monocytes and 
macrophages infected with L. mexicana promastigotes at the late phase was infection 
dose-dependent. Hence, the infection of target cells with L. mexicana promastigotes at 
a ratio of 1:10 (cell: parasites) has no effect on MHC class I expression, compared to 
infection with ratios of 1:20 and 1:30 (cell: parasite), when the MHC class I expression 
was gradually decreased using both virulent and avirulent parasites. 
Since the complete down regulation of MHC class I in infected cells was achieved at 
the ratio of infection of 1:30 (cell: parasites), this ratio was used for further analyses. It 
is important to mention that cell viability was checked, after the complete down 
regulation of MHC class I expression (Figure 5.2.7), using trypan blue and the MTT 
assay.  The results showed that the cell viability was 98% (data not shown). This was 
5) MHC class I expression following L. mexicana infection 
 
187 
 
further confirmed by restoration of MHC I expression after 48 hours of infection of 
U937 macrophages with 1:30 virulent and avirulent L. mexicana promastigotes (Figure 
5.2.8.C), which may be related to the ability of these cells to produce and secrete some 
anti-Leishmania reagents.  This was also in agreement with the previous results (Figure 
4.2.7) which illustrated the number of amastigotes of both virulent and avirulent 
parasites was significantly decreased in culture of infected U937 monocytes. On the 
other hand, this finding illustrated why the Leishmania parasites survive and proliferate 
in the macrophages compared to the monocytes, which has been reported by             
Yang, et. al (2007) and  Rabhi, et. al., (2010).        
One possible explanation for the down regulation of MHC class I in infected U937 
monocytes and MonoMac-6 cell lines with early log phase L. mexicana promastigotes 
after 24 hours, is parasite clearance, rather than an evasion mechanism. This theory is 
supported by the ability of the late log stage to transform and produce the amastigote 
stage after 24 hours infection, compared to the use of the early log phase, which failed 
to do so (Figure 5.2.5 B). On the other hand, the inability of late log phase parasites to 
down regulate MHC class I in infected target cells could be explained by the silent 
entrance of matured promastigotes, which is considered parasite evasion mechanism 
(Yang, et. al., 1996). 
Interestingly, the results of this study showed that treatment with 4µg per ml Fungizone 
(an anti-Leishmania agent) of target cells infected with late log phase of L. mexicana 
promastigotes for 2 or 24 hours, caused the restoration of the MHC class I expression. 
The ability of target cells to restore MHC class I expression may affect susceptibility 
to CTL activity, which is an important element for controlling Leishmaniasis. Because 
Leishmania spp are obligatory intracellular microbes, an adaptive immune response, 
which includes T helper cell activation and cytokine production is required to control 
the parasite infection. The process of T cell activation requires parasite antigen 
presentation by infected APCs via MHC class I and MHC class II. 
Many studies have identified the significant role of adaptive immune responses to 
contain infectious diseases such as Leishmaniasis, but this role has been shown mostly 
to be dependent on host genetic background. For example, macrophages derived from 
resistant mouse strains (C57BL/6 and C3H) were shown to produce a high level of IFN-
γ in response to Leishmania infection (Wilson, et, al., 2002; Bourreau, et. al., 2003). In 
contrast, the infection of susceptible Balb/c mice macrophages with L. major was 
usually accompanied by a Th2 cellular response, which is characterised by high levels 
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of IL-10 and IL-4 (Rogers, et. al., 2002; Gumy, et. al., 2004). Similar findings have 
been reported in human Leishmaniasis.  For example, an early study by Sundar, et. al., 
(1997) showed that the level of Th1 associated IFN-γ cytokine production was low 
compared to IL-4 present in blood samples of individuals with VL. However another 
study by Hailu, et. al., (2005) showed that the plasma levels of IFN-γ and IL-10 were 
high in VL patients, and that CD4+ and CD8+ T cells from these patients failed to 
produce IL-4 or IFN-γ. These findings have highlighted the important role of MHC 
class I and class II, which present the parasite antigens to CD8 and CD4 T cells. 
Studying the modulation of MHC class I expression in U937 macrophages has 
highlighted differences between the virulent and avirulent L. mexicana effect on MHC 
class I expression. The results of short time infection (2 hours) have demonstrated a 
significant down regulation of MHC class I expression in U937 macrophages infected 
with virulent and avirulent parasites. However, the MHC class I down regulation was 
greater in cells infected with the virulent parasite. Treatment of infected U937 
macrophages with Fungizone caused more restoration of MHC class I molecules in 
U937 macrophages infected with avirulent compared to virulent parasites. The 
difference of MHC class I spontaneous restoration between virulent and avirulent 
parasites was more obvious at 48 hours post-infection in U937 macrophages. 
While the expression of MHC class I in U937 macrophage infected with avirulent          
L. mexicana fluctuated among the three tested time points, infection with virulent 
parasites caused a gradual down regulation of MHC I molecules, with less expression 
at 48 hours post infection (Figure 5.2.9.C). It has been reported that the survival and 
proliferation of Leishmania parasites inside PVs of infected host cells is dependent 
on many factors, including their tolerance to the acidic conditions, resistance to 
degradation by lysosome enzymes, and avoidance of the macrophage's antigen-
presenting capacity (Russell, et. al., 1992).  The results of this study clearly show 
that there was little difference in levels of down regulation of MHC class I 
expression in host cells whether infected with virulent or avirulent L. mexicana 
promastigotes after 2 or 24 hours post-infection. In contrast, long term infection of 
48 hours induced a significant restoration of MHC class I expression in U937 
macrophages infected with avirulent, but not virulent L. mexicana promastigotes. 
These interesting findings may partly explain the failure of avirulent parasites to 
induce infection in vivo. This also shows that target cells infected with virulent but 
not avirulent parasite cannot be recognised any more by activated CTLs. Although 
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not much has been reported on MHC class I regulation by Leishmania parasite 
infection,   more is known with respect to virus infection. Rehm, et. al., (2009)  
have reported that infection with VACV (a live virus vaccine against 
human smallpox (TC1) and monkey pox viruses) has significantly down regulated 
MHC class II by APCs, and modulated the synthesis of 13 chemokines and 
cytokines. This virus has also significantly down regulated NO production in 
infected RAW macrophages and induced apoptosis. 
In this study we have reported that the number of infected cells with virulent , but 
not avirulent L. mexicana promastigotes was significantly decreased, suggesting 
cell death. In addition, results revealed that infection of U937 macrophages with 
virulent parasites significantly down regulated the NO production, compared to 
avirulent infection (data not shown). It has also been reported that regulation of 
virus virulence genes is associated with antigen presentation. For example Rehm 
et. al., (2010) has reported that A35R gene up regulation has significantly inhibited 
MHC II expression, with subsequent effects on chemokine and cytokine synthesis. 
We have previously reported that infection of U937 macrophages or U937 monocytes 
with virulent L. mexicana promastigotes for 2 hours caused a significant expression of 
pro-inflammatory cytokines, compared to infection with avirulent parasites, which may 
correlate with MHC class I expression in cells infected with virulent and avirulent 
parasites (Ali, et. al., 2013).  
Collectively these results have addressed the fact that there are different pathways and 
mechanisms followed by L. mexicana promastigotes once inside their target cells, to 
down regulate MHC class I. In addition, the results highlight the need to know the status 
of parasites being investigated, such as passage numbers and growth phase as well as 
the ratio of infection, in order to minimize the contradictory findings.  
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6. Chemokine-Cytokine-Toll like receptor 
network responses following infection with 
L. mexicana 
6.1  Introduction 
Apart from being the ultimate host cells for Leishmania spp, macrophages also have an 
essential role in the protective immune responses against these parasites through the 
antigen presentation process, secretion of microbicidal products, and production of 
inflammatory mediators such as cytokines and chemokines. Early events during host 
cell-parasite interaction are initiated by Toll-like receptors (TLRs), and these can 
eventually regulate the outcome of infection (Bosque, et. al., 2009). This is also 
Leishmania spp and host-cell type dependent. This study (as indicated by results from 
Chapter 5) clearly shows the dramatic effect of Leishmania parasite infection on the 
antigen presentation mechanisms of APCs. The data demonstrated a 30-100% down 
regulation of MHC class I expression occurred following the infection of susceptible 
human cell lines with L. mexicana promastigotes for 2 and 24 hours, respectively. 
Unexpectedly, there was no difference in MHC class I expression of cells infected with 
virulent and avirulent L. mexicana, apart from following the infection of U937 
macrophages for 48 hours. The results have shed some light on the importance and 
participation of other immune response elements (such as cytokines, chemokines and 
toll-like receptors) in the control of parasite infection, which links both innate and 
adaptive immune response.  
Among the three mentioned mediators, cytokines have been considered as the key 
factor in the immune response to Leishmania infection, and have been heavily 
investigated than the other two mediators (Noben-Trauth, et., al, 1996; Nishikomori, 
et. al., 2001). Cytokines such as IL-1β and TNF-α and IL-12 can be produced by 
macrophages which harbour the parasites. IFN-γ is also produced by Th1 cells and NK 
cells, whereas IL-4 and IL-10 can be produced by Th2 cells (Sacks and Noben, 2002). 
In addition to their direct contribution to Leishmania infection control or disease 
exacerbation, cytokines can also up regulate the expression of some chemokines, which 
in turn induce leukocyte recruitment to the site of the infection (Ohmori, et. al., 1993). 
For example, IL-1 and TNF-α secreted from infected macrophages or neutrophils 
induce the expression of chemokines in fibroblasts, endothelial and epithelial cells 
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(Moser, et. al., 2004). The cytokines and chemokines can also work collectively to 
control the Leishmania infection.  A study by Zaph and Scottit (2003) reported that IL-
12 was an important for the induction of XCL-1, CXCL-10 and CCL-2 expression in 
lymph nodes which required for L. major infection control. Chemokines can be divided 
into two types.  Firstly, Th1 related chemokines such as CXCL-9 and CXCL-10, which 
are induced by IFN-γ and secondly, Th2 related chemokines such as CCL-22 and CCL-
6, which are induced by IL-4 and IL-13 (Bonecchi, et. al., 1998).  
Chemokines are involved in both innate and adaptive immune responses to Leishmania 
infection. The immune response to Leishmania infection starts immediately following 
parasite delivery by an infected sand fly (or by deliberate injection in the case of 
experimental models), which involves parasite interaction with DCs and macrophages 
via their TLRs (Muzio, et. al., 2000). It has been reported that the saliva of the sand fly 
contains many mediators that trigger several types of immune response, including the 
attraction of polymorphonuclear leukocytes (PMNs) to the site of infection (Van, et. 
al., 2002).  In humans, as soon as PMNs cells arrive at the site of L. major entry, they 
start to secrete IL-8 (also known as CXCL-8 chemokine), and CXCL-1 in infected mice. 
These chemokines in turn attract more PMNs to the site of infection (Mülle, et. al., 
2001; Laufs, et. al., 2002). Leishmania spp can survive inside PMNs for some time 
while attracting macrophages to the site of infection, which take up the infected PMNs 
without activation of microbicidal factors (Van, et. al., 2004). This mechanism enables 
the parasite to enter the macrophages in a silent manner (Ribeiro, et. al., 2004). 
Chemokines also have an indirect role in the adaptive immune response to Leishmania 
infection via the activation of DCs. DCs act as APCs and are considered as a bridge 
between innate and adaptive immune response. They can become activated by 
chemokine secretion, which causes up-regulation of the expression of some co-
stimulatory molecules (CD54, CD40, CD80, CD86) and IL-12 production (Moll, 2002). 
The capability of activated DCs to transport the parasites from the site of the infection 
to Langerhans cells in mice infected with L. major has been associated with CCR-2 and 
CCR-7 expression, since CCR-2 deficient mice were susceptible to L. major             
(Sato, et. al., 2000).  Another study has reported that disease progression following 
infection with L. donovani was due to the down regulation of CCR-7, which also 
inhibited DC activation and their migration to lymph tissue (Ato, et. al., 2002).  
Full activation of the immune response relies on recognition of the pathogen through   
a wide range of molecules occupying the surface of APCs. These molecules, called 
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Toll-Like receptors, which can recognize various microbial antigens and link both the 
innate and adaptive immune response (Gazzinelli and Denkers, 2006; Medzhitov, 
2007). Engagement of TLRs with adaptor proteins such as MyD88 and/or TRIF leads 
to activation and migration of NF-κB to the cells’ nuclei, subsequently enhancing the 
transcription of inflammatory mediators such as tumour necrosis factor alpha (TNF-α), 
and IL-12 (Peter, 2009). The important role of TLRs in Leishmania parasite infection 
has been investigated using genetically modified mice (Liese, et. al., 2008; Tuon, et. 
al., 2008).  For example, many studies have revealed that resistant C57BL/6 mice 
become susceptible to L. major infection when MyD88 and TLR-4 genes are knocked 
out (Debus, et. al., 2003; Kropf, et. al., 2004; Muraille, et. al., 2003). Other studies have 
demonstrated that knock out of TLR-9 caused reduction in NK cell activation in mice 
models following infection with L. major, or L. infantum (Liese, et. al., 2007; Schleiche, 
et. al., 2007).  
Unlike other micro-organisms, information about the properties and structure of 
Leishmania antigens which interact with different TLRs is incomplete and limited. 
However, the participation of some of these antigens in the immune response to parasite 
infection is well documented. For example, L. major LPG has been described as a 
parasite ligand that interacts with TLR-2 and activates human NK cells or murine 
monocytes (De Veer, et. al., 2003). LPG-TLR-2 interaction induces parasite clearance 
through nitric oxide (NO) production by human PBMCs (Kavoosi, et. al., 2009). Vargas 
et. al., (2009) have reported that the P8 proteoglyco-lipid complex (P8 PGLC) 
expressed on L. pifano promastigotes can activate macrophages via TLR-4. Another 
study has found that DC activation can be induced by L. major DNA via TLR-9, which 
induces the production of IFN-γ by CD4 cells (Fakher, et. al., 2009). 
Unlike the mouse model, little is known on the effect of Leishmania parasite infection 
on the network of chemokines, cytokines, and toll-like receptors function in humans. 
Therefore, the modulation of TLR, interleukin and chemokine expression was 
investigated. After gaining entry into the host body, Leishmania parasites will not only 
be faced by macrophages, but also by other cell types including monocytes, it was 
decided to include (U937 monocytes, U937 macrophages and MonoMac-6 monocyte) 
cell lines in this investigation. In this Chapter the effect of pathogenic (virulent) and 
non-pathogenic (avirulent) L. mexicana promastigotes, or their antigens on host cells 
was evaluated and compared using qPCR. The dose of infection was chosen based on 
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the findings reported in Chapter 5. A ratio of 1:30 (cell: parasites) was used in this 
investigation, since this ratio caused the highest down regulation of MHC class I.    
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The work flow 
To investigate the effect of virulent and avirulent L. mexicana and their antigens on the 
expression profile of some TLR, interleukin and chemokine genes, experiments were 
conducted according to the following schedule:  
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6.2 The effect of L. mexicana promastigote infection on TLR, 
interleukin and chemokine gene expression profiles 
These experiments aimed to investigate the changes in the gene expression profile of 
target cells following infection with L. mexicana promastigotes that may help the 
parasite to escape and evade host immune system defences. The gene expression profile 
of some Toll-Like receptors (TLRs), cytokines (ILs) and chemokines (CCLs) after 
infection of three different susceptible human cell lines with L. mexicana promastigotes 
was determined using qPCR. MonoMac-6, U937 monocytes and U937 macrophages 
were infected with the late log phase of virulent and avirulent L. mexicana 
promastigotes for 24 hours. Total mRNA was extracted from infected and non-infected 
(control) cells and converted to one strand cDNA, which was used as a DNA template 
for qPCR analysis.  
6.2.1 Baseline gene expression profile of TLRs, ILs and CCLs in non-
infected human cell lines 
Table 6.2.1 shows the overall expression level of all target genes which varied across 
the cell lines used. All TLRs were highly expressed in U937 macrophages and U937 
monocytes, apart from TLR4, which was not expressed in U937 monocytes. The 
expression of TLRs was much less in MonoMac-6 cells compared to U937 monocytes 
and macrophages. Expression of interleukins (ILs) also varied among the different cell 
lines. IL-1 was similarly expressed in the three cell lines at the same level, in contrast 
IL-12 cytokines was not detectable in all cells. U937 macrophages only expressed  
CCL-1, CCL-2, and CCL-5, while U937 monocytes expressed CCL-1, CCL-2, CCL-4 
and CCL-5. In spite of their low expression, all chemokines apart from CCL-5 (highly 
expressed), were detectable in MonoMac-6. CCL-22 was not detected in any of the cell 
lines. 
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Table 6.2.1 The base line gene expression profile of TLRs, ILs and CCLs in U937 monocytes, U937 macrophages and MonoMac-6 controls 
(non-infected) cell lines 
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Expression level: less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); 
 between 0.25 and 0.75 (+++); more than 0.75 (++++)
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6.2.2 The effect of L. mexicana promastigote infection on gene expression 
profile of toll-like receptors (TLRs) in susceptible human cell lines 
Table 6.2.2 shows the effect of L. mexicana promastigote infection on TLRs gene 
expression.  Although the level of TLRs expression varied according to the host cell 
lines, general, infection with L. mexicana promastigotes caused down regulation of 
tested TLRs, irrespective of whether the avirulent or virulent parasite was used in the 
infection. 
Typically, infection of U937 monocytes with virulent and avirulent L. mexicana 
promastigotes for 24 hours significantly down regulated the expression of TLR-1, TLR-
2 and TLR-9, but not TLR-4, which was significantly up regulated.  
The symbol (↓) indicates there was less down regulation induced by the parasite, 
compared to (↓↓), where more down regulation was observed. In contrast, symbols (↑) 
and (↑↑) indicated up-regulation or more up-regulation respectively following parasite 
infection. 
The expression of TLR-1, TLR-2 and TLR-9 was significantly down regulated 
following the infection with virulent compared to avirulent parasite.  
The expression of TLRs of non-infected MonoMac-6 was relatively low. Infection of 
these cells with avirulent L. mexicana promastigotes significantly down regulated  
TLR-2 and TLR-4. In contrast, virulent parasites up regulated TLR-1 and TLR-9. 
In summary, the results show that the gene expression profiles of the tested TLRs in 
this study were different according to the cell line used and the virulence status of the 
parasite used for infection. The expression of TLR-1 and TLR-9 was down regulated 
after parasite infection across all tested cell lines, except the infection of MonoMac-6 
cells with virulent L. mexicana promastigotes, which up-regulated the expression of 
these genes. TLR-2 gene expression was down regulated following parasite infection 
across all tested cell lines. TLR-4 expression has a similar pattern to that of TLR-2, 
except the infection of U937 monocytes with L. mexicana promastigotes, which caused 
an up-regulation of TLR-4 expression. Some of the untransformed qPCR data are 
shown in Figure 6.2.1. 
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Table 6.2.2 The gene expression profile of TLRs after infection of three different cell lines with avirulent and virulent L. mexicana  
 
Expression level: less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); 
more than 0.75 (++++). The Mann-Whitney U-test was used for statistical analysis and a P value of < 0.05 was taken as significant.       
↓ one arrow indicates the presence of inhibition. ↑ indicated the presence of up-regulation. ↓↓ indicates the presence of more inhibition 
compared with ↓; ↑↑ indicates the presence of more up-regulation compared with ↑. * indicates the presence of a significant difference 
between infection and control cells. # indicates the presence of a significant difference between virulent and avirulent L. mexicana 
promastigotes. Shaded cells indicate a difference in regulation between virulent and avirulent parasites using the same cell line. 
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Finger 6.2.1 The effect of L. mexicana infection on gene expression profile of Toll-like  
receptors (TLRs) 
Target cells were infected with virulent or avirulent L. mexicana promastigotes for 
24 hours. RNA was extracted from control and infected cells. Extracted RNA was 
converted to cDNA, which was used as a template for qPCR analysis. Data are the 
averages of least 3 independent experiments, *P<0.05 was calculated using the 
Mann-Whitney test. Data are presented as mean + SEM.
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6.2.3 The effect of L. mexicana promastigote infection on gene expression 
profile of cytokines (ILs) in susceptible human cell lines 
Table 6.2.3 shows the effect of L. mexicana promastigote infection on the gene 
expression profile of cytokines (ILs) measured by qPCR these also varied depending 
on the cell line tested. Like TLRs, the gene expression profile of ILs changed after 
infection of target cells with L. mexicana promastigotes. Results clearly show that the 
gene expression profile of IL-1β, IL-6 and IL-12B was significantly up regulated in 
U937 monocytes infected with the avirulent parasite, while IL-10 expression was down 
regulated. The results in Table 6.2.3 also show a similar down regulation pattern of 
gene expression profile of TNF-α following infection of U937 monocytes and 
MonoMac-6 cells with avirulent and virulent parasites. In contrast, this cytokine was 
up regulated following the infection of U937 macrophages, and virulent L. mexicana 
induced more expression compared to avirulent parasites. 
The TGF-β expression profile in infected U937 macrophages was the same as the   
TNF-α expression profile, however, TGF-β expression was down regulated in infected 
U937 monocytes and MonoMac-6 cell lines (except for infection with virulent 
parasites). Although the base-line level of ILs gene expression was not identical for all 
tested cytokines in non-infected U937 macrophages, infection of U937 macrophages 
with Leishmania parasite caused  a significant up-regulation  of IL-1β, IL-6 (except 
where there was infection with virulent parasites), IL-12B, TNF-α and TGF-β 
expression. In contrast, infection with L. mexicana promastigotes caused a remarkable 
down regulation of IL-10 expression. Like the infected U937 monocytes, infection of 
macrophages with avirulent L. mexicana promastigotes also up-regulated IL-1β, IL-6 
more than with virulent parasites. However, infection with virulent L. mexicana caused 
a notable increase in IL-12B, TNF-α and TGF-β expression in comparison with 
infection with avirulent parasites.  
The expression of interleukins in infected MonoMac-6 was also altered. The results 
show that the gene expression profile of TNF-α and IL-10 cytokines after Leishmania 
parasite infection significantly decreased compared to non-infected MonoMac-6. In 
contrast, the level of IL-6 and IL-12B expression was considerably up-regulated. IL-1β 
cytokines was significantly up-regulated by infection with avirulent parasites, and down 
regulated after infection with virulent L. mexicana promastigotes.  
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Finally, L. mexicana promastigote infection has a major impact on interleukins gene 
expression profiles in the cell lines used. IL-12B expression was up regulated, in 
contrast to IL-10 which was down regulated following L. mexicana infection. Moreover, 
the levels of IL-1β and IL-6 were up-regulated across the used cell lines compared to 
non-infected cells, whereas the levels of TNF-α and TGF-β cytokines was down 
regulated in infected monocyte cell lines (U937 and MonoMac-6, except where there 
was infection with the virulent parasite) and up-regulated in infected U937 
macrophages. Some of the untransformed qPCR data are shown in Figure 6.2.2. 
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Table 6.2.3 The gene expression profile of ILs after infection of three different cell lines with avirulent and virulent L. mexicana  
 
Expression level:  less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); more than 0.75 
(++++).  The Mann-Whitney U-test was used for statistical analysis and a value of P < 0.05 was taken as significant. ↓ one arrow indicates the presence 
of inhibition. ↑ indicates the presence of an up-regulation. ↓↓ indicates the presence of more inhibition compared with ↓; ↑↑ indicates the presence of 
more up-regulation compared with ↑. * indicates the presence of a significant difference between infection and control cells. # indicates the presence 
of a significant difference between virulent and avirulent L. mexicana promastigotes. Shaded cells indicate a difference in regulation between virulent 
and avirulent parasites using the same cell line. 
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Finger 6.2.2 The effect of L. mexicana infection on gene expression profile of Cytokines 
(ILs) 
Target cells were infected with virulent or avirulent L. mexicana promastigotes for 
24 hours. RNA was extracted from control and infected cells. Extracted RNA was 
converted to cDNA, which was used as a template for qPCR analysis. Data are the 
averages of least 3 independent experiments, *P<0.05 was calculated using the 
Mann-Whitney test. Data are presented as mean + SEM. 
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6.2.4 The effect of L. mexicana promastigote infection on gene expression 
profile of chemokines (CCLs) in susceptible human cell lines 
Infection with the Leishmania parasite significantly affected the gene expression profile 
of CCL-1, CCL-2, CCL-3, CCL-4, CCL-5 and CCL-22 chemokines, by either down or 
up-regulated their expression in all cell lines used in this study (Table 6.2.4). 
Interestingly, L. mexicana infection of U937 monocytes caused a remarkable down 
regulation of all chemokines (CCL-1, CCL-2, CCL-4 and CCL-5) that were highly 
expressed in control (non-infected) cells. However, chemokines which were initially 
not expressed (CCL-22), or expressed at a low level (CCL-3) in non-infected cells were 
significantly up-regulated. Moreover, results in Table 6.2.4 show that the infection of 
U937 monocytes with virulent L. mexicana significantly down regulated CCL-1, CCL-
2 and CCL-4 expression when compared to avirulent parasites. 
The level of CCL (except CCL-5) expression was significantly up regulated after 
infection of U937 macrophages with Leishmania parasites (Table 6.2.4). The 
expression of CCL-1, CCl-2, and CCl-4 chemokines was significantly higher after 
infection of U937 macrophages with avirulent L. mexicana promastigotes when 
compared to infection with virulent parasites. On the other hand, infection with virulent 
parasites caused a notable increase in the level of expression of CCL-3 and CCL-22. 
Avirulent parasite infection induced more down regulation of CCL-5 in comparison to 
infection by virulent parasites. 
Unlike U937 monocytes, the infection of MonoMac-6 with L. mexicana promastigotes 
caused up-regulation of CCL-1, CCL-2, and CCL-4, and down regulated the expression 
of CCl-22 chemokines. Interestingly, infection of MonoMac-6 with virulent                       
L. mexicana promastigotes caused a significant increase of CCL-1, CCL-2, and CCL-4 
expression compared with avirulent parasites. Some of the untransformed qPCR data 
are shown in Figure 6.2.3. 
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Table 6.2.4 The gene expression profile of CCLs after infection of three different cell lines with avirulent and virulent L. mexicana  
  
Expression level: less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); more than 0.75 
(++++). The Mann-Whitney U-test was used for statistical analysis and a value of P < 0.05 was taken as significant. ↓ one arrow indicates the presence 
of an inhibition. ↑ indicates the presence of an up-regulation. ↓↓ indicates the presence of more inhibition compared with ↓; ↑↑ indicates the presence 
of more up-regulation compared with ↑. * indicates the presence of a significant difference between infection and control cells. # indicates the presence 
of a significant difference between virulent and avirulent L. mexicana promastigotes. Shaded cells indicate a difference in regulation between virulent 
and avirulent parasites using the same cell line.  
 
 CCL-1 CCL-2 CCL-3 CCL-4 CCL-5 CCL-22 
U
9
3
7
 
m
o
n
o
cy
te
s 
 
control ++++ ++++ + ++++ ++++ - 
Infected 
Avirulent 
↓* ↓* ↑↑* ↓* ↓↓* # ↑↑* # 
Infected 
virulent 
↓↓* # ↓↓* # + ↓↓* # ↓* ↑* 
U
9
3
7
 
m
a
cr
o
p
h
a
g
e
 
control ++++ ++++ - - ++++ - 
Infected 
Avirulent 
↑↑* # ↑↑* # ↑* ↑↑* # ↓↓* # ↑* 
Infected 
virulent 
↑* ↑* ↑↑* # ↑* ↓* ↑↑* # 
M
o
n
o
M
a
c-
6
 control + + + + +++ - 
Infected 
Avirulent 
↑* ↑* ↑* ↑* ↓* ↓↓* # 
Infected 
virulent 
↑↑* # ↑↑* # ↑* ↑↑* # ↑* ↓* 
6) Chemokines-Cytokines-Toll like receptors network 
 
203 
 
 
Finger 6.2.3 The effect of L. mexicana infection on gene expression profile of 
Chemokines (CCLs) 
Target cells were infected with virulent or avirulent L. mexicana promastigotes for 
24 hours. RNA was extracted from control and infected cells. Extracted RNA was 
converted to cDNA, which was used as a template for qPCR analysis. Data are the 
averages of least 3 independent experiments, *P<0.05 was calculated using the 
Mann-Whitney test. Data are presented as mean + SEM. 
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6.3 The effect of L. mexicana promastigote SLA on the gene 
expression profile of TLRs, ILs and CCLs 
To investigate and compare the immunogenicity of proteins extracted from virulent and 
avirulent L. mexicana promastigotes, human susceptible cell lines were stimulated with 
avirulent and/or virulent L. mexicana SLA. The level of gene expression profile of 
chemokines, cytokines and Toll-like receptors after stimulation of three different 
susceptible human cell lines with SLAs was determined using qPCR technique. Human 
MonoMac-6 cell line, U937 monocytes and U937 macrophages were cultured in 24 
well plates at a concentration of 2x105 per well, and stimulated with 10µg per ml of 
avirulent and/or virulent SLA for 24 hours.  Total mRNA was extracted, from each 
target cell, and converted into one strand cDNA as previously described, to be used as 
a DNA template for qPCR. 
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6.3.1 The effect of stimulation with L. mexicana promastigote SLA on gene 
expression profile of toll-like receptors (TLRs) in susceptible human 
cell lines. 
Table 6.3.1 shows the effect of stimulation with L. mexicana promastigote SLA on the 
expression profile of TLRs measured by qPCR. Stimulation of U937 monocytes with 
virulent L. mexicana SLA for 24 hours significantly down regulated the expression of 
TLR1, TLR2, TLR-4 and TLR-9.  
Control (non-infected) U937 macrophages were highly expressed all tested TLRs, and 
these were significantly down regulated after stimulation with L. mexicana SAL, (Table 
6.3.1). The results clearly show that virulent SLA induced more down regulation of 
TLR-1 and TLR-9 compared to stimulation with avirulent L. mexicana promastigote 
SLA, which induced more down regulation of TLR-2. 
The level of TLRs gene expression profile of the control MonoMac-6 was relatively 
low compared with that of U937 macrophages. A 24-hour stimulation with SLA 
significantly down regulated the expression of TLR-2, TLR-4 and TLR-9. However, 
TLR-1 was significantly up regulated following stimulation with avirulent SLA. 
In summary, the results show that the gene expression profiles of tested TLRs in this 
study were different according to the cell line and the status of the SLA (virulent or 
avirulent). The expression of TLR-2 and TLR-9 was down regulated after SLA 
stimulation in the three cell lines. TLR-1 gene expression profile was also down 
regulated following SLA stimulation across all tested cell lines, except in the case of 
stimulation of MonoMac-6 cells with virulent SLA. TLR-4 gene expression was also 
down regulated as a result of stimulation with L. mexicana SLA (except in U937 
monocytes stimulated with avirulent SLA). Some of the untransformed qPCR data are 
shown in Figure 6.3.1.    
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Table 6.3.1 The gene expression profile of TLRs after stimulation of three different cell lines with avirulent and virulent L. mexicana 
promastigotes SLA 
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Expression level: less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); more than 0.75 
(++++).The Mann-Whitney U-test was used for statistical analysis where a value of P < 0.05 was taken as significant. ↓ one arrow indicates the presence 
of an inhibition. ↑ indicates the presence of an up-regulation. ↓↓ indicates the presence of more inhibition compared with ↓; ↑↑ indicates the presence 
of more up-regulation compared with ↑. * indicates the presence of a significant difference between stimulated and control cells. # indicates the presence 
of a significant difference between stimulation with virulent and avirulent L. mexicana promastigotes SLA. Shaded cells indicate a difference in 
regulation between virulent and avirulent parasites using the same cell line.   
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Finger 6.3.1 The effect of the SLA stimulation on gene expression profile of Toll-like 
receptors (TLRs) 
Target cells were stimulated with 10µg virulent or avirulent L. mexicana SLA for 24 
hours. RNA was extracted from control, infected and stimulated cells and converted 
to cDNA, which was used as a template for qPCR analysis. Data are the averages of 
least 3 independent experiments, *P<0.05 was calculated using the Mann-Whitney 
test. Data are presented as mean + SEM.
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6.3.2 The effect of stimulation with L. mexicana promastigote SLA on gene 
expression profile of cytokines (ILs) in susceptible human cell lines. 
 
The effect of L. mexicana promastigote SLA on the level of gene expression profile of 
cytokines (ILs) as measured by qPCR also varied depending on the cell lines used, 
(Table 6.3.2).  
Stimulation of U937 monocytes with 10µg SLA per ml significantly down regulated 
the expression of IL-10 and TNF-α gene. In contrast, IL-6 and IL-12B cytokines were 
considerably up regulated after stimulation with avirulent SLA. IL-1 was significantly 
up regulated following stimulation of U937 monocytes with virulent SLA. TGF-β 
expression was significantly up regulated after SLA stimulation, and the level of 
expression was greater as a result of stimulation with avirulent in comparison to virulent 
SLA. In spite of variation in the baseline levels of interleukin gene expression in U937 
macrophages,  stimulation with  avirulent L. mexicana SLA caused a considerable up-
regulation of IL-12B, TNF-α, and TGF-β, compared to the level of the expression 
induced by virulent parasites. 
Like infection with Leishmania parasites, stimulation with SLA caused a significant 
down regulation of IL-10 expression. Moreover, down regulation produced by 
stimulation with virulent SLA was significantly greater compared to that caused by 
stimulation with avirulent SLA. Interestingly, IL-6 expression was significantly up 
regulated following stimulation with avirulent and down regulated with virulent SLA. 
However, IL-1 expression was up regulated after stimulation with avirulent SLA, and 
up regulated even more by virulent SLA stimulation. Similarly, stimulation of 
MonoMac-6 with 20µg SLA changed the level of ILs expression. 
IL-1β, IL-10 and TNF-α gene expression were significantly down regulated following 
SLA stimulation. In contrast, the level of IL-12B expression was significantly up 
regulated, but on the other hand IL-6 was significantly up and down regulated after 
stimulation of MonoMac-6 with avirulent and virulent L. mexicana SLA, respectively. 
TGF-β expression was also down and up regulated after stimulation with avirulent and 
virulent SLA.  
In general, treatment of target cells with SLA has a major impact on interleukin gene 
expression profile across the used cell lines. IL-1β expression was up regulated in 
macrophages and down regulated in both monocytes (apart from stimulation of U937 
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cells with virulent SLA). IL-6 expression was up regulated after stimulation with 
avirulent SAL, but was down regulated following stimulation with virulent SLA.          
IL-10 expression was down regulated after treatment of cells with SLA. IL-12B 
expression was up regulated in U937 macrophages and MonoMac-6 cells, whereas 
TNF-α expression was marginally regulated in U937 macrophages, and down regulated 
in the monocytes (U937 and MonoMac-6). TGF-β expression was also up regulated 
after SLA stimulation in U937 monocytes and U937 macrophages. Some of the 
untransformed qPCR data are shown in Figure 6.3.2.     
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Table 6.3.2 The gene expression profile of ILs after stimulation of three different cell lines with avirulent and virulent L. mexicana 
promastigotes SLA 
 
Expression level: less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); more than 0.75 
(++++). The Mann-Whitney U-test was used for statistical analysis. A value of P < 0.05 was taken as significant. ↓ one arrow indicates the presence of 
an inhibition. ↑ indicates the presence of an up-regulation. ↓↓ indicates the presence of more inhibition compared with ↓; ↑↑ indicates the presence of 
more up-regulation compared with ↑. * indicates the presence of a significant difference between stimulated and control cells. # indicates the presence 
of a significant difference between stimulation with virulent and avirulent L. mexicana promastigotes SLA. Shaded cells indicate a difference in 
regulation between virulent and avirulent parasites using the same cell line. 
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Finger 6.3.2 The effect of the SLA stimulation on gene expression profile of Cytokines 
(ILs) 
Target cells were stimulated with 10µg virulent or avirulent L. mexicana SLA, for 
24 hours. RNA was extracted from control, infected and stimulated cells and 
converted to cDNA which was used as a template for qPCR analysis. Data are the 
averages of least 3 independent experiments, *P<0.05 was calculated using the 
Mann-Whitney test. Data are presented as mean + SEM.
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6.3.3 The effect of stimulation with L. mexicana promastigote SLA on gene 
expression profile of chemokines (CCLs) in susceptible human cell 
lines. 
Stimulation of target cells with Leishmania parasite SLA has a wide range of significant 
effects on the gene expression profile of CCL-1, CCL-2, CCL-3, CCL-4, CCL-5 and 
CCL-22 chemokines depending on the virulency of parasites used for SLA preparation, 
(Table 6.3.3).  
Notable effects were observed on the level of chemokine gene expression after 
stimulation of U937 monocytes cell line. L. mexicana SLA significantly down regulated 
CCL-1, CCL-3 and CCL-4 chemokines. Moreover, the results show that stimulation of 
U937 monocytes cells with virulent SLA caused a significant down regulation of CCL-
1, CCL-4, CCL-5 gene expression compared to avirulent SLA.  Table 6.3.3 also shows 
that the level of chemokine gene expression was up regulated after stimulation of U937 
macrophages with Leishmania parasite SLA. 
The level of expression of CCL-1 and CCL-2 chemokines was significantly down 
regulated after stimulation of U937 macrophages with avirulent SLA compared to 
avirulent SLA stimulation. CCL-5 expression was significantly down regulated as            
a result of stimulation with virulent. In contrast, both avirulent and virulent SLA 
stimulation induced up regulation of CCL-22. Stimulation of MonoMac-6 with virulent 
L. mexicana SLA caused significant up regulation of all tested chemokines. whilst the 
expression of CCL-1 and CCL-22 chemokines were down and up regulated after 
treatment with avirulent and virulent SLA respectively.  
To summarise, the gene expression of tested chemokine was altered 
following the stimulation of target cells with L. mexicana SLA (Table 6.3.3). 
A similar pattern was observed on the level of CCL-3 and CCL-4 
chemokines (except U937 when stimulated with avirulent SLA) across tested 
cell lines. The expression of CCL-1 and CCL-2 had a similar pattern in 
immature U937 monocytes and U937 macrophages. CCL-22 expression was 
up regulated after SLA stimulation (except MonoMac-6 cells stimulated with 
avirulent SLA). Some of the untransformed qPCR data are shown in Figure 
6.3.3.
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Table 6.3.3 The gene expression profile of CCLs after stimulation of three different cell lines with avirulent and virulent L. mexicana 
promastigotes SLA 
 
Expression level:  less than 0.0001(-); between 0.0001 and 0.025 (+); between 0.025 and 0.25 (++); between 0.25 and 0.75 (+++); more than 0.75 
(++++). The Mann-Whitney U-test was used for statistical analysis. A value of P < 0.05 was taken as significant. ↓ one arrow indicates the presence of 
inhibition. ↑ indicates the presence of an up-regulation. ↓↓ indicates the presence of more inhibition compared with ↓. ND no significant different. 
↑↑ indicates the presence of more up-regulation compared with ↑. * indicates the presence of a significant difference between stimulated and control 
cells. # indicates the presence of a significant difference between stimulation with virulent and avirulent L. mexicana promastigotes SLA. Shaded cells 
indicate a difference in regulation between virulent and avirulent parasites using the same cell line.  
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Finger 6.3.3 The effect of the SLA stimulation on gene expression profile of Chemokines 
(CCLs) 
Target cells were stimulated with 10µg virulent or avirulent L. mexicana SLA for 24 
hours. RNA was extracted from control, infected and stimulated cells and converted 
to cDNA, which was used as a template for qPCR analysis. Data are the averages of 
least 3 independent experiments, *P<0.05 was calculated using the Mann-the 
Whitney test. Data are presented as mean + SEM.
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6.4 Discussion 
The immune response to foreign antigens is modulated by complex interactions 
between immune host cells and invading pathogens. Like many other infectious 
microorganisms, Leishmania parasites are obligate intracellular pathogens, which can 
regulate/modulate any stage of the host immune response and use it for their benefit to 
overcome immune system defenses. Therefore, a good understanding of the 
mechanisms of parasite interaction with the host immune system, particularly cells 
targeted by the parasite, would increase the possibility of developing a potential vaccine 
and/or therapeutic agent. The model of virulent and avirulent parasites produced in the 
current study (Ali, et. al., 2013) was further used to investigate and compare the ability 
of both sets of parasites to modulate the gene expression profile of target cells. The 
novelty of this investigation is the use of avirulent L. mexicana in parallel with its 
virulent counterpart which may be the best control.   
To investigate the in vitro modulation of TLRs, ILs, and CCLs, target cells were 
infected with the late log phase of virulent and avirulent L. mexicana for 24 hours. The 
expression of the target genes in infected cells was evaluated using qPCR. Although 
the final host for Leishmania spp in the mammalian host is tissue macrophages, the 
entry of Leishmania promastigotes into the host blood exposes them to other types of 
immune cells including monocytes (Rabhi, et. al., 2010). Therefore, in this study, three 
types of cell lines: MonoMac-6, U937 monocytes and U937 macrophages were used to 
compare their responses to infection with virulent and avirulent of L. mexicana 
promastigotes and their SLA. 
It was difficult to draw a single clear conclusion from this study, as too many 
experimental variables were considered for comparison including different host cells 
and parasite virulency. However, TLR-1 seems to be the most affected under those 
experimental conditions since it showed down regulation following the infection of 
U937 monocytes and U937 macrophages with virulent parasite and its SLA. Variable 
IL-1 responses, on the other hand, were also observed to infection with virulent and 
avirulent parasites, this cytokine was significantly up regulated after avirulent parasite 
infection compared to the virulent parasite in the three used cell lines. A significant up 
regulation of CCL-1, CCL-2 and CCL-5 was detected in MonoMac-6 cell line infected 
with virulent compared to avirulent L. mexicana.                                                                                                          
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Few studies have previously investigated the overall gene expression profile of host 
cells infected with different Leishmania parasite species using the microarrays method 
(Rodriguez, et. al., 2004; Dogra, et. al., 2007). However, little is known about the 
interaction between the Leishmania parasite and monocytes. Therefore, this may be the 
first study which has studied the effect of the infection with the late log phase of virulent 
and avirulent L. mexicana promastigotes and their antigens on TLRs, ILs and CCLs.  
Toll like receptors (TLRs) are group of signalling receptors involved in innate 
immunity by recognizing the pathogen associated molecular patterns (PAMPs) 
presented on the cell surface and on the endosomal membrane of different types of 
immune cells (Gallego, et. al., 2011). Pathogen recognition in the early stages of 
infection by TLRs leads to full activation of innate immunity. Binding TLRs to their 
specific set of microbial products enhances the activation of inflammatory cytokines, 
which work collectively to eliminate and destroy invading pathogens (Iwasaki and 
Medzhitov, 2004).                                                                                                                                       
Many studies have reported the importance of TLRs in the way the immune system 
controls Leishmania infection. For example, TLR-4 has an important role in L. major 
control in infected Balb/c mice through its binding with MyD88 adaptor (Kropf, et. al., 
2004). Animal model experiments show that TLR-9 is an essential molecule in control 
of visceral and cutaneous Leishmaniasis (Liese, et. al., 2008).  A study by Shadab and 
Nahid (2011), illustrated the role of TLR-2 in L. donovani and L. braziliensis infection 
control, through the binding of TLR-2 to Leishmania lypophosphoglycan (LPG), which 
triggered the intracellular killing factors. Results of the present  study have also 
illustrated that TLR-2 and TLR-1 are significantly down regulated after infection of 
U937 monocytes and U937 macrophages with virulent in comparison to avirulent L. 
mexicana. The failure of the avirulent parasite to down regulate the expression of these 
receptors may contribute to their killing and clearance. This is in agreement with a study 
by Lodge and Descoteaus (2005) who reported that the absence of TLR-2 was 
correlated with the increase in lesion numbers in C57BL/6 mice infected with L. major. 
Although it has been reported that TLRs are expressed on the surface of macrophages, 
DCs and NK cells, (Sen and Sarkar, 2005; Tuon, et. al., 2008), our results have 
confirmed the expression of TLR-1, TLR-2, and TLR-9 on U937 and MonoMac-6 
monocytes. 
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Additionally, results presented here have shown differences in the expression pattern 
of TLR-9 induced by infection with L. mexicana promastigotes based on their virulence 
status and cell type. TLR-9 is normally found on the surface of endosomes and is 
involved in the recognition of nucleic acid bases (Katz, et. al., 2006; Nicolle, et. al., 
2004).  In the current study, although infection of U937 monocytes with virulent L. 
mexicana promastigotes has down regulated the expression of TLR-9, more down 
regulation was induced following infection with avirulent parasites. This might be due 
to the susceptibility of virulent promastigotes to the microbial killing factors secreted 
by monocytes when they first enter them, resulting in the degradation of virulent 
parasites, this may require the activation of other immune mechanisms which may favor 
Leishmania infection. In contrast, the down regulation of TLR-9 in macrophages 
infected with virulent parasites was significantly greater compared to the same cells 
infected with avirulent L. mexicana. This might be due to the failure of avirulent but 
not virulent promastigotes to produce the parasitophorous vacuoles that are needed for 
successful differentiation into the amastigote stage.                                                                                                                                                                                     
The effect of SLA on the gene expression profile of TLRs has not been previously 
investigated. Results presented in this study showed that SLA extracted from virulent 
parasites induced more down regulation of almost all the studied TLRs, compared to 
the SLA extracted from avirulent parasites. This may be due to the high expression of 
the virulence molecules such as GP63, LPG2, and CPC proteinase in virulent but not 
in avirulent L. mexicana promastigotes (Chapter 4). Generally, activation of TLRs 
signalling is essential in ILs production through activation of the NF-KB pathway 
(Muzio, et. al., 2000). Therefore, the use of avirulent versus virulent SLA in vaccine 
preparation needs to be evaluated.                                           
The vast majority of published studies have agreed that resistance to Leishmania 
parasite infection is partly dependent on the suppression of pro-inflammatory cytokines 
such as TNF-α, IL-1β, IL-6 and IL-12B (Muraille, et. al., 2003). On the other hand, 
susceptibility to Leishmania parasite infection is associated with the up regulation of 
anti-inflammatory responses such as IL-4, IL-13 and TGF-β (Chaussabel, et. al., 2003; 
Rodriguez, et. al., 2004).  
IL-10 is one of the anti-inflammatory cytokines produced by monocytes, macrophages, 
DCs and B cells (Buxbaum and Scott, 2005). According to Imada and Leonard, (2000), 
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the biological function of IL-10 is to inhibit the production of pro-inflammatory 
cytokines by infected macrophages, which enhances parasite infection. 
In this study (Table 6.2.3), infection of target cells with avirulent parasites caused an 
up regulation of IL-6 and IL-12 compared to virulent infection, a finding that highlights 
the role of the pro-inflammatory response in controlling L. mexicana infection. 
Although the results show that the expression of IL-10 was down regulated in 
MonoMac-6 and U937 macrophages following parasite infection, infection with 
virulent parasites induced less down regulation compared to avirulent parasite infection. 
This agrees with Buxbaum (2013), who reported that chronic infection with L. 
mexicana, requires IL-10, which in turn suppressed IL-12 production from 
macrophages, decreased IFN-γ in T cells and nitric oxide production in infected cells. 
Other studies have reported that in human and experimental models of CL, high levels 
of IL-10 production are strongly associated with non-healing forms of the disease 
(Buxbaum and Scott, 2005; Tripathi, et. al., 2007). The results of the present study have 
also illustrated that infection with avirulent L. mexicana promastigotes caused a 
considerable increase in the expression of IL-1. A study by Xin, et. al., (2007), 
highlighted the importance of IL-1 in activation of DCs and T-cell priming. This could 
be one of many reasons behind the failure of avirulent promastigotes to initiate the 
infection of inoculated Balb/c mice. 
The biological role of IL-12 in controlling Leishmania infection has been reported 
through activation of Th1 type immune response and secretion of IFN-γ (Watford, et. 
al., 2004). In experimental models, treatment of resistant mice infected with L. major 
with neutralizing anti-IL-12 antibodies caused failure of these mice to overcome their 
infection. Meanwhile, treatment of susceptible Balb/c mice with recombinant IL-12 has 
been shown to control the infection (McDowell and Sacks, 1999). Results from the 
current study (Table 6.2.3) show that U937 monocytes, but not MonoMac-6 cell line 
and U937 macrophages, highly expressed IL-12 following infection with avirulent L. 
mexicana in comparison to virulent infection. These findings reflect the multiple roles 
that each cytokine can play during the course of the parasite infection, using different 
host cells under the same experimental conditions.   
It is well established that the expression or production of type one  IFN-γ and type 2 
INF-α, β as well as TNF-α is highly associated with resistance to Leishmania infection 
(Manna, et. al., 2006; Carrillo, et al., 2007). The biological role of these cytokines is 
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related to activation of the innate immune response through enhancement of 
microbicidal activity such as iNOS (inducible nitric oxide synthase) expression and NO 
secretion by macrophages (Mosser and Edwards, 2005). In the present study, infection 
of U937 monocytes and MonoMac-6 cell line with virulent promastigotes down 
regulated TNF-α when compared to infection with avirulent parasites. This may inhibit 
NO secretion in the early stages after infection with the virulent parasite               
(Kavoosi, et. al., 2009) thus enhancing their survival inside infected cells. 
On the other hand, the up regulation of TNF-α following infection of U937 
macrophages with virulent compared to avirulent parasites, may be correlated with the 
successful differentiation of virulent but not avirulent parasites to the more resistant 
amastigote stage. 
The other interesting finding from this study is the expression of TGF-β, well known 
as an important immune regulatory cytokine.  Infection of MonoMac-6 monocytes with 
virulent L. mexicana induces high expression of this cytokine, but infection with 
avirulent parasites induced its down regulation. Results also showed that although   
TGF-β was up regulated following infection with both sets of parasites, its expression 
was several hundred fold more in U937 macrophages infected with virulent compared 
to avirulent parasites, This may explain survival of virulent L. mexicana inside the host 
cells.  
As mentioned above, no investigations have been reported on the effect of SLA on 
interleukin gene expression profile in vitro. In this study, results showed the regulation 
of cytokines by parasite infection was both cell line- and parasite-virulence dependent.  
Chemokines are group of polypeptides, and group CC Chemokines (which have their 
first two cysteines adjacent to each other) were chosen to be investigated in this study 
because they act on a large group of cells, such as monocytes and macrophages, but not 
PMNs (Moser and Willimann, 2004). In comparison, CXC Chemokines can act mainly 
on PMNs cells (Antoniazi, et. al., 2004).   In this study, the gene expression profile of 
CCL-1, CCL-2, CCL-3, CCL-4, CCL-5 and CCL-22 was investigated in three different 
cell lines in response to infection with virulent and virulent L. mexicana promastigotes, 
and stimulation with their extracted SLA. 
Since the biological role of chemokines is to recruit immune cells to the site of infection, 
understanding their gene regulation by modulation following Leishmania infection is 
an important tool in infection control (Ritter and Korner, 2002; Antoniazi, et. al., 2004). 
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Results presented in Table 6.2.4 show that all tested CCLs (except CCL-5) were up 
regulated in U937 macrophages infected with parasites. The level of up regulation was 
variable depending on virulence of the parasite and the type of CCLs. For example pro-
inflammatory CCL-1 chemokine was significantly up regulated following infection of 
U937 macrophages with virulent L. mexicana compared to infection with avirulent 
parasites. These findings were similar to those reported by Ritter, et. al., (1996) who 
showed that patients suffering from CL exhibited higher levels of CCL-1.  
Collectively, the results of this study have addressed some aspects of the complexity of 
the immune response to Leishmania spp, which is characterised by potent modulation 
of gene expression profile of TLRs, interleukins and chemokines in susceptible human 
cell lines infected with virulent or avirulent L. mexicana promastigotes, this clearly 
illustrated some of the parasites mechanisms to induce the infection. Most importantly, 
the results illustrate differences between infection with virulent and avirulent L. 
mexicana promastigotes using the same cell line, and these differences may help to 
understand how the parasite evade host immune response. Moreover, the results have 
clearly shown that differences were not only induced by infecting cell lines with 
avirulent and virulent L. mexicana, but also with their antigens (SLA), which may have 
a potential application as vaccine candidates.   
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7. 1 General Discussion 
Leishmaniasis is still a major public health problem across the globe, and recently 
Visceral Leishmaniasis (VL), has been reported as an opportunistic infection in patients 
with HIV infection (Nascimento, et. al., 2011). Most of the new cases of Leishmaniasis 
(50-75%) belong to Cutaneous Leishmaniasis (CL), therefore this has been considered 
the most common form of this disease (Hide, et. al., 2007). CL is caused by infection 
with several different Leishmania spp, such as L. mexicana, L. major, L. amazonensis 
and L. braziliensis, which are transmitted to the final host by the bite of an infected sand 
fly. The outcome of Leishmania spp infection is ultimately dependent on the ability of 
target cells to suppress or support the transformation process from the injected 
promastigotes into amastigotes. Although chemotherapy drugs are available and widely 
used to treat Leishmania infection, they are compromised by unpleasant side effects 
and resistance. Therefore, working towards the development of a protective vaccine 
remains the ultimate goal to control Leishmaniasis as well as other parasitic diseases. 
There is so far no effective vaccine available to control the spread of Leishmaniasis, 
and to date the only method which has demonstrated an acceptable level of protection 
in humans was Leishmanisation (to mimic the natural parasite infection), via a 
deliberate inoculation of the mammalian host with attenuated Leishmania spp,  which 
was banned by WHO (Laabs, et. al., 2009). The use of DNA vaccine was developed as 
an alternative method to obtain the benefits (good immune response), and avoid the 
limitations of Leishmanisation. In addition, DNA itself can enhance the innate immune 
response via the activation of TLR-9 (Liu and Ulmer, 2005). It has also been illustrated 
that immunisation of C57BL/6 mice with CpG DNA caused activation of DCS, but not 
bone marrow DCs, to produce high levels of IL-2, which in turn promotes the migration 
of NK cells to the site of infection which, enhanced the secretion of IFN-γ, and T cell 
proliferation, and parasite growth in immunised mice (Laabs, et. al., 2009). Wu et. al., 
(2006) have reported that the activation of dermal DCs can also induce the production 
of IL-6, which in turn inhibits the accumulation of regulatory (Treg) cells at the site of 
infection.  
The outcome of many DNA vaccine studies varied since it depended on the DNA 
vector, Leishmania antigen, and the method of delivery as well as the immunisation 
schedule. For example, immunisation with the L. major GP63 gene cloned into the 
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eukaryotic expression vector pCDNAI, which has the human cytomegalovirus (CMV) 
promoter, as a DNA vaccine induced a strong Th1 response. The immunised Balb/c 
mice developed significantly smaller lesions compared to the control group (immunised 
with emptily plasmid) following L. major challenge (Xu and Liew, 1995). A similar 
finding was reported by Welker, et. al., (1989), where splenocytes from Balb/c mice 
immunised with L. major GP63 cloned into pcDNA-3 plasmid produced high levels of 
IFN-γ but not IL-4, and also proliferated in response to L. major SLA, however, only 
30% of immunised Balb/c mice were lesion free following a challenge with L. major.  
Another comparative study illustrated that intramuscular immunisation (I.M) with the 
eukaryotic expression vector pCMV3ISS encoding L. major LACK, PSA2, GP63, and 
LeIF genes as DNA vaccine, induced a significant reduction in lesion size only in mice 
immunised with pCMV3ISS-LACK. However, immunisation of Balb/c mice with 
pCMV3ISS encoding other L. major genes developed lesions very close in size to 
control mice (Ahmed, et. al., 2004), a study by Dumonteil, et. al., (2003) demonstrated 
that VR1012-GP46, VR1012-GP63 and VR1012-CPB DNA constructs partially 
protected Balb/c mice against infection with L. mexicana. 
DNA vaccines also showed promising results against VL. In a study by Melby, et. al., 
(2000) it was reported that immunisation of Balb/c mice with L. donovani cDNA library 
(extracted from the amastigote stage), cloned into pcDNA3.1 plasmid, induced a Th1 
immune response and protected against challenge with L. donovani amastigotes. 
However, immunisation of dogs with multi-antigenic plasmid DNA vaccines encoding 
L. infantum KMPII, TRYP, LACK and GP63 antigens failed to protect against 
challenges with L. infantum, which also showed no humoral or cellular immune 
responses (Rodríguez, et. al., 2007). A study by Asteal (2011) demonstrated that 
immunisation of Balb/c with pcRT7/CT-TOPO and pcDNA3.1/Hygro(-) plasmids 
encoding L. donovani centrin3 produced different immune responses, which may be 
vector dependent. 
 The current study thus first aimed to analyse this theory, and to do so the 
immunogenicity of three Leishmania genes constructed in three different plasmids         
(9 DNA constructs) was investigated. Five out of the nine Leishmania DNA constructs 
used were prepared during this study (highlighted in Table 2.2.2). The expression 
efficacy of the chosen plasmids was analysed by transfection in mammalian cells 
(Figure 3.2.7). The Leishmania genes used to prepare the DNA constructs are highly 
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conserved genes across Leishmania spp. In addition, the Leishmania GP63 gene is a 
known virulence factor in promastigote and amastigote stages, and which can be 
expressed as a secreted or membrane bound protein of the promastigote’ surface 
(Oliver, et. al, 2012). Leishmania centrins are important for parasite proliferation and 
survival inside the mammalian host and were have previously been used as potential 
vaccine candidates (Duncan, et. al., 2009, Asteal, 2011). 
One of the findings of the present study is that immunisation of Balb/c mice with              
L. mexicana GP63, L. donovani centrin1, and L. donovani centrin3 genes cloned into 
three different plasmids induced significant immune responses. In addition, the induced 
immune response using these plasmids encoding L. donovani genes following the in 
vitro stimulation with L. mexicana SLA, indicates possible cross-protection against 
Leishmania species using theses DNA constructs.  
The present work has also demonstrated that using Leishmania DNA constructs as a 
DNA vaccine model can induce different immune responses as has been measured 
using a range of different immune assays. On the other hand, the results of this study 
indicate that more differences in the plasmid immunogenicity were related to antigen 
type. For example, CTLs activity was induced in mice immunised with plasmids 
encoding the L. donovani centren3 gene compared to L. donovani centren1 and                 
L. mexicana GP63 genes. Cell proliferation results have illustrated that plasmids 
encoding L. mexicana GP63 induced a greater proliferation rate compared to plasmids 
encoding L. donovani centrin1 and L. donovani centrin3 (Figure 3.3.2). The results have 
also shown that VR1012-L.mexgp63 induced less proliferation compared to 
pcRT7/CT-TOPO and pcDNA3.1/Hygro(-) plasmids encoding the same gene. Due to 
a lack of similar comparative investigations, there was no published data against which 
to compare the results of this study.  
It has been also demonstrated in the present study that both Th1 and Th2 immune 
responses were induced, as indicated by a significant increase in IgG1 and IgG2a levels, 
respectively. This was in agreement with Rezvan (2007) using VR1012-L.mexgp63 and 
Asteal (2011), using pcRT7/CT-TOPO-Ldcen3 and pcDNA3.1/Hygro(-)-Ldcen3 in 
immunised Balb/c mice.  
The efficacy of DNA constructs used in this study to induce the Th1 and Th2 immune 
responses might be appropriate for controlling Leishmania parasites, as has been 
reported by many researchers. For example, early studies demonstrated that 
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susceptibility and resistance to L. major infection were dependent on the activation of 
Th2 or Th1 T cell subsets, as characterised by the production of IL-4, IFN-, 
respectively. However, the use of IL-4 gene deficient mice did not confirm the role of 
IL-4 in disease progression (Kopf, et. al., 1996; Noben-Trauth, et. al., 1996; Kropf, et. 
al., 2003). On the other hand, transgenic IL-12 Balb/c mice developed non-healing 
lesions following L. major challenge, despite high levels of IL-12 (Alexander and 
Bryson, 2005). These contradictory reports indicate that other regulatory cytokines may 
be involved in Leishmania parasite pathogenicity, such as IL-13 (Mohrs, et. al., 1999). 
Another study reported that IL-13 transgenic resistant C57BL/6 mice developed non-
healing lesions following L. major infection (Matthews, et. al., 2000). In addition to the 
L. mexicana LACK antigen, cysteine proteases expressed in promastigotes and 
amastigote were also found to be virulence factors (Matthews, et. al., 2004).  
It has been reported that the sensitivity of Balb/c mice to L. major infection was due to 
the expression of LACK antigen, a factor that activates IL-4 production through binding 
with vβ4Vα8 CD4+ T cells, and suppresses IL-12 production (Launois, et. al., 1995). 
Similar to that of L. major infection, IL-4 cytokine was also found to play a major role 
in non-healing lesions developed in Balb/c mice infected with L. mexicana 
promastigotes, compared to the contribution of IL-10 and IL-13 (Padigel, et. al., 2003). 
Other studies by Alexander, et. al., (1998) and Pollock, et. al., (2003) have reported 
that IL-4 was induced due to the presence of the virulence factor Cathepsin-L in mice 
infected with L. mexicana. Different scenarios of the role of the Th2 response during L. 
donovani infection using genetically modified mice have been recorded. The results 
showed that IL-4 deficient B6/129 and Balb/c mice were more susceptible to L. 
donovani infection, compared to wild types (Stäger, et. al., 2003; Stäger, et. al., 2003). 
Furthermore, cured Balb/c mice have been characterised by the presence of Th1 and 
Th2 related cytokines (Engwerda, et. al., 1998).   
The immunogenicity of the constructed plasmids was further analysed by a novel assay, 
which has been developed during the course of this study (section 3.3-6). This assay 
clearly shows that immunisation with these constructs caused dramatic effects on the 
parasite’s natural life cycle in Balb/c BM-DMs. This was characterized by the inability 
of the amastigote stage harvested from macrophages generated from immunised mice 
to transform into the promastigote stage. To the best of our knowledge, this is the first 
study designed to compare the immune response induced by immunisation with 
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different Leishmania DNA constructs encoding the same gene to evaluate the vector 
effect on the immune response. However, further investigations are required, including 
live parasite challenge experiments, to assess the efficacy of protection against live 
parasites.  
In this study, the growth characteristics of L. mexicana have been investigated, and the 
effect of in vitro culturing on L. mexicana promastigote infectivity was compared at 
different passage numbers (P1, P7 and P20).  The loss of L. mexicana virulency has 
been reported in vitro and in vivo (Chapter 4), which has been published (Ali, et. al., 
2013). 
Loss of parasite infectivity by long in vitro culture has been previously reported 
(Wozencraft and Blackwell, 1987). In this study the effect of long-term culture on 
different aspects of L. mexicana promastigote growth, such as parasite infectivity in 
vitro and in vivo and virulence associated gene expression was examined. For example, 
L. mexicana virulence associated genes (listed in table 2.2.4) were significantly down 
regulated in avirulent promastigotes, which may explain the failure of the parasite at 
passage 20 to initiate the infection in Balb/c mice, and also the failure of amastigote 
transformation in infected host cells. In addition, for the first time, the correlation 
between parasite body size and virulency loss is reported. This model of virulent 
(Passage 1), and avirulent (Passage 20) L. mexicana has been extensively investigated 
in the current study, and many differences between both types of parasite have been 
reported (Ali, et. al., 2013). 
Attenuated parasites have been produced using various methods, for example by 
irradiation, chemical mutagenesis or culturing under antibiotic pressure, and recently, 
by deleting specific genes from the parasite genome. In particular attenuation using 
dihydrofolate reductase-thymidylate synthetase (DHFR-TS), in long term survival in 
host cells (Titus, et. al., 1995; Veras, et. al., 1999). 
Early studies reported limited protection against infection with L. major and                      
L. amazonensis following immunisation of a mouse model with DHFR-TS knockout   
L. major (Titus and Veras 1995). However, these parasites failed to induce protection 
in monkeys (Amaral, 2002). Although the virulence genes knockout method has been 
widely used to produce attenuated parasites (by deleting particular genes such as 
cysteine proteinase or LPG1), these parasites were still able to induce the infection 
(Ryan, 1993; Huango and Turo 1993). In another study, LPG2 knockout L. major 
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(responsible for encoding an enzyme involved in the transport of GDP-mannose to the 
Golgi apparatus) was able to survive in Balb/c mice and provided protection against 
homologous infection (Uzonna, 2002). Unlike the protection induced by other vaccines, 
Kedzierski, and Zhu (2006) suggested the involvement of different mechanisms in 
Leishmania infection control, since the protection induced by attenuated parasites was 
not related to the Th1 response and IFN-γ production. 
It has been reported that a successful Leishmaniasis vaccine is based on a continuous 
presence of Leishmania antigens inside the host which can be achieved by vaccination 
with attenuated parasites or subunit vaccines (Paoletti and McInnes, 1999). In addition, 
that attenuated parasites can be taken up by the host cells in the same way as virulent 
parasites and persist inside them without the induction of the infection (Kedzierski, and 
Zhu, 2006). In this study, the infectivity of avirulent L. mexicana (P20) was evaluated. 
Although the percentage of infected cells with avirulent parasites was very low 
compared to infection with virulent parasites after 2 hours, 48 hours after infection 
many avirulent parasites were observed inside the target cells, indicating their ability to 
survive inside host cells. In addition, these promastigotes were unable to transform into 
the pathogenic amastigote stage. Furthermore, the growth of avirulent L. mexicana 
promastigotes was inhibited in conditioned medium derived from L. mexicana infected 
host cells illustrating the inability of these parasites to proliferate in the presence of 
secreted material from infected target cells. These findings indicate poor infectivity of 
avirulent (P20) compared to virulent L. mexicana (P1). Since, the results also show the 
down regulation of virulent genes, which contribute to parasite pathogenicity, avirulent 
parasites produced in this study, might be a good attenuated vaccine candidate as a 
model against Leishmania parasite infection. 
It has been reported that the number of parasites per ml can define the stationary phase 
of Leishmania growth curve. This number was considered to be above 2.5x107 
depending on Leishmania species, type of medium and growth conditions (Fritsche, et. 
al., 2007).  The results of this study have demonstrated that L. mexicana promastigote 
numbers (cultured in Drosophila Schneider medium supplemented with 10% v/v 
HIFCS at 25ºC) dramatically decreased after reaching a concentration of 6x107 per ml. 
There was no recognised stationary phase, which was in agreement with Fritsche et. 
al., (2007). The decreased number of Leishmania promastigotes is due to the depletion 
of nutrients, the increase of waste metabolites, and presence or absence of oxygen 
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(Iqbal, et. al., 2006; Fritsche, et. al., 2007). The L. mexicana growth conditions used in 
this study gave no stationary phase compared to their growth in the presence of O2, 
where the stationary phase can be seen in the growth curve (Appendix 14). As a result, 
the stationary phase in this study was referred to as the late log phase which has the 
same properties as the stationary phase (Figure 5.2.5, A, B, C). 
The virulency of the parasite following growth in two different conditions was 
compared and the results clearly show that growth was better in the absence of O2 which 
was associated with high expression of virulence associated genes, compared to  
parasite grown in the presence of O2 (Appendix 15). 
Investigations carried out in the current study also extended to address the effect of 
mouse host living conditions on the virulency of the parasites. It is reported here that 
the virulency of L. mexicana promastigotes (measured by expression of virulence 
associated genes by qPCR), which was generated in mice living in a Barrier Unit (under 
completely sterile conditions), was significantly less compared to L. mexicana 
generated in mice kept in a conventional unit, where the mice are exposed to normal 
(non-sterile) conditions (Appendix 12).  
Although a lot is known about the interaction of the host with Leishmania parasites, 
most of the available data are obtained from murine models, and there is still a lack of 
research assessing human-specific responses to Leishmania infection (Stockdale and 
Newton, 2013). In this study, three human cell lines: U937 monocytes, U937 
macrophages, and MonoMac-6 monocyte, were used as host cells to investigate their 
interaction with virulent and avirulent L. mexicana promastigotes. Intracellular 
pathogens such as the Leishmania parasite can subvert the host’s immune responses 
using various mechanisms, one of which is the down regulation of MHC class I. This 
phenomenon was investigated in the current study, using both virulent and avirulent L. 
mexicana promastigotes (Chapter 5). 
Presentation of the parasite antigens by MHC class I is essential for the recognition and 
killing of infected cells by CD8+ T cells (Lieberman, 2003). Down regulation of MHC 
class I molecules keeps infected cells undetectable by effector cells which may help the 
parasites to survive and successfully differentiate into the more resistant intracellular 
amastigote stage (Hansen and Bouvier, 2009).  
This study has focused on the effect of infection with L. mexicana promastigotes taken 
at different growth stages in vitro on the expression of MHC class I, using susceptible 
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human cell lines. The infectivity of L. mexicana promastigotes varies from phase to 
phase during its cell cycle, and the growth stages.  
Interestingly, infection of target cells with the more infectious mid log or late log stages 
of L. mexicana promastigotes has significantly less effect on MHC class I expression 
compared to the less infectious early log stage, using a ratio of infection 1:10 (cell: 
parasites). In addition, no differences between virulent and avirulent                                       
L. mexicana promastigotes on MHC class I expression were noted in either cell lines 
used in this study. It is well documented that, during their growth cycle Leishmania 
promastigotes go through a series of maturation steps, including differences in 
morphology and motility (Wozencraft and Blackwell 1987). Investigations on the 
infectivity of L. mexicana promastigote during the less effective early log stage 
compared to late log growth stage revealed that the parasite infectivity was greater in 
the late log phase. Therefore, the parasites during the late log phase were considered as 
metacyclic promastigotes for further investigation. Infection of the host cells with a 
ratio of 1: 20 (cell: parasites) significantly down regulated MHC class I expression 
following infection with both virulent and avirulent parasites. 
Although these findings suggest that MHC class I expression was infection-dose 
dependent, however, the expression of MHC class I was restored following the 
treatment of infected cells with an anti-parasite agent (Fungizone). This was in 
agreement with an early study by Wolfram, et. al., (1995) who demonstrated that 
infected BM-DMs efficiently presented L. mexicana antigen when the infected cells 
were treated with L-leucine methylester which caused parasite killing and degradation, 
so T cells were strongly stimulated.  
Intracellular pathogens such as viruses have developed various mechanisms to establish 
the infection, such as interference with biosynthesis, assembly, transportation, 
localization and down regulation of MHC class II and MHC class I (Yewdel and Hill, 
2002; Peterlin and Trono, 2003). Since Leishmania parasites are also intracellular 
pathogens, they are likely to follow the same strategies as viruses in order to evade 
immune system defences. In addition to the direct effect of down regulation of MHC 
class I or class II expression on the interaction of T cells with APCs, there is an 
inhibition effect on leishmanicidal cytokines (Green, et. al., 1990; Kaye, 1995). This 
emphasised the importance of antigen presentation in the control of parasite infection, 
and so a number of studies investigated the presentation of Leishmania antigen. 
7/ General Discussion 
 
229 
 
However, the results from these studies were mostly conflicting and difficult to 
interpret. 
For example, specific CD8+ T cells specifically proliferated in a response to antigens 
presented via MHC class I molecules following infection with L. amazonensis (Kima, 
et. al., 1997). In contrast, a study by Wolfram, et. al., (1995) demonstrated that  infected 
bone marrow-derived macrophages failed to stimulate the proliferation of specific T 
helper 1 (Th1) cell line which had been generated against L. mexicana cysteine 
proteinases, when they were induced to express MHC class II by interferon IFN-γ, and 
that there was no effect on parasite viability.  A study reported that antigen presentation 
by Balb/c BM-DMs infected with L. donovani has a limited effect on T cell response 
(Meier, et. al., 2003).  Consequently, in the current study, different aspects have been 
considered, such as the effect of passage number, L. mexicana growth stages, and 
infection doses on MHC class I expression, which can cause considerable variation in 
the obtained results. 
Parasitophorous vacuoles are important for the parasites. In these, the parasites can 
create their own environment and cover themselves with endoplasmic membrane within 
a closed vesicle that is advantageous to transformation of the susceptible promastigote 
stage to the more resistant amastigote stage (Gregory, et. al., 2008). One possible 
explanation for losing infectivity of avirulent L. mexicana might be due to the failure 
of promastigotes to produce the PV, which ultimately leads to their failure to 
differentiate into the amastigote stage (Ali, et. al., 2013). In addition, qPCR results in 
this study showed the absence of phagosome maturation (Rab7 and Rab9) in target cells 
infected with virulent L. mexicana promastigotes, whereas these markers were highly 
expressed in cells infected with avirulent parasites.  
To evaluate the modulation induced by L. mexicana or their antigens on innate and 
adaptive immune responses, susceptible human cell lines were infected with virulent 
and avirulent parasites, or stimulated with parasite antigens extracted from virulent and 
avirulent parasites, and the gene expression profile of some TLRs, CCLs, and ILs were 
investigated (Chapter 6). 
Many studies have reported the important of the understanding the early events of 
immune response to the parasite infection in order to control Leishmaniasis (Teixeira, 
et. al., 2006; Tuon, et. al., 2008; Gallego, et. al., 2011). The early immune response to 
foreign antigens involves recognition by TLRs, this will trigger the release of 
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chemokines, cytokines and recruitment of other cell types to the infection site. These 
three key elements (TLRs, CCLs, and ILs) have mechanisms in place to regulate each 
other (reviewed by Teixeira, et. al., 2006).  Although there is a general agreement that 
the Th1 immune response is associated with L. major infection control, and Th2 is 
associated with disease progression in susceptible Balb/c mice, other work has also 
reported the role of both types of immune response in L. donovani infection (Palatnik, 
et. al., 2008). Interestingly, the immune response can also contribute to disease 
progression (Gonzalez, et. al., 2013). For example in CL, where the parasites are 
localized in skin macrophages, the inflammatory response can also help parasite 
survival in infected cells (Terabe, et. al., 2000). This confirms the fact that Leishmania-
host cell interaction is poorly understood. Therefore, a comprehensive understanding 
of the possible pathways that the parasite follows during the infection, and the 
regulatory mechanisms of the immune system is essential, not only for vaccine 
development, but also for the development of Leishmania immunotherapy. 
To develop a model which enables understanding of the interaction network and 
possible immune response induced by parasite infection, susceptible human cell lines 
(U937 monocytes, U937 macrophages, MonoMac-6 monocytes) were infected with 
virulent and avirulent L. mexicana or stimulated with their antigens for 24 hours, 
followed by RNA extraction and cDNA synthesis. The same products were used to 
analyse the expression profile of TLRs, CCLs, and ILs, and to the best of our 
knowledge, no similar approaches have been reported so far to investigate host cell-
parasite interaction. In addition, using virulent and avirulent L. mexicana promastigotes 
or their antigens (SLA) to infect or stimulate the target cells, would help to understand: 
I) How the virulent parasites evade the immune response. 
II) How the immune response controls infection through the response of target 
cells to avirulent parasite. 
III) How parasite antigens stimulate immunity. 
The parasite antigens have a similar pattern of effects on TLRs, which reflect the fact 
that these parasites after 24 hours of infection can suppress the role of TLRs, which in 
turn inhibits the activation of other immune response mechanisms. More importantly, 
different time points should also be considered since parasites have different impacts 
on target cells. For example TLR-1, TLR-2, and TLR-9 were down regulated 24 hours 
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after infection with the virulent parasite but first significantly up regulated 2 hours post 
infection with the same parasites (data nor shown). 
Generally, these results are in agreement with other findings.  For example, it has been 
reported by Chandra and Naik (2008) that infection of THP-1 monocytes, and 
monocytes derived from human peripheral blood with L. donovani, caused down 
regulation gene expression profile  of TLR-2  (which was down regulated by virulent 
infection in this study) and led to IL-10 production. Another study has demonstrated 
that infection of susceptible Balb/c mice with L. donovani caused down regulation of 
TLR-2, which in turn suppressed the production of IL-12 (Bhattacharya, et. al., 2010). 
Pro-inflammatory cytokines such as IL-1, IL-6 were up regulated as a result of avirulent 
infection, and published data by Ali et. al., (2013) showed IL-1 was highly expressed 
after 2 hours infection with virulent parasites, compared to infection with avirulent 
parasites. 
The scenario followed by virulent parasite can be explained as follows: 
When L. mexicana first interacts with host cells, they activate their immune 
mechanisms, which causes recruitment of many cells to the site of infection, which 
allows the parasite to enter and infect as many as possible. In 24 hours, once the 
parasites are inside the host cells and transformed into the more resistant stage 
(amastigotes), they suppress the immune responses. 
Activation and suppression of tested TLRs, ILs, and CCLs in infected human cell lines 
infected with virulent and avirulent L. mexicana promastigotes for 24 hours, or 
stimulation with their antigens, were complex and depend on the state of the cell type, 
the parasite virulence status, and the time point at which events were measured. These 
findings have addressed an important fact, which is the diversity and complexity of the 
immune response to Leishmania parasites and it may one of reasons behind a failure to 
develop an effective vaccine to Leishmania parasites. 
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7.2 Future work 
The data presented in this study have addressed some aspects of Leishmania DNA 
vaccines and interaction of L. mexicana promastigotes with host cells. Further studies 
are required to address the many questions generated: 
1) The data presented demonstrates the ability of Leishmania DNA constructs to 
stimulate both Th1 and Th2 immunity, along with high levels of IFNgamma 
secretion and splenocyte proliferation in immunised Balb/c mice. The ability of 
these constructs to protect in vivo against challenges with live L. mexicana needs 
further investigation. 
2) Since results of this study have demonstrated the immunogenicity of                      
L. mexicana GP63, L. donovani centrin1 and centrin3 genes individually, it 
would be useful to sub clone them in one plasmid, and then test their 
immunogenicity.  
3) More investigations are required to evaluate the interesting findings of the 
survival assay, such as inoculation of Balb/c mice with amastigotes obtained 
from immunised mice, and monitoring their ability to induce infection.  
4) This study has shown the inability of avirulent L. mexicana promastigotes to 
induce infection. Therefore, these parasites or other attenuated species (using 
the same methods) might be promising Leishmaniasis vaccine candidates. 
5) Results also have demonstrated the presence of growth factors that enhance or 
inhibit the growth of virulent and avirulent L. mexicana. Secreted by infected 
host cells, the content of these growth factors needs to be identified using mass 
spectrometry.  
6) The contradictory findings related to MHC class I expression following parasite 
infection were evaluated and controlled in this study, so the effect of other 
Leishmania species on MHC class I expression needs to be investigated and 
compared. 
7) Further understanding of the role of TLRs, ILs, and CCLs in Leishmania 
parasite-host cell interaction mechanisms is required. This would show which 
changes in the immune regulatory mechanism are responsible for allowing 
promastigotes to interact with and enter the host cells, (short time infection), 
and which of them are required for  amastigote maintenance and proliferation 
(long time infection). In addition, these molecular changes need to be confirmed 
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at protein levels by flow cytometry analysis and immunofluorescence staining, 
this will illustrate if there is a direct relationship between gene expression and 
protein secretion in response to  Leishmania infection. 
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Appendix 1- The alignment of sequenced L. mexicana gp63 gene 
Sequence alignment of the region of L. mexicana gp63 gene that was sequenced using primer 1 
and 2 (Table 2.2.4). Sequence 1 is the standard L. mexicana gp63 gene, and Sequence 2 
corresponds to Source BioScience results.  
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Appendix 2- The alignment of sequenced L. donovani centrin1 gene 
Sequence alignment of the region of L. donovani centrin1 gene that was sequenced using primer 5 
(Table 2.2.2). Sequence 1 is the standard L. donovani centrin1 gene, sequence 2 corresponds to the 
sequence produced by MWG-Biotech.  
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Appendix 3- The alignment of sequenced L. donovani centrin3 gene 
Sequence alignment of the region of L. donovani centrin3 gene that was sequenced using primer 3 
(Table 2.2.2). Sequence 1 corresponds to the sequence produced by MWG-Biotech. Sequence 2 is 
the standard L. donovani centrin3 gene.  
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Appendix 4- Scheme illustrated the lymph nodes (marked red square) which were collected 
from control and immunised mice.  
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Appendix 5- Standard curves of BSA used to determine SLA concentrations.  
A standard curve was produced for each experiment 
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Appendix 6- Standard curve used to determine the level of IFN-γ 
 (Standard curve was performed to each plate)  
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Appendix 7- cytokines secreted from splenocytes of immunised mice 
Splenocytes from controls and immunised mice were cultured at a concentration of one million 
cells per ml in 24 well plates and stimulated with L. mexicana SLA. Plates were incubated at 37C, 
and supernatants were collected at 8 hours, 24 hours, 3 days, and 5 days. The level of secreted 
cytokines was measured using ELISA method according to the manufacturer’s protocol. Results 
showed there was no differences in the cytokine production when the cells from control and 
immunised mice were cultured in the presence or absence of SLA.   
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Appendix 8- Nitrite Standard reference curves which used to evaluated the NO 
concentration 
To evaluate the NO concentration in the serum of infected cells, a standard curve was performed 
for each experiment according to the manufacture’s protocol as described in the material a 
method section 
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Appendix 9- Quality of RNA analysis using agarose gel 
 3ul of extracted RNA (A from human cell lines, B from L. mexicana promastigotes) was run into 
1.5% agarose gel in one X TAE buffer for 50 munities at voltage 80. The upper band is 28S, and 
the lower band is 18S 
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Appendix 10- Quantity analysis of RNA from human cell lines using the Nano-Drop 
spectrophotometer.  
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Appendix 11- Quantity analysis of RNA from L. mexicana promastigotes using the Nano-
Drop spectrophotometer  
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Appendix 12- The differences in associated gene expression profile in L. mexicana generated 
by passaging in Balb/c mice in Conventional unit and Barrier unit.  
P<0.05 a using Mann–Whitney U test. 
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Appendix 13- L. mexicana promastigote growth curve span in high concentration 
L. mexicana were cultured in  Schneider media supplemented with 10% HFCS at 25°C. The graph 
was prepared by daily counting of parasite cultures which started at a concentration of 1x106 
promastigotes per ml. The graph illustrate that the growth curve only last 8 days when the cultures 
were started with high parasite concentrations. 
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Appendix 14- Effect of oxygen on the parasites growth carves 
Virulent and avirulent L. mexicana were cultured with and without oxygen at a concentration of 
5x105 promastigotes per ml in Schneider media supplemented with 10% HFCS at 25°C. 10µl of 
each culture was fixed and counted daily using a Neubauer Hemocytometer. (A) virulent, (B) 
avirulent. The graphs represent the average of three independent experiments, which clearly shows 
that the stationary phase can be produced if the parasites growing in the presence of O2. However, 
there is no stationary phase, when the parasites were growing without O2. Each excrement consist 
of three cultures. Data are mean ± SE.   
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Appendix 15- Effect of oxygen on the expression of virulence associated genes 
RNA was extracted from the late log stage of virulent L. mexicana promastigotes growing in the 
presence and absence of oxygen. RNA was converted into CDN which was used as a DNA template 
for qPCR analysis. The results showed target genes were expressed more when the parasites were 
growing without oxygen. P<0.05 using Mann–Whitney U test 
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Appendix 16- virulent and avirulent L. mexicana promastigotes 
 
